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* Short version, see Chapter 6 for detailed Summary V
Abstract* 
 
In this doctoral thesis, iodotrimethylplatinum(IV) complexes of different pyridine and 
2,2´-bipyridine ligands are investigated. The crystal structures of both the mononuclear and 
dinuclear pyridine complexes reveal an octahedral coordination around the platinum(IV) and 
a facial arrangement of the methyl groups. The crystal structure of the dinuclear complexes 
confirms that the iodide ligand acts as a bridging ligand that holds the two platinum metal 
ions together. 
 
The reaction of the mononuclear pyridine complexes with iodotrimethylplatinum(IV) in 
chloroform results in the formation of the corresponding dinuclear complexes (both cis and 
trans isomers) of pyridines. Although the pyridine substituents have no significant influence 
on the crystal structures of either the mononuclear or the dinuclear complexes, the equilibrium 
population of these complexes in solution depends largely on the electronic effect of the 
pyridine substituent as well as on the steric bulk of the pyridine substituent.  
 
Iodotrimethylplatinum(IV) on treatment with 2,2´-bipyridine and its derivatives gives mono-
nuclear 2,2´-bipyridine complexes. The crystal structure of the bipyridine complexes confirms 
the fac-octahedral coordination of the trimethylplatinum moiety and the bidentate 
coordination of the 2,2´-bipyridines. Bond length comparison shows that Pt-N bond distances 
in bipyridine complexes are slightly shorter than in the corresponding pyridine complexes, 
reflecting the better π-acceptor character of the 2,2´-bipyridines. In addition, the N-Pt-N bite 
angle in the bipyridine complexes is much lower than in the pyridine complexes. It was also 
observed that in the crystal packing of 4,4´-Dichloro-2,2´-bipyridine complex of 
iodotrimethylplatinum(IV), intermolecular non-covalent interaction between methyl hydrogen 
and chlorine atom leads to the formation of zig-zag chain structures, which are  linked through 
weak π-π interactions to form two-dimensional layer structure. 
 
The reaction of iodotrimethylplatinum(IV) complexes of pyridines with the corresponding 
2,2´-bipyridines lead to the substitution of ligands resulting in the formation of chelate 
bipyridine complexes. The equilibrium for these substitution reactions strongly favours the 
formation of chelate products. The formation of chelate complexes in solution at equilibrium 
depends largely on the electronic effect of the substituent as well as on the nature of the 
solvent. 
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* Kurzfassung, eine detaillierte Zusammenfassung finden Sie in Kapitel 7 VI
Abstract (in German Language)* 
 
In dieser Arbeit wurden Iodidotrimethylplatin(IV)-Komplexe mit verschiedenen Pyridin- und 
2,2´-Bipyridin-Liganden untersucht. Die Kristallstrukturen von sowohl mononuklearen und 
dinuklearen Pyridin-Komplexen zeigen eine oktaedrische Koordination des Platin(IV) und 
eine faciale Anordnung der Methylgruppen. Die Kristallstrukturen von dinuklearen 
Komplexen bestätigen, dass der Iodid-Ligand als verbrückender Ligand, der zwei Platin-
Ionen zusammenhält, dient. 
 
Die Reaktion von mononuklearen Pyridin Komplexen mit Iodidotrimethylplatin(IV) in 
Chloroform resultiert in der Bildung des entsprechenden dinuklearen Pyridinkomplexes 
(sowohl cis- als auch trans-Isomer). Obwohl die Pyridinsubstituenten keinen signifikanten 
Einfluss auf die Kristallstruktur sowohl von mononuklearen als auch von dinuklearen 
Komplexen haben, hängt das Gleichgewichtsverhältnis beider Spezies in Lösung zu einem 
großen Teil von den elektronischen Einflüssen der Substituenten, sowie deren sterischem 
Anspruch ab. 
 
Die Reaktion von Iodidotrimethylplatin(IV) mit 2,2´-Bipyridin und dessen Derivaten erzeugt 
mononukleare 2,2´-Bipyridin-Komplexe. Die Kristallstrukturen der Bipyridin-Komplexe 
bestätigen die fac-oktaedrische Koordination des Trimethylplatin-Rests und die bidentale 
Koordination der 2,2´-Bipyridine. Ein Vergleich der Bindungslängen zeigt, dass der Pt-N 
Bindungsabstand in Bipyridin-Komplexen leicht kürzer ist als in den entsprechenden Pyridin-
Komplexen, was die besseren π-Akzeptor Eigenschaften von 2,2´-Bipyridinen zeigt. Des 
Weiteren ist der N-Pt-N Winkel in Bipyridin-Komplexen wesentlich kleiner als in Pyridin-
Komplexen. Zudem wurden in der Kristallpackung des 4,4´-Dichlorido-2,2´-bipyridin-
Komplexes von Iodidotrimethylplatin(IV) intermolekulare, nicht kovalente 
Wechselwirkungen zwischen den Methyl-Wasserstoffatomen und den Chloratomen 
festgestellt, die zu der Ausbildung von kettenartigen Zick-Zack-Strukturen führen, die über 
schwache π-π-Wechselwirkungen verbunden sind und eine zweidimensionale Schichtstruktur 
erzeugen. 
 
Die Reaktion von Iodidotrimethylplatin(IV)-Pyridinkomplexen mit den entsprechenden 2,2´-
Bipyridinen führt zu einer Substitution der Liganden, die in der Bildung von Chelat-
Bipyridin-Komplexen resultiert. Im Gleichgewicht ist die Bildung des Chelatprodukts bei 
dieser Substitutionsreaktion stark bevorzugt. Die Bildung von Chelat-Komplexen in Lösung 
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  VII
hängt im Gleichgewicht zu einem großen Teil von den elektronischen Effekten der 
Substituenten sowie von der Natur des Lösungsmittels ab. 
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1 Introduction 
 
1.1 The Element Platinum 
 
Platinum is a chemical element with the symbol Pt and is classified as a ‘‘Transition Metal’’. 
The atomic number of platinum is 78 and the electron configuration is [Xe] 4f14 5d9 6s1. The 
name platinum originates from the Spanish word platina del Pinto, meaning ‘‘little silver of 
the Pinto River’’.[1] Platinum is an extremely rare metal, occurring at a concentration of only 
0.005 ppm in the Earth´s crust. It occurs in native form, accompanied by small amounts of 
other metals belonging to the same group (osmium, iridium, ruthenium, palladium, and 
rhodium). Another source of platinum is sperrylite (PtAs2).[2] Platinum is a beautiful silvery-
white metal, when pure, and is malleable and ductile. Platinum has six naturally occurring 
isotopes: 190Pt, 192Pt, 194Pt, 195Pt, 196Pt, and 198Pt. The most abundant of these is 195Pt, 
comprising 33.83% of all platinum and it is the only stable isotope with a non-zero spin 
(I = ½). The most common oxidation states of platinum are +2 and +4. The +1 and +3 
oxidation states are less common, and often stabilized by metal bonding in bimetallic (or 
polymetallic) species. The predominant geometry for +2 oxidation state is square planar, 
while for the +4 oxidation state it is octahedral.[3,4] 
 
Platinum is generally unreactive and is remarkably resistant to corrosion, even at high 
temperatures, and thus is considered a noble metal. It is insoluble in hydrochloric acid and in 
nitric acid but dissolves in aqua regia to form hexachloroplatinic acid, H2PtCl6.[5] 
 
Platinum is used in a variety of different applications, the largest amount being used in the car 
industry. It is also used in electronics, laboratory equipment, spark plugs, turbine engines and 
oxygen sensors.[6] Another common use of platinum is as a catalyst for chemical reactions 
such as the decomposition of hydrogen peroxide into water and oxygen gas,[7] ignition of 
hydrogen. As a precious metal, large amounts of platinum are also consumed in jewellery. 
Being a heavy metal, it leads to health issues upon exposure to its salts, but due to its 
corrosion resistance, it is not toxic as a metal. 
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1.2 The Platinum(II) Chemistry 
 
One of the most important platinum(II) complexes, cis-[Pt(NH3)2Cl2] (cis-platin) was 
described by Michele Peyrone (known as Peyrone´s chloride).[8] It is a chemotherapy drug as 
shown by Rosenberg et al.[9] and is used to treat various types of cancers, including small cell 
lung cancer, ovarian cancer and germ cell tumours. It was the first member of a class of 
platinum-containing anti-cancer drugs. Along with cis-platin, carboplatin[10] and oxaliplatin[11] 
are also used as chemotherapy drugs. 
 
Pt
H3N Cl
ClH3N
Cis-platin: cis-diamminedichloroplatinum(II)
Pt
H3N O
OH3N
O
O
Carboplatin: cis-diammine(1,1-
cyclobutanedicarboxylato)platinum(II)
Pt
O
H2
N
ON
H2
O
O
Oxaliplatin: [(1R,2R)-cyclohexane-1,2-diamine]dicarboxylatoplatinum(II)
 
 
Scheme 1.1 Platinum(II) compounds exhibit anti-cancer activity. 
 
 
Platinum(II) complexes also play a catalytic role in synthesizing different organic compounds 
from the hydrocarbon. Periana et al.[12] reported the direct, low temperature, oxidative 
conversion of methane to methanol in the presence of concentrated sulfuric acid catalyzed by 
(2,2´-bipyrimidine)platinum(II), [Pt(bpym)Cl2] at greater than 70% one-pass yield with 81% 
selectivity. Johansson et al.[13] also reported the benzene and methane C-H activation under 
mild and neutral conditions in hydroxylic solvent, 2,2,2-trifluoroethanol (TFE) at a cationic 
platinum(II) diimine aqua complex.  
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Scheme 1.2 Proposed mechanism for the oxidation of methane to methanol.[12,14b] 
 
 
 
1.3 The Platinum(IV) Chemistry 
 
Like platinum(II) chemistry, platinum(IV) chemistry has attracted tremendous attention over 
the last few decades due to their involvement in the Shilov Process.[14,15] It was shown 
experimentally that five-coordinated unsaturated platinum(IV) complexes are involved as key 
intermediates in the platinum(IV)/platinum(II)-mediated C-X (X = H, halide, OR, etc.) bond-
breaking or -making processes.[15-20]  
 
Pt
I
L Me
Me
MeL
-L
fast
Pt
I
L Me
Me
Me
slow
Pt
I
Me
L
Me
Me
L
C2H6
Pt
I
Me
L L
 
 
Scheme 1.3 Mechanism for the reductive elimination of ethane from [PtMe3L2I] (L = tertiary phosphane 
ligand).[15a,15c] 
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These five-coordinated unsaturated cationic platinum(IV) complexes can be isolated when 
bulky anionic or neutral N,N-chelating ligands[19-21] are attached to the platinum(IV) metal ion 
which provides enough steric protection to the vacant platinum(IV) coordination site.  
 
N
HC
N
Pri
iPr
iPr
Pri
N
N
Pri
iPr
iPr
Pri
N
NBu
t
tBu
N
N
N
N
I II III
IV
 
 
Scheme 1.4 Bulky anionic N,N-chelating ligands (I-III) and neutral N,N-chelating ligand (IV) which stabilize 
five-coordinate platinum(IV) species. 
 
          
 
Figure 1.1 Crystal structures of [{(o-iPr2C6H3)NC(CH3)}2CH]PtMe3 (left);[19c] (BAB)PtMe3 [BAB = 1,2-bis(N-
7-azaindolyl)benzene] (right).[21] 
 
Platinum(IV) chemistry also has some applications in biology. Like platinum(II) complexes 
such as cis-platin, carboplatin, oxaliplatin, platinum(IV) complexes such as CHIP [cis-
dichloro-trans-dihydroxy-bis-isopropylamineplatinum(IV)], JM216 [cis-dichloro-trans-
diacetato-ammine-cyclohexylamineplatinum(IV)],  cis-1,4-diaminocyclohexane complexes 
of platinum(IV) have been a subject of several clinical trials for cancer treatment.[22-26]  
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The first organic compound of platinum, iodotrimethylplatinum(IV), was prepared by Pope 
and Peachy by the reaction of anhydrous platinum tetrachloride with methyl magnesium 
iodide in 1909.[27] Later in 1975, Baldwin et al. developed the synthetic route of this 
compound.[28] X-ray investigations[29-31] have shown that in iodotrimethylplatinum(IV) four 
platinum atoms describe a tetrahedron, as do the four iodine atoms, and the two tetrahedra are 
interpenetrating so as to give a heterocubane structure of platinum and iodine atoms. Each 
platinum atom is hexa-coordinated by the three terminal methyl groups and three bridged 
iodine atoms (Figure 1.2). It is soluble in most non-polar solvents and essentially insoluble 
in polar media such as water and acetone. The related trimethylplatinum(IV) derivatives 
[PtMe3X]4 (where X = chlorine,[32] bromine,[33] SCH3,[29] SCN,[34] azide,[35] triflate[36]) also 
form heterocubane structures where Pt and X atoms occupy alternate corners of slightly 
distorted cubes. 
 
 
 
Figure 1.2 Molecular structure of iodotrimethylplatinum(IV).[29] 
 
The trimethylplatinum(IV) cation, PtMe3+ is highly versatile and forms wide variety of 
complexes with both neutral and anionic ligands. Schlecht et al.[36] showed that tetranuclear 
trimethylplatinum(IV) triflate converts to trinuclear, dinuclear and mononuclear complexes by 
treatment with various bases (Scheme 1.5). Tetranuclear iodotrimethylplatinum also converts 
to corresponding mononuclear and dinuclear complexes depending on the coordination nature 
and amount of nitrogen ligand (Scheme 1.6). 
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[PtMe3(OSO2CF3)]4
PMDTA
TMEDA
THF
Ag(OSO2CF3)
toluene
[(PtMe3)2Ag(OSO2CF3)3(toluene)2]
[PtMe3(OSO2CF3)(THF)]2
[PtMe3(OSO2CF3)(TMEDA)]
[PtMe3(PMDTA)]+OSO2CF3-
(trinuclear complex)
(dinuclear complex)
(mononuclear complex)
(mononuclear complex)
 
 
Scheme 1.5 Effect of different bases on trimethylplatinum(IV) triflate complex. TMEDA = N,N,N´,N´-
tetramethylethylenediamine, PMDTA = N,N,N´,N´´,N´´-pentamethyldiethylenetriamine).[36] 
 
 
[PtMe3I]4
excess en
1 equivalent bipy
1 equivalent py
excess py [PtMe3(py)2I]
[PtMe3(py)I]2
[PtMe3(bipy)I]
[(PtMe3I)2(en)3]
(mononuclear complex)
(mononuclear complex)
(dinuclear complex)
(dinuclear complex)
 
 
Scheme 1.6 Effect of nitrogen ligands on iodotrimethylplatinum(IV) complex. py = pyridine, bipy = 2,2´-
bipyridine, en = ethylenediamine.[37-39] 
 
 
Many of the trimethylplatinum(IV) complexes containing neutral chelating nitrogen donor 
ligands such as 2,6-bis[1-(phenylimino)ethyl]pyridine (BIP),[40] TMEDA[41] exhibit dynamic 
behaviour in solution. Also trimethylplatinum(IV) complexes of organochalcogen ligands 
such as thio and seleno ethers,[42-45] anionic nitrogen/oxygen or oxygen/oxygen ligands[46-49] 
have been a subject of dynamic investigation because of their fluxional behaviour in solution. 
 
 
 
Scheme 1.7 The fluxional behaviour of [PtMe3(TMEDA)OTf] (OTf = OSO2CF3).[41] 
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Scheme 1.8 The fluxional behaviour of [PtMe3(ppdm)(H2O)] where ppdm = 1-phenylpropane-1,2-dione 2-
oximate.[47] 
 
It was also shown that some trimethylplatinum(IV) complexes containing pyridazine and its 
derivatives such as 4-methylpyridazine and 3-methylpyridazine display a 1,2-metallotropic 
shift in the solution phase due to the presence of a contiguous pair of nitrogen atoms in the 
pyridazine ligands.[50-52] 
 
 
Scheme 1.9 Effect of 1,2-metallotropic shift in [PtMe3(pydz)2X] (where X = Cl, Br, I; pydz = pyridazine) 
complexes.[51]   
 
 
1.4 The Chelate Effect 
 
When a multidentate ligand coordinates to a metal ion from more than one donor site forming 
a ring with the metal, it is said to be a chelating ligand and the resulting compound is said to 
be a chelate complex. Chelate complexes are usually found to be more stable than the 
comparable non-chelate complexes with the same donor atoms. This extra stability of a 
coordination complex containing chelate rings is known as ‘‘the chelate effect’’. Scheme 1.10 
illustrates the example of a chelate complex of Mg2+. 
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Scheme 1.10 [Mg(EDTA)]2- chelate complex. 
 
The increased stability of the chelate complexes can be explained by the thermodynamic 
approach. The equilibrium constant, Keq for a chemical reaction is related to the standard 
Gibbs free energy (∆G°) according to equation 1.1. 
 
∆G° = - RT ln Keq                                                       (1.1)                                             
 
Here, R is the universal gas constant and T is the temperature in Kelvin.  
 
For chelation reaction Keq is usually positive, i.e., ∆G° = negative. 
 
Now, ∆G° is related to ∆H° and ∆S° according to equation 1.2. 
 
     ∆G° = ∆H° - T∆S°      (1.2) 
 
Here, ∆H° is the standard enthalpy change of the reaction; ∆S° is the standard entropy change. 
 
Now, consider the following chelation reaction: 
 
Cd(NH3)42+  +   2 en Cd(en)22+  +  4 NH3  (1.3)                           
     
Since the bonding characteristics of ammonia and ethylenediamine (en) are very similar, the 
change in enthalpy for the above reaction is negligible. However, positive entropy changes for 
the forward reaction make the reaction thermodynamically favourable, which explains the 
stability of the chelate complex. This is supported by Spike et al.[53] (who showed 
experimentally that the enthalpy change for the above chelation reaction is very small and the 
increase in the stability of the cadmium chelates is purely an entropy factor).  
Mg2+
O
O N
O
NO
CH2
CH2
CH2CH2
CH2CH2
O
O
O
O
2-
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1.5 Nuclear Magnetic Resonance (NMR) Spectroscopy 
 
Nuclear Magnetic Resonance (NMR) spectroscopy is an extremely important technique used 
to determine the content and purity of a sample as well as the molecular structure of the 
compounds. NMR spectroscopy is based on the principle of energy difference between the 
two states. The two states of a nucleus with a nuclear spin quantum number of ½ [commonly 
named as α (the lower energy state) and β (the higher energy state)], and hence the energy 
difference, are generated in the presence of an external magnetic field (Bo) by the magnetic 
moment of the electrically charged atomic nucleus (for example, 1H, 13C, 15N, etc.). Thus, an 
energy transfer takes place between the two states at a wavelength that corresponds to radio 
frequency. The signal that matches this transfer is measured and processed in order to yield an 
NMR spectrum for the nucleus concerned. 
 
 
 
 
Figure 1.3 The basis of NMR in the case of spin ½ nuclei such as 1H, 13C, 15N, 31P, 195Pt, etc.[54] 
 
The energy difference (∆E) between the two states is  
 
∆E = γħBo                             (1.4) 
 
Where γ is the gyromagnetic ratio for a given nucleus and ħ is the reduced Planck´s constant. 
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The relative population of a state is given by the Boltzmann distribution: 
 
    Nβ/Nα = e - ∆E/kT= e - γħBo/kT ≈ 1- γħBo/kT                                        (1.5)  
 
Where Nβ, Nα represents the number of nuclei in the β and α states, respectively; k is the 
Boltzmann constant and T is the temperature in Kelvin. The equation (1.5) shows that the 
population of the states is affected by several factors. Nuclei that have large gyromagnetic 
ratio are more sensitive than nuclei with lower gyromagnetic ratio. Proton has the largest 
gyromagnetic ratio among the naturally abundant nuclei, and thus, is the most sensitive 
nucleus. The sensitivity can also be increased by decreasing the temperature or by increasing 
the magnetic field. 
 
Each nucleus in a molecule has different molecular surroundings, and thus, different 
electronic environments. Electrons around the nucleus shield it from the external magnetic 
field, and thus their resonance frequencies will be different. The resonant frequency is 
strongly dependent on the electronegativity of the nucleus. The ring current (anisotropy) and 
bond strain also affect the frequency shift. The difference between the frequency of the 
reference signal and the frequency of the signal is divided by the frequency of the reference 
signal to give the chemical shift. In 1H NMR spectroscopy, chemical shifts are usually 
referenced to TMS (tetramethylsilane), whose chemical shift is set to zero ppm. 
 
The energy state of a nucleus is also affected by the orientation of the neighbouring nuclei. In 
such cases, the nuclei are said to be spin-spin-coupled to each other and the phenomenon is 
known as spin-spin coupling. The magnitude of the splitting (coupling constant J) depends on 
the strength of the coupling; however, it is independent of the strength of the magnetic field. 
The multiplicity of the splitting depends on the number of chemically bonded nuclei in the 
vicinity of the observed nucleus. 
 
The most important parameter in NMR spectroscopy is the area of NMR signal. The area 
under each signal arising from non-exchangeable proton is directly proportional to the number 
of equivalent nucleus responsible for that signal, or in other words, is directly proportional to 
the molar amount of the detected isotope. 
 
Quantitative one-dimensional NMR spectroscopy of complex mixtures is usually hindered 
due to severe overlap of signals. This can be circumvented with higher magnetic fields or by 
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expanding the proton spectrum to another dimension, running a two-dimensional experiment. 
Types of two-dimensional NMR include correlation spectroscopy (COSY), exchange 
spectroscopy (EXSY), nuclear overhauser effect spectroscopy (NOESY), and diffusion 
ordered spectroscopy (DOSY). 
 
NMR DOSY technique is a method for separating compounds in a multicomponent mixture 
based on the translational diffusion coefficients of each chemical species in solution. 
Therefore, the technique depends on the size and shape of the molecule, as well as the 
physical properties of the surrounding environment such as viscosity, temperature, etc.  
 
The measurement of diffusion is carried out by observing the attenuation of the NMR 
signals during a pulsed field gradient experiment. The degree of attenuation is a function of 
the magnetic gradient pulse amplitude (G) and occurs at a rate proportional to the diffusion 
coefficient (D) of the molecule. Assuming that a line at a given (fixed) chemical shift δ 
belongs to a single sample component A with a diffusion coefficient DA, we have 
 
         S(δ, z) = SA(δ) exp (-DAZ)                                            (1.6)                          
 
Where SA(δ) is the spectral intensity of component A in zero gradient (‘normal’ spectrum of 
A), DA is its diffusion coefficient and Z encodes different gradient amplitudes used in the 
experiment.[55] 
 
 
 
1.6 X-ray Crystallography 
 
X-ray crystallography is the most commonly used method for determining the three 
dimensional structure of molecules. The most precise method of X-ray crystallography is 
single-crystal X-ray diffraction. It is based on constructive interference of monochromatic X-
rays and a crystalline sample. When X-rays are beamed at the crystal, the interaction of the X-
rays with the sample produces constructive interference (and a diffracted ray) when 
conditions satisfy Bragg´s law (nλ = 2dsinθ, where θ is the scattering angle, λ is the X-ray 
wavelength, d is the interplanar distance), thereby causing a diffraction pattern. This 
diffraction pattern converted to electron density map using the mathematical Fourier 
transformation. Since electrons more or less surround atomic nucleus uniformly, it is possible 
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to determine the location of atoms; however, due to the presence of only one electron, it is 
difficult to map hydrogen. As the crystal is gradually rotated, multiple sets of electron density 
maps were obtained for each angle of rotation. These data are combined computationally with 
complementary chemical information to produce and refine the crystal structure of the 
crystalline sample. 
 
 
1.7 Aim of the Thesis 
 
The central aim of this thesis is the study of the chelate effect in platinum(IV) complexes 
containing aromatic nitrogen ligands. This requires a systematic analysis of binding and 
exchange of monovalent pyridine based ligands with the bivalent 2,2´-bipyridine based 
ligands in the molecular complexes of trimethylplatinum(IV). As described in Section 1.3, the 
trimethylplatinum(IV) cation is highly versatile and forms complexes with both the 
monovalent and bivalent nitrogen donor ligands, and hence this is a good system for the study 
of the chelate effect. In view of this, several pyridine and 2,2´-bipyridine complexes of 
iodotrimethylplatinum(IV) were studied throughout this thesis.   
 
Chapter 2 describes the results of investigations in regard to the iodotrimethylplatinum(IV) 
complexes obtained with several pyridine ligands. In detail, the following results are 
discussed: 
 
• Solution behaviour of mononuclear iodotrimethylplatinum(IV) complexes containing 
strongly electron donating pyridine (4-DMAP) and electron withdrawing pyridines 
(4-CNPy and 3-BrPy) were investigated in order to examine the effect of pyridines on 
the solution phase. Furthermore, the X-ray crystallographic studies of [PtMe3(4-
DMAP)2I] and [PtMe3(3-BrPy)2I] were carried out to establish the solid state structure 
of these mononuclear pyridine complexes (Chapter 2.1). 
 
N
R
R1
4-DMAP: R= NMe2, R1 = H
4-CNPy: R= CN, R1= H
3-BrPy: R= H, R1= Br
 
 
Scheme 1.11 Different pyridines used for the solution behaviour study of [PtMe3L2I] (L = pyridines) 
complexes. 
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• The influence of the nucleophilicity and the steric bulk of the pyridine substituent 
on the reaction of mononuclear iodotrimethylplatinum(IV) complexes of pyridines 
with tetranuclear iodotrimethylplatinum(IV) leading to the formation of the dinuclear 
complexes were explored. This study also includes the crystal structures of four 
mononuclear iodotrimethylplatinum(IV) complexes of pyridines [PtMe3L2I] (L = 
4-MePy, 4-EtPy, 4-OMePy and 3-OMePy) (Chapter 2.2). 
 
[PtMe3I]4  +   4 Pt
Me
I
Me
Me
L
L
[PtMe3L2I]
Pt
Me
L
Me
Me
I
I
Pt
L
Me
Me
Me
Pt
Me
L
Me
Me
I
I
Pt
Me
L
Me
Me
trans-[PtMe3LI]2 cis-[PtMe3LI]2
4 n (1-n)+
L = 4- and 3- Substituted pyridines
N
R1
L = 3-Substituted pyridines
3-MePy: R1 = Me
3-EtPy: R1 = Et
3-OMePy: R1 = OMe
3-ClPy: R1= ClN
R
L = 4-Substituted pyridines
4-MePy: R = Me
4-EtPy: R = Et
4-OMePy: R = OMe
4-DMAP: R = NMe2
4-tBuPy: R = CMe3
4-CNPy: R = CN
 
 
Scheme 1.12 Different pyridines (4- and 3-substituted) used for the reaction of [PtMe3L2I] with 
iodotrimethylplatinum(IV). 
  
• The crystal structures of five dinuclear pyridine complexes of iodotrimethylplatinum 
{trans-[PtMe3(py)I]2, cis-[PtMe3LI]2 (L = 4-EtPy, 4-OMePy, 4-CNPy and 3-ClPy)} 
were investigated to verify the molecular structure of these dinuclear complexes 
(Chapter 2.3). 
 
Chapter 3 deals with the complexation of iodotrimethylplatinum(IV) with 2,2´-bipyridine 
ligands which gives rise to mononuclear [PtMe3(L-L)I] (where L-L = bipy, 4Me-bipy, 5Me-
bipy, OMe-bipy, Me2N-bipy, Cl-bipy] complexes. The complexes were characterized by 1H 
NMR, EI-MS, IR spectroscopy, elemental analyses, and X-ray crystallography. X-ray 
structural investigations of these complexes reveal the expected facial octahedral coordination 
geometry of the PtMe3 moiety and bidentate coordination of the bipyridine ligand. Moreover, 
the crystal packing of [PtMe3(Cl-bipy)I] shows the intermolecular non-covalent interaction 
between methyl hydrogen and a chlorine atom leading to the formation of one-dimensional 
zig-zag chain structures which are linked through weak π-π interactions to generate a two-
dimensional layer structure. 
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N
N
R
R
bipy: R = H
4Me-bipy: R = Me
OMe-bipy: R = OMe
Me2N-bipy: R = NMe2
Cl-bipy: R = Cl
N
N
R1
R1
5Me-bipy: R1 = Me
4,4´-Disubstituted-2,2´-bipyridine 5,5´-Disubstituted-2,2´-bipyridine
 
 
 
Scheme 1.13 Different 2,2´-bipyridines. 
 
 
Chapter 4 describes the substitution of pyridine ligands with the 2,2´-bipyridine ligands in 
the molecular complexes of iodotrimethylplatinum(IV). Four different pyridines (py, 4-MePy, 
4-OMePy and 4-DMAP) and corresponding 2,2´-bipyridines (bipy, 4Me-bipy, OMe-bipy and 
Me2N-bipy) were used for the substitution reaction to determine the influence of rigidity and 
the electronic effect of the substituent on the chelation reaction. The ligand-exchange reaction 
was conducted in two different solvents (CDCl3 and nitrobenzene-d5) in order to examine the 
dependence of the exchange equilibria on the solvent in iodotrimethylplatinum(IV) system. 
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2 Iodotrimethylplatinum(IV) Complexes of Pyridines 
 
2.1 A Comparative Study of the Solution Behaviour of Iodotrimethyl-
platinum(IV) Complexes of Pyridines 
 
2.1.1 Introduction 
 
As described in the introduction the chemistry of trimethylplatinum(IV) complexes has 
received considerable interest in the last few decades. Among the iodotrimethylplatinum(IV) 
complexes the study of the mononuclear [PtMe3(py)2I] (py = pyridine) complex was found to 
be quite interesting. This complex was reported to be mononuclear[39] and have a 
concentration-dependent molecular weight due to the dissociation into the dinuclear complex 
[PtMe3(py)I]2 and pyridine.[38] In order to investigate whether the solution behaviour of 
iodotrimethylplatinum(IV) complex is influenced by the coordinated pyridine or not, it was 
decided to extend the study to iodotrimethylplatinum(IV) complexes involving substituted 
pyridines having different electron density on the pyridine ring nitrogen. In this context the 
ligands 4-dimethylaminopyridine (4-DMAP), 4-cyanopyridine (4-CNPy), 3-bromopyridine 
(3-BrPy) (Scheme 2.1.1) having different electron density on the pyridine nitrogen are well 
suited for the study. In this chapter the syntheses of [PtMe3L2I] (L = 4-DMAP, 4-CNPy, 
3-BrPy) complexes are reported and the investigation of several features of their solution 
behaviour by 1H NMR study discussed.  The crystal structures of [PtMe3L2I] (L = 4-DMAP, 
3-BrPy) complexes are also reported here. 
 
 
N
R
R1 4-DMAP: R= NMe2, R1 = H
4-CNPy: R= CN, R1= H
3-BrPy: R= H, R1= Br
 
 
Scheme 2.1.1 Different substituted pyridines.  
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2.1.2    Syntheses and characterization of the complexes 
 
Tetranuclear iodotrimethylplatinum(IV), [PtMe3I]4 reacts with substituted pyridines to give 
six-coordinate mononuclear trimethylplatinum(IV) complexes, [PtMe3L2I] (where L = 4-
DMAP, 3-BrPy, 4-CNPy) according to equation 2.1.1. 
 
[PtMe3I]4  +   8 L   →  4 [PtMe3L2I]                                 (2.1.1) 
 
These synthesized mononuclear complexes are pale yellow to yellow crystalline solids, being 
stable in the solid state and soluble in chloroform. The C-H stretching region in the infrared 
spectra of all three complexes comprised three bands: two due to C-H stretching modes and 
one due to the overtone of the asymmetric C-H deformation mode. The C-H stretching modes 
and Pt-C modes are consistent with the PtMe3 moiety having facial octahedral coordination 
geometry.[39] The complexes were also characterized by elemental analyses. Full synthetic and 
analytical data of the complexes are reported in Chapter 5.3.3. 
 
 
 
2.1.3 X-ray crystallographic characterization of [PtMe3(4-DMAP)2I] (1) and [PtMe3(3-
BrPy)2I] (2)  
 
The yellow crystals of complexes 1 and 2 were obtained by slow diffusion of n-hexane into 
their chloroform solution. Both the complexes crystallize in P21/n space group with a 
monoclinic crystal system and contain four molecules in their unit cell. The crystal structures 
of both complexes consist of a discrete monomeric unit in which the central platinum atom is 
hexa-coordinated by the three methyl groups in a facial arrangement, two pyridine ligands 
and an iodine atom (see Figures 2.1.1-2.1.2). Selected bond lengths and bond angles of 
the complexes are given in Tables 2.1.1-2.1.2, while X-ray diffraction parameters and 
crystallographic data are reported in Tables 5.4.1-5.4.2. 
 
The Pt-C bond lengths vary according to the cis/trans influences,[56,57] i.e., the methyl group 
trans to the π-donating iodide ligand exhibits a longer bond to the metal in 2 while this effect 
appears less pronounced for 1. The Pt-I bond distance (2.79 Å in 1 and 2.78 Å in 2) in both 
structures is essentially identical and is only slightly shorter than the corresponding value 
(2.83 Å) for the bridging iodides in the reported complex [PtMe3I]4.[29] Also, the Pt-I bond 
distance in both complexes is significantly longer than the PtIV-I bond distance that has been 
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observed in several octahedral platinum(IV) complexes, e.g., 1,6-[Pt(en)2I2]I2.2H2O 
(2.68 Å),[58] [PtI6(phen)] (2.66, 2.67 Å),[59] [PtI5(phen)] (2.67, 2.67 Å),[59] [PtMe2I2(Pz2CH2)] 
(2.65, 2.65 Å),[60] [PtMe2I2{(Me2Pz)2CH2}] (2.65, 2.65 Å),[60] [PtMe2I(O2C3H7)(C12H8N2)] 
(2.62 Å),[61] trans-bis(acetylacetonato)di-iodoplatinum(IV) (2.67 Å).[62]  The Pt-N bond 
distances in 1 (2.17 and 2.18 Å) are only marginally shorter than in 2 (2.17 and 2.21 Å) and 
are close to the values found for the Pt-N bonds in [PtMe3(pydz)2Cl] (2.18, 2.19 Å),[51] 
[PtMe2I2(Pz2CH2)] (2.18 Å).[60] The Pt-N bond distances in both complexes are somewhat 
longer than the Pt-N bond distances reported for a number of platinum(IV) complexes, e.g., 
trans-[Pt(NH3)2(2,4-pentanediiminate)2](ClO4)2 (2.00 Å),[63] [PtI6(phen)] and [PtI5(phen)] 
(range 2.06-2.12 Å).[59] Longer Pt-N bond distances are also observed in several platinum(IV) 
complexes such as [PtMe2I2{(Me2Pz)2CH2}] (2.24 Å),[60] [PtMe3(OSO2CF3)(TMEDA)] 
(2.24 Å).[36] The N1-Pt1-N2 angle (89.2°) in 1 only slightly deviates from regular octahedral 
geometry which opens up the N1-Pt1-C2 and N2-Pt1-C1 cis angles to 93.0° and 91.2° 
respectively, and narrows down the N1-Pt1-C1 and N2-Pt1-C2 trans angles to 177.9° and 
176.4° respectively. Similarly, the N1-Pt1-N2 angle (92.9°) in 2 also deviates from regular 
octahedral geometry which opens up the N1-Pt1-C2 and N2-Pt1-C3 cis angles to 90.8° and 
92.8° respectively, and narrows down the N1-Pt1-C1 and N2-Pt1-C2 trans angles to 176.8° 
and 176.1° respectively. Other angular distortions are consistent with the minimum 
interligand non-bonded interactions. The dimensions of the ring systems are as expected.  
 
 
 
Figure 2.1.1 Molecular structure of [PtMe3(4-DMAP)2I] (1) showing the atom labelling scheme. Thermal 
ellipsoids are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
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Figure 2.1.2 Molecular structure of [PtMe3(3-BrPy)2I] (2) showing the atom labelling scheme. Thermal 
ellipsoids are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
Table 2.1.1 Selected bond lengths [Å] and angles [°] for [PtMe3(4-DMAP)2I] (1) 
 
 
Pt1-C1 2.050(2) 
Pt1-C2 2.051(2) 
Pt1-C3 2.065(2) 
 
Pt1-N2 2.173(2) 
Pt1-N1  2.1804(19) 
Pt1-I3 2.7953(4) 
 
C1-Pt1-C2 86.43(11) 
C1-Pt1-C3 86.31(11) 
C2-Pt1-C3 87.11(10) 
N2-Pt1-N1 89.20(7) 
C1-Pt1-N2                               91.24(9) 
C2-Pt1-N2     176.38(9) 
C3-Pt1-N2 89.97(9) 
C1-Pt1-N1 177.93(9) 
C1-Pt1-I3 91.00(8) 
C2-Pt1-I3 91.61(7) 
C3-Pt1-I3 177.09(7) 
N2-Pt1-I3 91.20(5) 
N1-Pt1-I3 91.01(5) 
C2-Pt1-N1 93.03(9) 
C3-Pt1-N1 91.68(9) 
 
 
 
 
Table 2.1.2 Selected bond lengths [Å] and angles [°] for [PtMe3(3-BrPy)2I] (2) 
 
 
Pt1-C1  2.025(10) 
Pt1-C2 2.036(12) 
Pt1-C3  2.180(13) 
 
Pt1-N1  2.171(8) 
Pt1-N2  2.211(9) 
Pt1-I3 2.7796(8) 
 
C1-Pt1-C2 86.7(5) 
C1-Pt1-C3 89.0(4) 
C2-Pt1-C3 86.1(5) 
N1-Pt1-N2 92.9(3) 
N1-Pt1-I3 89.2(2) 
N2-Pt1-I3 89.9(2) 
C1-Pt1-I3 92.8(3) 
C2-Pt1-I3 91.3(4) 
 
C1-Pt1-N1 176.8(4) 
C2-Pt1-N1 90.8(4) 
C3-Pt1-N1 88.9(3) 
C1-Pt1-N2 89.5(4) 
C2-Pt1-N2 176.1(4) 
C3-Pt1-N2 92.8(4) 
C3-Pt1-I3 176.8(3) 
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2.1.4 Solution behaviour of [PtMe3L2I] (L = 4-DMAP, 3-BrPy, 4-CNPy) complexes in 
CDCl3 
 
[PtMe3(4-DMAP)2I] (1) 
 
The ambient-temperature (300 K) solution 1H NMR spectrum of [PtMe3(4-DMAP)2I] (1) at a 
concentration of 0.06 M in CDCl3 exhibited well resolved signals, consistent with 4-DMAP 
acting as a monodentate ligand. The spectrum comprised three regions: (i) the platinum-
methyl region (δ = 1.05-1.44 ppm); (ii) the N,N-dimethylamine region (δ = 3.02 ppm) and 
(iii) the aromatic (ligand) region (δ = 6.40-8.31 ppm). The 1H NMR spectrum of 1 is shown in 
Figure 2.1.3. 
 
                                                                                                                    
Pt
I
MeA N
MeB
NMeA
NMe2(C)
NMe2(C)HD
HE
 
1.11.21.31.4 ppm3.03.5 ppm789 ppm
D
X
E
C A
B
, ,
 
Figure 2.1.3 The 400 MHz 1H NMR spectrum of [PtMe3(4-DMAP)2I] (1) in CDCl3 at a concentration of 
0.06 M. For labelling, see inset. X is the solvent peak. 
 
The platinum-methyl region of the 1H NMR spectrum of 1 comprised two signals, with 
satellites due to 195Pt-H scalar coupling, in a 1:2 intensity ratio. The relative intensities of the 
signals were assigned to the trans I (signal B) and trans 4-DMAP (signal A) platinum-methyl 
environments, respectively. 2JPt-H scalar coupling constant observed for signal B is higher than 
for signal A, indicating that 4-DMAP exerts a stronger trans influence than iodide. 
 
The aromatic region of the 1H NMR spectrum displayed two signals (D and E), assigned to 
HD and HE of the 4-DMAP ligand respectively. HD and HE were distinguished by the coupling 
of HD to 195Pt (see Table 2.1.3) which allowed an assignment to the hydrogen atom adjacent 
to the coordinated nitrogens. The coordinated ligand sub-spectra were assigned on the basis of 
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their scalar coupling networks and by comparison with the 1H NMR spectrum of the free 4-
DMAP ligand. 
 
The signal due to the N,N-dimethylamine group comprised an intense singlet (C) in the 1H 
NMR spectrum of 1. 
 
 
[PtMe3(3-BrPy)2I] (2) and [PtMe3(4-CNPy)2I] (3) 
 
The solution behaviour of both complexes, [PtMe3(3-BrPy)2I] (2) and [PtMe3(4-CNPy)2I] (3) 
proved very interesting. Unlike complex 1, which exists only as a monomer in solution, it was 
found that even highly concentrated solution of both complexes 2 and 3 dissociates in CDCl3 
resulting in the formation of a mixture of cis and trans dinuclear complexes [PtMe3LI]2 and 
the free pyridine ligand L (L = 3-BrPy in the case of 2, 4-CNPy in the case of 3)  (see 
Schemes 2.1.2-2.1.3). However, the cis isomer formed only to a very small degree relative to 
the trans isomer in the case of 3. The 1H NMR spectra of 2 and 3 in CDCl3 at 0.06 M at 300 
K are illustrated in Figures 2.1.4-2.1.5 respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.1.2 The dissociation of [PtMe3(3-BrPy)2I] (2) into cis and trans-[PtMe3(3-BrPy)I]2 and 3-
bromopyridine (3-BrPy) in CDCl3 (showing the labelling). 
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Figure 2.1.4 The 400 MHz 1H NMR spectrum of [PtMe3(3-BrPy)2I] (2) in CDCl3 at 0.06 M at 300 K. X is the 
solvent peak and Y is the peak for water present in CDCl3. For labelling, see Scheme 2.1.2. Due to close 
proximity, the signals G and H were not fully resolved and not assigned unambiguously. The signals I and M 
have virtually identical chemical shifts and not assigned unambiguously. 
 
The platinum-methyl regions of the spectra each comprised three sets of signals, one set due 
to the mononuclear complex while other two sets of signals correspond to the cis and trans 
dinuclear complexes. The signals A and B with intensity ratio of 2:1 were assigned to trans 
pyridine ligand (3-BrPy in the case of 2, 4-CNPy in the case of 3) and trans I platinum-methyl 
environments, respectively for the mononuclear complex. For both cis and trans dinuclear 
complexes, the environment of the methyl groups trans to bridging iodide would be almost 
identical so that little, if any, difference in chemical shifts would be expected. Thus, the 
signals D and F were assigned to trans and cis isomer respectively. On the other hand, the 
methyl groups trans to pyridine ligand would be expected to have markedly different 
chemical shifts for the two isomers, since the shielding effect of the pyridine ring would be 
significant for trans isomer and insignificant for cis isomer. Thus, the signal at higher field 
(C) assigned to trans isomer and the one at much lower field (E) to cis dinuclear form.  
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The aromatic regions of the spectra each displayed four sets of signals, one set due to the 
mononuclear complex [PtMe3L2I], two sets due to the cis and trans dinuclear complexes 
[PtMe3LI]2, and the one set due to the free pyridine ligand L. In the case of the 3-BrPy 
system, each set comprised four signals while it is two for the 4-CNPy system. Because of the 
influence of the aromatic ring current, aromatic ring protons for the cis isomer is slightly more 
shielded relative to the trans isomer. The signal for the trans isomer thus appears at higher 
frequency relative to the cis isomer in both complexes. The hydrogen atoms adjacent to the 
coordinated nitrogen exhibit 195Pt scalar coupling in each of the mononuclear and dinuclear 
complexes.  
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Scheme 2.1.3 The dissociation of [PtMe3(4-CNPy)2I] (3) into cis and trans-[PtMe3(4-CNPy)I]2 and 4-
cyanopyridine (4-CNPy)  in CDCl3 (showing the labelling). 
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Figure 2.1.5 The 400 MHz 1H NMR spectrum of [PtMe3(4-CNPy)2I] (3) in CDCl3 at 300 K at 0.06 M. Signals 
X, Y are the peak for the solvent and water present in CDCl3, respectively. For labelling, see Scheme 2.1.3. 
Signals K and L were not fully resolved and not assigned unambiguously. 
 
While it is clear from the 1H NMR spectra of both the complexes 2 and 3 that there are indeed 
different Pt(IV) species present in CDCl3, their assignment cannot be made on the basis of 
this one-dimensional data alone. Therefore, these signals were distinguished by a 1H DOSY 
experiment. The advantage of the DOSY technique is its ability to fully resolve multi-
component mixtures arraying resonances based on their molecular weights along the diffusion 
axis. As shown in Figure 2.1.6 for 2, the 1H DOSY spectrum provides a direct observation 
about which of the Pt(IV) species diffuses more quickly, and therefore a fast determination of 
which signal originates from the free ligand and which are the dinuclear Pt(IV) species. The 
1H DOSY spectrum of 2 shows the expected diffusion order, with the free ligand 3-
bromopyridine (signals S, T) having the largest diffusion coefficient and diffusing most 
quickly, followed by the mononuclear complex 2 (signals G, H) and dinuclear cis-[PtMe3(3-
BrPy)I]2 (signals O, P) and finally trans-[PtMe3(3-BrPy)I]2 (signals K, L) having smallest 
diffusion coefficients and moving slowest. Since both the cis and trans dinuclear complexes 
have equal molecular weight, the DOSY peaks are not well resolved along the diffusion axis. 
The small modification in the diffusion values of mononuclear complex 2 and dinuclear cis-
[PtMe3(3-BrPy)I]2 compared to trans-[PtMe3(3-BrPy)I]2 can be interpreted in terms of 
enlargement of the spheric size and changes in the hydrodynamic radius and shape by the 
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trans arrangement of the ligand molecules. Similarly, the signals which appeared in the one-
dimensional 1H spectrum of 3 were also analyzed with the help of 1H DOSY spectroscopy 
(see Figure 2.1.7).  
log(m2/s)
8.89.09.29.4 ppm
-8.4
-8.6
-8.8
-9.0
-9.2
-9.4
8.89.09.29.4 ppm
K L O P
G,H
S T
-8,996
-8,974
-8,964
-8,718
 
 
Figure 2.1.6 Part of aromatic ligand region of the 600 MHz 1H DOSY spectrum of [PtMe3(3-BrPy)2I] (2) in 
CDCl3 at 0.06 M showing the presence of [PtMe3(3-BrPy)2I] (2), cis and trans-[PtMe3(3-BrPy)I]2 and 3-
bromopyridine (3-BrPy). For labelling, see Scheme 2.1.2. 
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8.99.09.19.29.39.49.59.69.7 ppm
-8.75
-8.80
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-8.90
-8.95
-9.00
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I
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M
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Figure 2.1.7 Part of aromatic ligand region of the 600 MHz 1H DOSY spectrum of [PtMe3(4-CNPy)2I] (3) in 
CDCl3 at 0.02 M showing the presence of [PtMe3(4-CNPy)2I] (3), cis and trans-[PtMe3(4-CNPy)I]2 and 4-
cyanopyridine (4-CNPy). For labelling, see Scheme 2.1.3. 
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Table 2.1.3 1H NMR dataa of 4-DMAP, 3-BrPy and 4-CNPy complexes of iodotrimethyl- 
platinum(IV) in CDCl3 at 300 K 
 
 
Pt(IV) species 
 
Species present in 
solution 
 
 
δ(Pt-CH3)b, e 
 
Trans ligand 
 
δ(aromatic ligand H)c, e 
 
[PtMe3(4-
DMAP)2I] 
(Figure 2.1.3) 
 
[PtMe3(4-DMAP)2I] 
 
 
A 1.35 (69.3) 
B 1.14 (71.5) 
 
4-DMAP 
I 
 
C 3.02 
D 8.29 (7.2) (19.6)d 
E 6.40 (7.2) 
 
 
[PtMe3(3-BrPy)2I] 
(Figure 2.1.4) 
[PtMe3(3-BrPy)2I] 
 
A 1.51 (71.1) 
B 1.17 (68.3) 
3-BrPy 
I 
G 8.83  
H 8.79  
I 8.01 
J 7.28 
 
trans-[PtMe3(3-BrPy)I] 2 
 
C 1.46 (72.4) 
D 1.28 (74.3) 
3-BrPy 
I 
K 9.38  
L 9.17 (5.8) (17.9)d 
M 8.01 
N 7.32 
 
cis-[PtMe3(3-BrPy)I] 2 
 
E 2.00 (72.2) 
F 1.23 (74.6) 
3-BrPy 
I 
O 8.99(13.9)d  
P 8.92 (5.4) (17.7)d 
Q 7.73 (8.0) 
R 7.11 (13.5) 
 
Free 3-BrPy 
 
  S 8.70 
T 8.54 (4.0) 
U 7.83 (8.1) 
V 7.21 
 
 
[PtMe3(4-CNPy)2I] 
(Figure 2.1.5) 
[PtMe3(4-CNPy)2I] A 1.53 (71.2) 
B 1.18 (67.3) 
4-CNPy 
I 
G 9.04 (6.4) (17.9)d 
H 7.64 (6.5) 
 
trans-[PtMe3(4-CNPy)I] 2 C 1.41 (72.5) 
D 1.27 (73.9) 
4-CNPy 
I 
I 9.47 (6.4) (18.5)d 
J 7.67 (6.5) 
 
cis-[PtMe3(4-CNPy)I] 2 E 2.04 (72.6) 
F 1.25  
4-CNPy 
I 
K 9.18  
L 7.37  
 
Free 4-CNPy   M 8.82 (4.9) 
N 7.54 (5.0) 
 
 
a Chemical shifts quoted in ppm are relative to an internal solvent peak (CDCl3, δ = 7.26 ppm). b 2JPt-H/Hz in 
parentheses. c 3JH-H/Hz in parentheses. d 3JPt-H/Hz in parentheses. e labelling refers to inset in Figure 2.1.3 and 
Schemes 2.1.2 and 2.1.3; not all scalar couplings resolved.        
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Table 2.1.4 Concentration-dependent solution behaviour of [PtMe3L2I] complexes (L = 4-
DMAP, 3-BrPy, 4-CNPy)  
 
 
Pt(IV) species 
 
Concentration (in M) 
 
Population of Monomer 
/Population of Dimer 
 
 
[PtMe3(4-DMAP)2I] (1) 
 
6.0 x 10-2 
 
∞ a 
5.4 x 10-3 
 
∞ a 
[PtMe3(3-BrPy)2I] (2) 6.0 x 10-2 7.33 
5.4 x 10-3 3.0 
 
[PtMe3(4-CNPy)2I] (3) 6.0 x 10-2 2.23 
5.4 x 10-3 1.08 
 
a
 In the case of [PtMe3(4-DMAP)2I], only monomer is present in solution (both in high and low concentration). 
 
 
 
 
The population ratios of the mononuclear form to the dinuclear form for the [PtMe3L2I] (L= 
4-DMAP, 3-BrPy, 4-CNPy) complexes at different concentration in CDCl3 are reported in 
Table 2.1.4. This shows that complex [PtMe3(4-DMAP)2I] (1) is highly stable in solution and 
exists only as a monomer. However, the other two complexes [PtMe3(3-BrPy)2I] (2) and 
[PtMe3(4-CNPy)2I] (3) are not very stable in solution and both undergo dissociation which 
increases with dilution. Dissociation of 3 is much more pronounced than for 2. This 
relationship may be rationalised in terms of a decrease in the Pt-N interaction in the 
mononuclear complexes, and would therefore be expected to be in accordance with the 
electron density present on the pyridine ring nitrogen. The relative electron densities present 
on the pyridine ring nitrogen are in the order: 4-DMAP > 3-BrPy > 4-CNPy. This implies that 
electron density on the pyridine ring N decreases from 4-DMAP to 4-CNPy. As the electron 
density on the pyridine ring N decreases, the Pt-N interaction weakens, thereby leading to a 
destabilisation of the mononuclear complexes. The resulting dissociation of the mononuclear 
complexes in solution leads to the formation of the iodide bridged dinuclear complexes. The 
increase in the extent of dissociation of the mononuclear complexes with dilution is most 
likely due to increasing stabilization of the free pyridine ligand by the solvent molecules. 
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2.1.5     Conclusion 
 
Three mononuclear iodotrimethylplatinum(IV) complexes of pyridines, [PtMe3L2I] [where L= 
4-dimethylaminopyridine (4-DMAP), 3-bromopyridine (3-BrPy), 4-cyanopyridine (4-CNPy)] 
were successfully synthesized and fully characterized. The crystal structures of [PtMe3(4-
DMAP)2I] (1) and [PtMe3(3-BrPy)2I] (2) reveal the expected fac-octahedral coordination of 
the PtMe3 moiety in these trimethylplatinum(IV) complexes of pyridines. Although the 
pyridine substituents have no significant influence on the crystal structures of the 
trimethylplatinum complexes of pyridines, solution behaviour of these mononuclear 
complexes depends largely on the coordinated pyridines and on the concentration of the 
mononuclear complexes. For strongly electron donating pyridines, the complexes do not 
undergo dissociation in solution while increasing electron deficiency in the pyridine ring 
nitrogen leads to the increasing dissociation of the complexes in solution. As a result of the 
dissociation of the mononuclear complexes, iodide bridged dinuclear complexes [PtMe3LI]2 
(L= 3-BrPy and 4-CNPy) are formed in solution. 1H NMR spectra exhibit evidence of two 
isomers (cis and trans-[PtMe3LI]2) present in solution. Dissociation of the mononuclear 
complexes also leads to the formation of free pyridine ligands (3-BrPy in the case of 2 and 4-
CNPy in the case of 3) along with the corresponding dinuclear complexes, thereby 
equilibrium between these species is formed in solution. The dissociation of the mononuclear 
complexes also increases with the dilution of the complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2                                                    Iodotrimethylplatinum(IV) Complexes of Pyridines 
   
  28
2.2 Substituent Effects on the Reaction of Iodotrimethylplatinum(IV) 
Complexes of Pyridines with Tetranuclear Iodotrimethylplatinum(IV) 
 
2.2.1 Introduction 
 
The solution phase investigation of mononuclear iodotrimethylplatinum(IV) complexes of 
substituted pyridines as described in Chapter 2.1 reveals that the formation of aggregation 
equilibrium depends on the type of pyridine substituent attached to the trimethylplatinum(IV) 
moiety and also on the concentration of the mononuclear complexes. Furthermore, the 
influence of pyridine substituent on the solution dynamics proved more significant than the 
influence on the crystal structure of these mononuclear trimethylplatinum(IV) complexes of 
pyridines. In extending the studies on the aggregation behaviour of trimethylplatinum(IV) 
system, we hereby describe the reaction of mononuclear iodotrimethylplatinum(IV) 
complexes of pyridines with tetranuclear iodotrimethylplatinum(IV) in chloroform. 
Iodotrimethylplatinum reacts with mononuclear [PtMe3L2I] (L = pyridines) complexes in 
equimolar ratio in chloroform to form a mixture of dinuclear complexes, cis and trans-
[PtMe3LI]2. Two types of pyridines were chosen for this reaction, namely 4-substituted 
pyridines [4-methylpyridine (4-MePy), 4-ethylpyridine(4-EtPy), 4-methoxypyridine 
(4-OMePy), 4-dimethylaminopyridine (4-DMAP), 4-cyanopyridine (4-CNPy), and 
4-tbutylpyridine (4-tBuPy)] and 3-substituted pyridines [3-methylpyridine (3-MePy), 
3-ethylpyridine (3-EtPy), 3-methoxypyridine (3-OMePy), and 3-chloropyridine (3-ClPy)] 
(Scheme 2.2.1). The reaction has been followed by 1H NMR spectroscopy. The effects of the 
electron density on the pyridine nitrogen, influenced by the nature of the substituent present 
on the pyridine ring, on the equilibrium population of the dinuclear form and the mononuclear 
form for this reaction are discussed. The steric influences of the pyridine substituent are also 
investigated here. The crystal structures of [PtMe3L2I] (L = 4-MePy, 4-EtPy, 4-OMePy and 3-
OMePy) are also reported here. 
 
N
R
4-Substituted pyridines
4-MePy: R = Me
4-EtPy: R = Et
4-OMePy: R = OMe
4-DMAP: R = NMe2
4-tBuPy: R = CMe3
4-CNPy: R = CN N
R1
3-Substituted pyridines
3-MePy: R1 = Me
3-EtPy: R1 = Et
3-OMePy: R1 = OMe
3-ClPy: R1 = Cl
 
 
Scheme 2.2.1 Different substituted pyridines used for the reaction of [PtMe3L2I] with [PtMe3I]4. 
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2.2.2  Syntheses and characterization of the complexes 
 
The pale yellow to yellow crystalline mononuclear iodotrimethylplatinum(IV) complexes, 
[PtMe3L2I] (L= 3- and 4-substituted pyridines) were synthesized in a similar way by the 
reaction of iodotrimethylplatinum(IV) with different substituted pyridines as described in 
Chapter 2.1. All the synthesized complexes are soluble in chloroform and characterized by IR, 
1H NMR spectroscopy and elemental analyses (see Chapter 5.3.3). 
 
 
 
 
2.2.3 X-ray crystallographic characterization of [PtMe3L2I] complexes (L = 4-MePy, 4-
EtPy, 4-OMePy and 3-OMePy)  
 
Single crystals of the complexes [PtMe3L2I] complexes (L = 4-MePy, 4-EtPy, 4-OMePy and 
3-OMePy) were obtained by slow diffusion of n-hexane into their chloroform solution. X-ray 
diffraction parameters and crystallographic data of the complexes are given in Tables 5.4.3-
5.4.6. The molecular structures of the complexes are depicted in Figures 2.2.1-2.2.4, while 
selected bond lengths and bond angles are summarized in Table 2.2.1. 
 
 
 
Figure 2.2.1 Molecular structure of [PtMe3(4-MePy)2I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
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Each of the three complexes [PtMe3(4-MePy)2I], [PtMe3(4-EtPy)2I] and [PtMe3(3-OMePy)2I] 
has four, whereas [PtMe3(4-OMePy)2I] has eight molecules in the unit cell. [PtMe3(4-
MePy)2I] crystallized in the monoclinic P21/n space group, [PtMe3(4-EtPy)2I] in monoclinic 
P21/c, [PtMe3(3-OMePy)2I] in monoclinic P21/a, and [PtMe3(4-OMePy)2I] in orthorhombic 
Pbca. All the structures consist of a discrete monomeric unit in which the platinum atom is 
six-fold coordinated by the three methyl groups in a facial arrangement, two pyridine ligands 
and an iodine atom. 
 
 
 
Figure 2.2.2 Molecular structure of [PtMe3(4-EtPy)2I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
The Pt-N bond distances in all the four structures do not differ significantly (2.17-2.20 Å) and 
are essentially identical to those found in the complexes [PtMe3(4-DMAP)2I] (2.17, 2.18 Å) 
and [PtMe3(3-BrPy)2I] (2.19 and 2.21 Å). The Pt-I bond distance in all the structures is almost 
the same (2.77-2.78 Å). Except [PtMe3(4-MePy)2I], where one of the two Pt-Ctrans N bonds is 
marginally longer than the Pt-Ctrans I bond, in all the other three complexes Pt-Ctrans N bonds 
are shorter than the Pt-Ctrans I bond as observed in the complexes [PtMe3(4-DMAP)2I] and 
[PtMe3(3-BrPy)2I]. Little distortion from the regular octahedral geometry in all complexes 
is revealed. Adjacent 4-ethylpyridine ligands in [PtMe3(4-EtPy)2I] open up the N1-Pt1-N2 
angle to 90.7°, thereby reducing the angles of the trans related bonds, namely N1-Pt1-C1 and 
N2-Pt1-C2 from 180° to 176.8° and 178.5° respectively. Similarly adjacent 4-
methoxypyridine ligands in [PtMe3(4-OMePy)2I] open up the N1-Pt1-N2 angle to 90.7°, 
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thereby reducing the angles of the trans related bonds, namely N1-Pt1-C1 and N2-Pt1-C2 
from 180° to 176.3° and 179.3° respectively. N1-Pt1-N2 bond angle (88.9°) in [PtMe3(4-
MePy)2I] narrows down the N1-Pt1-C1 and N2-Pt1-C2 trans angles to 177.0° and 178.4° 
respectively. Also, adjacent 3-methoxypyridine ligands in [PtMe3(3-OMePy)2I] open up the 
N1-Pt1-N2 angle to 90.5°, thereby reducing N1-Pt1-C1 and N2-Pt1-C2 angles to 177.6° and 
176.5° respectively. 
 
 
 
Figure 2.2.3 Molecular structure of [PtMe3(4-OMePy)2I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
 
Figure 2.2.4 Molecular structure of [PtMe3(3-OMePy)2I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
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Table 2.2.1 Selected bond lengths [Å] and angles [°] for [PtMe3L2I] (L = 4-MePy, 4-EtPy, 4-
OMePy, 3-OMePy) complexes  
 
  
[PtMe3(4-MePy)2I] 
 
 
[PtMe3(4-EtPy)2I] 
 
[PtMe3(4-OMePy)2I] 
 
[PtMe3(3-OMePy)2I] 
 
Pt1-C1 
 
2.049(8) 
 
2.053(2) 
 
2.087(6) 
 
2.030(6) 
Pt1-C2 2.031(7) 2.054(2) 2.053(6) 2.024(6) 
Pt1-C3 2.041(8) 2.067(2) 2.232(7) 2.058(6) 
Pt1-N1 2.178(6) 2.1751(16) 2.174(4) 2.188(5) 
Pt1-N2 2.177(6) 2.1863(16) 2.196(5) 2.184(5) 
Pt1-I3 2.7746(7) 2.7774(3) 2.7701(6) 2.785(5) 
 
 
    
C2-Pt1-C1 88.3(4) 87.77(9) 87.4(2) 87.1(3) 
C2-Pt1-C3 88.5(4) 89.57(9) 90.1(2) 85.7(3) 
C1-Pt1-C3 85.8(4) 85.34(9) 84.5(2) 89.3(3) 
C1-Pt1-N1 177.0(3) 176.81(8) 176.3(2) 177.6(2) 
C2-Pt1-N1 90.9(3) 90.51(7) 89.9(2) 91.9(2) 
C3-Pt1-N1 91.3(3) 91.96(8) 92.96(17) 88.5(2) 
C1-Pt1-N2 91.8(3) 91.00(8) 91.9(2) 90.4(2) 
C2-Pt1-N2 178.4(3) 178.51(7) 179.3(2) 176.5(2) 
C3-Pt1-N2 89.9(3) 89.49(8) 90.02(17) 91.9(2) 
C1-Pt1-I3 92.1(3) 92.88(7) 92.5(2) 89.0(2) 
C2-Pt1-I3 92.1(3) 90.04(6) 90.02(19) 90.3(2) 
C3-Pt1-I3 177.8(3) 178.20(7) 176.96(13) 175.7(2) 
N1-Pt1-I3 90.83(15) 89.80(4) 90.08(12) 93.2(13) 
N2-Pt1-I3 89.45(15) 90.87(4) 89.82(12) 92.06(13) 
N1-Pt1-N2 88.9(2) 90.67(6) 90.72(16) 90.48(17) 
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2.2.4 1H NMR studies for the reaction of [PtMe3I]4 with [PtMe3L2I] complexes (L = 4-
MePy, 4-EtPy, 4-OMePy, 4-DMAP, 4-tBuPy, 4-CNPy, 3-MePy, 3-EtPy, 3-
OMePy, 3-ClPy) 
 
Tetranuclear iodotrimethylplatinum(IV) reacts with mononuclear [PtMe3L2I] (L= 3- and 4-
substituted pyridines) complexes to form the corresponding dinuclear complexes of 
iodotrimethylplatinum(IV), [PtMe3LI]2. The ambient temperature (300 K) solution 1H NMR 
spectrum for the reaction of an equimolar mixture of iodotrimethylplatinum(IV) and 
[PtMe3L2I] at equilibrium exhibited well resolved signals. The 1H NMR spectrum for the 
reaction of an equimolar mixture of [PtMe3(4-OMePy)2I] and iodotrimethylplatinum(IV) at 
equilibrium in CDCl3 is shown in Figure 2.2.5, while the 1H NMR spectrum for the reaction 
of [PtMe3(3-ClPy)2I] with [PtMe3I]4 in equimolar mixture at equilibrium is shown in Figure 
2.2.6. 
 
[Pt(MeC)3I]4  +   4 Pt
MeB
I
MeA
MeA
L
L
[PtMe3L2I]
Pt
MeE
L
MeD
MeD
I
I
Pt
L
MeE
MeD
MeD
Pt
MeG
L
MeF
MeF
I
I
Pt
MeG
L
MeF
MeF
trans-[PtMe3LI]2 cis-[PtMe3LI]2
4 n (1-n)+
L = 4- and 3- Substituted pyridines
N
HJ
R1HK
HI HH
L = 3-Substituted pyridines
3-MePy: R1 = Me
3-EtPy: R1 = Et
3-OMePy: R1 = OMe
3-ClPy: R1= ClN
R
HI
HH
L = 4-Substituted pyridines
4-MePy: R = Me
4-EtPy: R = Et
4-OMePy: R = OMe
4-DMAP: R = NMe2
4-tBuPy: R = CMe3
4-CNPy: R = CN
 
 
Scheme 2.2.2 The reaction of an equimolar mixture of iodotrimethylplatinum(IV) and mononuclear [PtMe3L2I] 
(L = 4- and 3-substituted pyridines) complexes in chloroform showing the proton labelling.  
 
 
The platinum-methyl regions of the spectra each comprised four sets of signals (one set due to 
the mononuclear [PtMe3L2I], one to [PtMe3I]4 and two others corresponding  to cis and trans 
dinuclear [PtMe3LI]2 complexes) with satellites due to 195Pt-H scalar coupling. The mono-
nuclear [PtMe3L2I] shows two platinum-methyl signals in an intensity ratio of 2:1, assigned to 
the trans L (signal A) and trans I (signal B) platinum-methyl environments, respectively with 
same or different coupling constants (see Tables 2.2.2-2.2.3). The iodotrimethylplatinum(IV) 
shows only a single platinum-methyl resonance (signal C) at δ = 1.72 ppm. The signals D and 
E correspond to trans-[PtMe3LI]2, while F and G were assigned to cis-[PtMe3LI]2. 
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The aromatic regions of the spectra each consist of signals for three complexes ([PtMe3L2I], 
cis and trans-[PtMe3LI]2). For 4-substituted pyridine based systems, each of the three 
complexes comprised two signals for the ring protons while there are four signals for 3-
substituted pyridines. Due to the shielding effect caused by the presence of aromatic ring 
current, the signal for the trans isomer appears at higher frequency than for the cis isomer. 
The highest frequency signals in each set of complexes displayed measurable 195Pt-H scalar 
coupling (see Tables 2.2.2-2.2.3), which enabled an assignment to the hydrogen atoms 
adjacent to the coordinated nitrogens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.5 The 400 MHz 1H NMR spectrum for the reaction of [PtMe3(4-OMePy)2I] with [PtMe3I]4 in 
equimolar mixture at equilibrium in CDCl3 at 300 K. For labelling, see Scheme 2.2.2. (t) = trans-[PtMe3(4-
OMePy)I]2. (c) = cis-[PtMe3(4-OMePy)I]2. (m) = [PtMe3(4-OMePy)2I]. X is the solvent peak and Y is the peak 
for water present in CDCl3. 
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Figure 2.2.6 The 400 MHz 1H NMR spectrum for the reaction of [PtMe3(3-ClPy)2I] with [PtMe3I]4 in equimolar 
mixture at equilibrium in CDCl3 at 300 K. For labelling, see Scheme 2.2.2. (t) = trans-[PtMe3(3-ClPy)I]2. (c) =                   
cis-[PtMe3(3-ClPy)I]2. (m) = [PtMe3(3-ClPy)2I]. X is the solvent peak and Y is the peak for water present in 
CDCl3. 
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Table 2.2.2 1H NMR dataa for the reaction of [PtMe3I]4 with [PtMe3L2I] at equilibrium at 
300 K (L = 4-substituted pyridines) in CDCl3 
 
 
Ligand L of  
[PtMe3L2I] 
 
Pt(IV) species  
present at equilibrium 
 
 
δ(Pt-Me)b, e 
 
Trans ligand 
 
δ(ligand H)c, e 
 
N
Me
HI
HH
 
 
4-Methylpyridine  
(4-MePy) 
 
[PtMe3(4-MePy)2I] 
 
A 1.45 (70.0) 
B 1.17 (70.0) 
 
4-MePy 
 I 
 
H 8.61 (6.4) (19.0)d 
I 7.12 (6.0) 
Me 2.38 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(4-MePy)I]2 D 1.27 (75.1) 
E 1.37 (71.1) 
I 
4-MePy  
H 9.08 (6.5) (19.6)d 
I 7.19 (6.0) 
Me 2.41 
 
cis-[PtMe3(4-MePy)I]2 F 1.25 (75.1) 
G 1.97 (71.1) 
I 
4-MePy  
H 8.76 (6.4) (19.2)d 
I 6.84 (5.8) 
Me 2.33 
 
 
N
CH2Me
HI
HH
 
 
4-Ethylpyridine  
(4-EtPy) 
 
 
 
 
 
 
 
 [PtMe3(4-EtPy)2I] A 1.45 (70.1) 
B 1.18 (70.2) 
4-EtPy 
 I 
H 8.64 (6.4) (18.9)d 
I 7.15 (6.4) 
CH2 2.68 
Me 1.27 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(4-EtPy)I]2 D 1.28 (75.1) 
E 1.36 (71.0) 
I 
4-EtPy 
H 9.11 (6.6) (19.8)d 
I 7.21 (6.3) 
CH2 2.72 
Me 1.30 
 
cis-[PtMe3(4-EtPy)I]2 F 1.28 (75.1) 
G 1.99 (71.1) 
I 
4-EtPy  
H 8.79 (6.5) (19.4)d 
I 6.88 (6.1) 
CH2 2.62 
Me 1.26 
 
 
N
OMe
HI
HH
 
 
4-Methoxypyridine  
(4-OMePy) 
 
 
 
 
[PtMe3(4-OMePy)2I] A 1.42 (70.0) 
B 1.15 (70.2) 
4-OMePy  
I 
H 8.58 (7.0) (19.0) d 
I 6.80 (7.0) 
OMe 3.89 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(4-
OMePy)I]2 
D 1.27 (75.1) 
E 1.38 (71.0) 
I 
4-OMePy 
H 9.04 (6.9) (19.7)d 
I 6.86 (7.0) 
OMe 3.92 
 
cis-[PtMe3(4-OMePy)I]2 F 1.24 (75.2) 
G 1.93 (71.0) 
I 
4-OMePy  
H 8.73 (6.8) (19.5)d 
I 6.51 (6.9) 
OMe 3.85 
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(Continued) 
 
Ligand L of  
[PtMe3L2I] 
 
Pt(IV) species  
present at equilibrium 
 
 
δ(Pt-Me)b, e 
 
Trans ligand 
 
δ(ligand H)c, e 
 
N
NMe2
HI
HH
 
 
4-
Dimethylaminopyridine  
(4-DMAP) 
 
[PtMe3(4-DMAP)2I] 
 
A 1.35 (69.3) 
B 1.14 (71.5) 
 
4-DMAP  
I 
 
H 8.29 (7.2) (19.6)d 
I 6.40 (7.2) 
NMe2 3.02 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
 
trans-[PtMe3(4-DMAP)I]2 D 1.27 (75.6) 
E 1.39 (70.0) 
I 
4-DMAP  
H 8.74 (7.1) (20.6)d 
I 6.49 (7.1) 
NMe2 3.05 
 
cis-[PtMe3(4-DMAP)I]2 F 1.27 (75.6) 
G 1.90 (70.1) 
I 
4-DMAP  
H 8.48 (7.0) (20.3)d 
I 6.20 (7.0) 
NMe2 2.99 
 
 
N
CMe3
HI
HH
 
 
4-tButylpyridine  
(4-tBuPy) 
[PtMe3(4-tBuPy)2I] A 1.45 (69.9) 
B 1.19 (70.1) 
4-tBuPy  
I 
 
H 8.66 (6.5) (19.0)d 
I 7.30 (6.7) 
tBu 1.33 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(4-tBuPy)I]2 D 1.30 (75.1) 
E 1.35 (70.8) 
I 
4-tBuPy 
H 9.12 (6.6) (19.8)d 
I 7.36 (6.6) 
tBu 1.35 
 
cis-[PtMe3(4-tBuPy)I]2 F 1.34 (75.1) 
G 2.01 (71.2) 
I 
4-tBuPy  
H 8.82 (6.6) (19.4)d 
I 7.09 (6.4) 
tBu 1.32 
 
 
N
CN
HI
HH
 
 
4-Cyanopyridine  
(4-CNPy) 
[PtMe3(4-CNPy)2I] A 1.53 (71.2) 
B 1.18 (67.3) 
4-CNPy  
I 
H 9.04 (6.4) (17.9)d 
I 7.64 (6.5) 
 
[PtMe3I]4 C 1.72 (77.4) I - 
 
trans-[PtMe3(4-CNPy)I]2 D 1.27 (73.9) 
E 1.41 (72.5) 
I 
4-CNPy  
H 9.47 (6.4) (18.5)d 
I 7.67 (6.5) 
 
cis-[PtMe3(4-CNPy)I]2 F 1.25 
G 2.04 (72.6) 
I 
4-CNPy  
H 9.18  
I 7.37  
 
a
 Chemical shifts quoted in ppm are relative to an internal solvent peak (CDCl3, δ = 7.26 ppm). b 2JPt-H/Hz in 
parentheses. c 3JH-H/Hz in parentheses. d  3JPt-H/Hz in parentheses. e labelling refers to Scheme 2.2.2. Not all scalar 
coupling resolved. 
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Table 2.2.3 1H NMR dataa for the reaction of [PtMe3I]4 with [PtMe3L2I] at equilibrium at 
300 K (L = 3-substituted pyridines) in CDCl3 
 
 
Ligand L of  
[PtMe3L2I] 
 
 
Pt(IV) species  
present at equilibrium 
 
δ(Pt-Me)b, e 
 
Trans ligand 
 
δ(ligand H)c, e 
 
N
HJ
HK
HI
Me
HH
 
 
3-Methylpyridine  
(3-MePy) 
 
 
 
 
 
 
 
 
 
 
[PtMe3(3-MePy)2I] 
 
A 1.48 (70.0) 
B 1.18 (69.8) 
 
3-MePy 
I 
 
H 8.67  
I 8.51 (5.7) (17.8) d 
J 7.64  
K 7.20 (13.2) 
Me 2.35 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(3-MePy)I]2 D 1.30 (75.1) 
E 1.40 (71.1) 
I 
3-MePy 
 
H 9.16  
I 9.01 (6.0) (19.4) d 
J 7.64  
K 7.28 
Me 2.44 
 
cis-[PtMe3(3-MePy)I]2 F 1.26 (75.0) 
G 1.98 (71.0) 
I 
3-MePy 
 
H 8.76  
I 8.73  
J 7.38 (7.4) 
K 6.91 (13.2) 
Me 2.23 
 
 
N
HJ
HK
HI
CH2Me
HH
 
 
3-Ethylpyridine  
(3-EtPy) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[PtMe3(3-EtPy)2I] A 1.48 (70.0) 
B 1.19 (69.7) 
3-EtPy 
 I 
H 8.64  
I 8.56 (5.7) (17.2) d 
J 7.66  
K 7.23  
CH2 2.65 
Me 1.20 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(3-EtPy)I]2 D 1.30 (75.0) 
E 1.39 (70.9) 
I 
3-EtPy 
H 9.20  
I 9.00 (6.4) (17.9) d 
J 7.66  
K 7.30  
CH2 2.76 
Me 1.32 
 
cis-[PtMe3(3-EtPy)I]2 F 1.28 (75.1) 
G 1.99 (71.1) 
I 
3-EtPy 
H 8.78  
I 8.75 
J 7.43 (7.3) 
K 6.89 (13.3) 
CH2 2.55 
Me 1.19 
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(Continued) 
 
Ligand L of  
[PtMe3L2I] 
 
 
Pt(IV) species  
present at equilibrium 
 
δ(Pt-Me)b, e 
 
Trans ligand 
 
δ(ligand H)c, e 
 
N
HJ
HK
HI
OMe
HH
 
 
3-Methoxypyridine  
(3-OMePy) 
 
 
 
 
 
[PtMe3(3-OMePy)2I] 
 
A 1.49 (70.4) 
B 1.20 (69.7) 
 
3-OMePy 
 I 
 
H 8.61  
I 8.30 (6.1) (16.9)d 
J 7.33 
K 7.24 
OMe 3.84 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
 
 
trans-[PtMe3(3-
OMePy)I]2 
D 1.29 (74.8) 
E 1.42 (71.6) 
I 
3-OMePy 
H 9.02  
I 8.82 (6.3) (18.2)d 
J 7.29 
K 7.22 
OMe 3.94 
 
cis-[PtMe3(3-OMePy)I]2 F 1.25 (75.0) 
G 1.98 (71.4) 
I 
3-OMePy  
 
 
H 8.68  
I 8.52 (6.1) (17.2)d 
J 7.06 
K 6.94 (13.8) 
OMe 3.82 
 
 
N
HJ
HK
HI
Cl
HH
 
 
3-Chloropyridine  
(3-ClPy) 
[PtMe3(3-ClPy)2I] A 1.52 (71.1) 
B 1.18 (68.3) 
3-ClPy 
 I 
H 8.77  
I 8.75  
J 7.87  
K 7.34 
 
[PtMe3I]4 C 1.72 (77.3) I - 
 
trans-[PtMe3(3-ClPy)I]2 D 1.29 (74.3) 
E 1.46 (72.2) 
I 
3-ClPy 
H 9.28  
I 9.15 (6.1) (16.8)d 
J 7.87  
K 7.38 
 
cis-[PtMe3(3-ClPy)I]2 F 1.24 (74.5) 
G 2.02 (72.3) 
I 
3-ClPy 
H 8.93  
I 8.87 (5.6) (17.3)d 
J 7.59 (8.4) 
K 7.14 (13.6) 
 
a
 Chemical shifts quoted in ppm are relative to an internal solvent peak (CDCl3, δ = 7.26 ppm). b 2JPt-H/Hz in 
parentheses. c 3JH-H/Hz in parentheses. d  3JPt-H/Hz in parentheses. e labelling refers to Scheme 2.2.2. Not all scalar 
coupling resolved.  
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Table 2.2.4 Population ratios of different Pt(IV) species for the reaction of an equimolar 
mixture of [PtMe3L2I] (L = 4-substituted pyridines) with iodotrimethylplatinum(IV) in 
CDCl3 at equilibrium at 300 K 
 
 
Ligand L  
  
[PtMe3LI]2/ 
 [PtMe3L2I] 
 
cis-[PtMe3LI]2  
(in %) 
 
 
trans-[PtMe3LI]2  
(in %) 
 
trans-[PtMe3LI]2  
/cis-[PtMe3LI]2  
 
4-Cyanopyridine (4-CNPy) 
 
4.7 
 
7.7 
 
74.7 
 
9.70 
 
4-Methoxypyridine (4-OMePy) 1.2 21.1 33.7 1.60 
 
4-Methylpyridine (4-MePy)  1.11 15.3 37.2 2.43 
 
4-Ethylpyridine (4-EtPy) 0.97 13.3 35.2 2.65 
 
4-tButylpyridine (4-tBuPy) 0.8 8.8 36.2 4.11 
 
4-Dimethylaminopyridine   
(4-DMAP) 
 
0.68 11.4 28.8 2.52 
 
 
 
 
Table 2.2.5 Population ratios of different Pt(IV) species for the reaction of an equimolar 
mixture of [PtMe3L2I] (L = 3-substituted pyridines) with iodotrimethylplatinum(IV) in 
CDCl3 at equilibrium at 300 K 
 
 
Ligand L  
 
[PtMe3LI]2/ 
[PtMe3L2I] 
 
cis-[PtMe3LI]2  
(in %) 
 
 
trans-[PtMe3LI]2  
(in %) 
 
trans-[PtMe3LI]2  
/cis-[PtMe3LI]2  
 
3-Methylpyridine (3-MePy) 
 
1.37 
 
18.9 
 
38.9 
 
2.06 
 
3-Ethylpyridine (3-EtPy) 1.16 15.0 38.7 2.58 
 
3-Methoxypyridine (3-OMePy) 1.34 24.3 33.0 1.36 
 
3-Chloropyridine (3-ClPy) 3.15 32.8 43.1 1.31 
 
 
 
 
The population ratios of the dinuclear [PtMe3LI]2 complexes to the mononuclear [PtMe3L2I] 
complexes and the relative populations of cis and trans-[PtMe3LI]2 complexes for the reaction 
of an equimolar mixture of iodotrimethylplatinum(IV) and mononuclear [PtMe3L2I] 
complexes in chloroform at equilibrium at 300 K in the case of L= 4-substituted pyridines are 
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reported in Table 2.2.4. It is clear that the electron density on the pyridine ring nitrogen which 
is influenced by the substituent attached to the pyridine ring plays a significant role in 
determining the population of both the mononuclear and dinuclear forms at equilibrium in 
iodotrimethylplatinum(IV) complexes of 4-substituted pyridines. For a strongly electron 
withdrawing pyridine such as 4-cyanopyridine, the dinuclear form is much more favourable 
than the mononuclear form. On the other hand, a strongly electron donating pyridine such as 
4-dimethylaminopyridine (4-DMAP) favours the mononuclear form over the dinuclear form. 
This can be explained in terms of the stability of the mononuclear complexes associated with 
the Pt-N interaction in solution and would therefore be expected to be in accordance with the 
nucleophilicity of the pyridines, characterized by the electron density on the pyridine ring 
nitrogen. Cyano group (-CN), owing to its strong mesomeric effect (-M effect) and inductive 
effect (-I effect) considerably decreases the electron density on the pyridine nitrogen, thereby 
reducing the nucleophilicity of the heterocyclic nitrogen atom drastically. With the decrease 
in the nucleophilicity of the pyridine nitrogen, the Pt-N interaction in the mononuclear form is 
weakened, thus resulting in the destabilisation of the mononuclear form in solution. On the 
other hand, the strong mesomeric effect (+ M effect) of the NMe2 group increases the electron 
density on the pyridine nitrogen significantly leading to a strong Pt-N interaction in the 
mononuclear complex. As a result of the strong Pt-N interaction, the mononuclear form 
[PtMe3(4-DMAP)2I] becomes highly stable in solution. The observed trend of population 
ratios of dinuclear to mononuclear form for 4-substituted pyridines is as follows: 4-CNPy >>     
4-OMePy > 4-MePy > 4-EtPy > 4-tBuPy > 4-DMAP (see Table 2.2.4). To explain the order 
of population ratio of the dinuclear to the mononuclear forms of trimethylplatinum(IV) 
complexes among the pyridine ligands (4-OMePy, 4-MePy, 4-EtPy and 4-tBuPy), the steric 
and the electronic influences of the p-substituent of the pyridine ligands are taken into 
consideration. As the steric bulk of the p-substituent increases from Me to Et to tBu, the 
stability of the cis dinuclear form also decreases due to the increasing interaction of the 
pyridine ligands with the neighbouring pyridine ligands in the cis dinuclear form. The relative 
population of the cis-[PtMe3LI]2 for the pyridine ligands follows the order: 4-OMePy > 4-
MePy > 4-EtPy > 4-tBuPy (see Table 2.2.4). The higher stability of the cis dinuclear form in 
the case of 4-OMePy ligand than for 4-MePy ligand may be explained by the fact that the 
magnitude of repulsive steric interaction among the oxygen atoms in the cis dinuclear form in 
the case of 4-OMePy ligand is less than the steric interaction between the methyl groups in 
the case of 4-MePy ligand. The higher population of trans dinuclear form (where interaction 
between the pyridine ligands is absent) relative to the cis dinuclear form for all the 4-
Chapter 2                                                    Iodotrimethylplatinum(IV) Complexes of Pyridines 
   
  42
substituted pyridines further proves the steric influences of the p-substituent in determining 
the population of both the mononuclear and dinuclear forms in solution. The formation of a 
very small amount of cis isomer relative to trans isomer in the case of 4-cyanopyridine ligand 
is most likely due to the weak stabilisation of the high dipole moment of the cis isomer by the 
rather apolar chloroform solvent. 
 
The population ratios of the dinuclear to mononuclear pyridine complexes and the relative 
populations of cis and trans-[PtMe3LI]2 complexes in chloroform at equilibrium at 300 K for 
L= 3-substituted pyridines are reported in Table 2.2.5. Here the population of both the 
mononuclear and dinuclear trimethylplatinum(IV) complexes also depends on the substituent 
attached to the pyridine ring. The chlorine atom with its strong inductive effect and weak 
mesomeric effect considerably decreases the nucleophilicity of the pyridine nitrogen and thus 
favours the dinuclear form much more than the mononuclear form.  
 
The population of the cis dinuclear form for 3-methylpyridine (3-MePy) is higher than for 4-
methylpyridine (4-MePy). Similarly population of cis dinuclear form: 3-EtPy > 4-EtPy; 
3-OMePy > 4-OMePy
 
. This confirms that the repulsive steric interaction among the pyridine 
ligands in the cis dinuclear form is less in the case of 3-substituted pyridines as compared to 
the 4-substituted pyridines. On the other hand, the population ratio of dinuclear to 
mononuclear form at equilibrium for the 3-substituted pyridines is greater than for the 4-
substituted pyridines [ (populationdimer/populationmonomer) : (i) 3-MePy > 4-MePy; (ii) 3-EtPy 
> 4-EtPy; (iii) 3- OMePy > 4-OMePy]. This is due to a decrease in both the nucleophilicity of 
the pyridine nitrogen and the steric influences of the substituent as we go from 4-substituted 
pyridines to 3-substituted pyridines. 
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2.2.5 Conclusion 
 
Several mononuclear iodotrimethylplatinum(IV) complexes of 4- and 3-substituted pyridines, 
[PtMe3L2I] were successfully synthesized and characterized by different techniques. The 
crystal structures of [PtMe3L2I] (L = 4-MePy, 4-EtPy, 4-OMePy and 3-OMePy) confirmed 
the slightly distorted octahedral geometry in these iodotrimethylplatinum(IV) complexes of 
pyridines. All the synthesized mononuclear trimethylplatinum(IV) complexes of pyridines 
undergo reaction with iodotrimethylplatinum(IV) in equimolar ratio to form the iodide 
bridged dinuclear complexes, [PtMe3LI]2. These dinuclear complexes exist as a mixture of cis 
and trans isomers in chloroform. The equilibrium population of both the mononuclear and 
dinuclear iodotrimethylplatinum(IV) complexes depends to a large extent on both the 
electronic effect and the steric bulk of the pyridine substituent. Substituents with strong 
electron donating ability such as NMe2 favour the mononuclear complexes over the dinuclear 
complexes. On the other hand, for strongly electron withdrawing substituents such as cyano 
and chlorine, the dinuclear complexes are more stable than the mononuclear complexes. The 
steric bulk of the substituent attached to the pyridine ring also plays a significant role. As the 
size of the pyridine substituent increases, the interaction of the pyridine ligand with the 
neighbouring pyridine ligand in the cis dinuclear form also increases. As a result, the stability 
of the cis dinuclear form decreases in solution. For all pyridine ligands, the cis dinuclear 
complexes are less stable than the trans form. However, the steric interaction among the 
pyridine ligands in the cis dinuclear form is smaller in the case of 3-substituted pyridines as 
compared to the 4-substituted pyridines.  
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2.3 Crystallographic Investigation of Dinuclear Iodotrimethylplatinum(IV) 
Complexes of Pyridines 
 
2.3.1 Introduction 
 
In coordination chemistry, the iodide ligand is considered as a versatile ligand because of its 
ability to bind the metal ion in monodentate fashion as well as in bridging fashion. In case of 
trimethylplatinum(IV) system, the extent of formation of octahedral geometry around Pt metal 
ion is so high that in absence of suitable ligand the binuclear or polynuclear species forms 
readily. Thus reaction of iodotrimethylplatinum(IV) with pyridine in equimolar ratio results in 
the formation of dinuclear complex [PtMe3(py)I]2.[38] Treatment of mononuclear pyridine 
complex, [PtMe3(py)2I] with one mole of dilute acid also gave the corresponding dinuclear 
complex [PtMe3(py)I]2.[38] It was shown in Chapter 2.2 that reaction of iodotrimethylplatinum 
with a series of mononuclear trimethylplatinum complexes of pyridines in equimolar ratio 
also results in the formation of a mixture of cis and trans dinuclear pyridine complexes. In 
order to establish the structure of these complexes, X-ray structural investigation of some 
dinuclear pyridine complexes was carried out. This chapter describes the structural 
characterization of five dinuclear pyridine complexes, trans-[PtMe3(py)I]2, cis-[PtMe3LI]2 {L 
= 4-ethylpyridine (4-EtPy), 4-methoxypyridine (4-OMePy), 4-cyanopyridine (4-CNPy) and 3-
chloropyridine (3-ClPy)}. 
 
 
2.3.2 Crystal structures of trans-[PtMe3(py)I]2, cis-[PtMe3LI]2 (L = 4-EtPy, 4-OMePy, 
4-CNPy, 3-ClPy] 
 
The yellow crystals of the dinuclear complexes, trans-[PtMe3(py)I]2 and cis-[PtMe3LI]2 (L = 
4-EtPy, 4-OMePy, 4-CNPy, 3-ClPy) were obtained by slow diffusion of n-hexane into an 
equilibrium mixture of equimolar iodotrimethylplatinum(IV) and corresponding mononuclear 
pyridine complexes in CDCl3. In each of the five complexes, two bridged iodine atoms hold 
two platinum atoms together. In trans-[PtMe3(py)I]2, two pyridine ligands are positioned 
trans to each other, while in the other four dinuclear complexes, substituted pyridine ligands 
are cis to each other (see Figures 2.3.1-2.3.5). The X-ray diffraction parameters and 
crystallographic data of the complexes are reported in Tables 5.4.7-5.4.11. 
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Figure 2.3.1 Molecular structure of trans-[PtMe3(py)I]2 showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Pt---Pt distance is 4.07 Å. Hydrogen atoms omitted for clarity. 
 
 
 
 
Figure 2.3.2 Molecular structure of cis-[PtMe3(4-EtPy)I]2 showing the atom labelling scheme. Thermal 
ellipsoids are at the 50% probability level. Pt---Pt distance is 4.05 Å. Hydrogen atoms omitted for clarity. 
 
 
The complex trans-[PtMe3(py)I]2 crystallized in C2/c space group with monoclinic crystal 
system and possess an inversion centre at the centre of the four-membered Pt2I2 ring. The 
complexes, cis-[PtMe3(4-OMePy)I]2 and cis-[PtMe3(4-CNPy)I]2, both crystallize in 
monoclinic P21/n space group. On the other hand, cis-[PtMe3(4-EtPy)I]2 crystallized in 
orthorhombic Pnam space group and possess a mirror plane where two iodides lie on the 
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mirror plane. The complex cis-[PtMe3(3-ClPy)I]2 also crystallized in orthorhombic crystal 
system (though space group is different, P212121). All the complexes contain four molecules 
in their unit cell. In case of cis-[PtMe3(3-ClPy)I]2, one molecule of [PtMe3I]4 also crystallized 
with it.  
 
 
 
Figure 2.3.3 Molecular structure of cis-[PtMe3(4-OMePy)I]2 showing the atom labelling scheme. Thermal 
ellipsoids are at the 50% probability level. Pt---Pt distance is 4.06 Å. Hydrogen atoms omitted for clarity. 
 
 
The important change at the Pt2I2 fragment caused by the change from pyridine to substituted 
pyridines is the slight shortening of the platinum-platinum non-bonded distance, from 4.07 Å 
in pyridine to 4.05 - 4.06 Å in 4-substituted pyridines to 4.03 Å in 3-chloropyridine analogue. 
This could be due to the change in trans geometry of the pyridine ligands in trans-
[PtMe3(py)I]2 to cis-geometry of the substituted pyridine ligands in the dinuclear complexes. 
The Pt---Pt non-bonded distance in these pyridine complexes is much longer than the           
Pt---Pt distance in [(PtMe3I)2MeSeSeMe] (3.90 Å),[64] [(PtMe3Br)2MeSeSeMe] (3.74 Å),[65] 
[(PtMe3Br)2(dmas)2] (3.79 Å) where  dmas = (dimethylarsino)sulphide,[66] Pt(DMG)2 (3.23 Å) 
where DMG = dimethylglyoxime.[67] This confirms that the Pt---Pt non-bonded distance 
depends on the nature of bridging ligand. Interestingly the changes of pyridine to substituted 
pyridines (both electron donating and electron withdrawing) do not produce any significant 
change in either the Pt-I, Pt-C or the Pt-N bond lengths (selected bond lengths and angles of 
the complexes are given in Tables 2.3.1-2.3.5). This also confirms that the Pt-N bond 
distances in the solid state structure of these complexes are not affected significantly by the 
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electronic effect of the pyridine substituent. The configuration about each platinum atom in 
each of the complexes is approximately octahedral, with interbond angles in the range of      
85-95° and 177-179°. 
 
 
Figure 2.3.4 Molecular structure of cis-[PtMe3(4-CNPy)I]2 showing the atom labelling scheme. Thermal 
ellipsoids are at the 50% probability level. Pt---Pt distance is 4.06 Å. Hydrogen atoms omitted for clarity. 
 
 
 
 
Figure 2.3.5 Molecular structure of cis-[PtMe3(3-ClPy)I]2 showing the atom labelling scheme. Thermal 
ellipsoids are at the 50% probability level. Pt---Pt distance is 4.03 Å. Hydrogen atoms omitted for clarity. 
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Table 2.3.1 Selected bond lengths [Å] and angles [°] for trans-[PtMe3(py)I]2 
 
Pt1-C1  2.061(9) 
Pt1-C2  2.031(9) 
Pt1-C3  2.050(8) 
Pt1-N1  2.174(6) 
Pt1-I2  2.811(6) 
Pt1-I2i                                                          2.800(7)  
 
C2-Pt1-C3 85.7(4) 
C2-Pt1-C1 87.0(5) 
C3-Pt1-C1 89.4(4) 
C2-Pt1-N1 91.6(4) 
C3-Pt1-N1 89.4(3) 
C1-Pt1-N1 178.2(3) 
I2i -Pt1-I2 87.15(2) 
Pt1 i -I2-Pt1 92.85(2) 
C2-Pt1-I2 93.7(3) 
C3-Pt1-I2 178.4(3) 
C1-Pt1-I2 92.0(3) 
N1-Pt1-I2 89.17(17) 
C2-Pt1- I2i 177.2(4) 
C3-Pt1- I2i 93.6(3) 
C1-Pt1- I2i 90.3(3) 
N1-Pt1- I2i 91.14(17) 
 
Symmetry transformations used to generate equivalent atoms:   
(i) 0.5-x, 1.5-y, -z 
 
 
 
Table 2.3.2 Selected bond lengths [Å] and angles [°] for cis-[PtMe3(4-EtPy)I]2 
 
Pt1-C1  2.054(8) 
Pt1-C2 2.039(9) 
Pt1-C3 2.059(9) 
 
Pt1-N1  2.188(6) 
Pt1-I2  2.8171(6) 
Pt1-I3  2.7793(6) 
C2-Pt1-C3 85.3(5) 
C2-Pt1-C1 88.1(4) 
C3-Pt1-C1 88.7(4) 
C2-Pt1-N1 90.3(3) 
C3-Pt1-N1 90.7(3) 
C1-Pt1-N1 178.3(3) 
I3-Pt1-I1 86.828(18) 
Pt1-I1-Pt1i 91.98(3) 
Pt1i-I2-Pt1 93.61(3) 
C2-Pt1-I2 178.1(3) 
C3-Pt1-I2 93.1(3) 
C1-Pt1-I2 90.8(3) 
N1-Pt1-I2 90.81(17) 
C2-Pt1-I1 94.7(3) 
C3-Pt1-I1 178.5(3) 
C1-Pt1-I1 89.9(3) 
N1-Pt1-I1 90.75(18) 
 
Symmetry transformations used to generate equivalent atoms:  
(i) x, y, -z+1/2  
 
 
 
Table 2.3.3 Selected bond lengths [Å] and angles [°] for cis-[PtMe3(4-OMePy)I]2 
 
Pt1-C1  2.054(8) 
Pt1-C2  2.053(8) 
Pt1-C3  2.044(7) 
Pt1-N1  2.186(7) 
Pt1-I1  2.7839(6) 
Pt1-I2  2.8117(5) 
 
Pt2-C4  2.051(9) 
Pt2-C5  2.037(9) 
Pt2-C6  2.031(7) 
Pt2-N2  2.182(7) 
Pt2-I1  2.8020(6) 
Pt2-I2  2.7986(6) 
 
C3-Pt1-C2 86.6(3) 
C3-Pt1-C1 86.7(4) 
C2-Pt1-C1 88.0(4) 
C6-Pt2-C5 86.4(4) 
C6-Pt2-C4 87.3(4) 
C5-Pt2-C4 89.1(4) 
C3-Pt1-N1 90.5(3) 
C2-Pt1-N1 91.1(3) 
C1-Pt1-N1 177.1(3) 
C4-Pt2-N2 177.3(3) 
Pt1-I1-Pt2 93.159(18) 
Pt2-I2-Pt1 92.632(17) 
I2-Pt2-I1 86.822(18) 
I1-Pt1-I2 86.916(18) 
C3-Pt1-I1 93.7(3) 
C2-Pt1-I1 179.6(3) 
C1-Pt1-I1 92.3(3) 
C3-Pt1-I2 176.7(3) 
C2-Pt1-I2 92.8(2) 
C1-Pt1-I2 90.0(2) 
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C6-Pt2-N2 90.0(4) 
C5-Pt2-N2 90.8(4) 
N2-Pt2-I2 87.99(16) 
N2-Pt2-I1 91.97(15) 
N1-Pt1-I1 88.60(16) 
N1-Pt1-I2 92.78(15) 
C6-Pt2-I2 94.2(3) 
C5-Pt2-I2 178.6(3) 
C4-Pt2-I2 92.2(3) 
C6-Pt2-I1 177.8(3) 
C5-Pt2-I1 92.6(3) 
C4-Pt2-I1 90.7(3) 
 
 
Table 2.3.4 Selected bond lengths [Å] and angles [°] for cis-[PtMe3(4-CNPy)I]2 
 
Pt1-C1  2.030(16) 
Pt1-C2 2.048(16) 
Pt1-C3  2.084(15) 
Pt1-N1 2.229(11) 
Pt1-I1  2.7902(11) 
Pt1-I2  2.7968(11) 
 
Pt2-C4 2.024(15) 
Pt2-C5 2.015(15) 
Pt2-C6 2.030(15) 
Pt2-N2 2.210(10) 
Pt2-I1  2.7984(10) 
Pt2-I2 2.7966(11) 
C1-Pt1-C2 89.5(8) 
C1-Pt1-C3 86.3(7) 
C2-Pt1-C3 88.6(7) 
C1-Pt1-N1 91.6(6) 
C2-Pt1-N1 90.7(6) 
C3-Pt1-N1 177.8(6) 
C1-Pt1-I2 90.8(6) 
C2-Pt1-I2 179.7(6) 
C3-Pt1-I2 91.6(5) 
N1-Pt1-I2 89.1(3) 
I1-Pt1-I2 86.82(3) 
C5-Pt2-I2 177.8(4) 
C4-Pt2-I2 94.4(6) 
C6-Pt2-I2 91.0(6) 
N2-Pt2-I2 90.6(3) 
Pt1-I1-Pt2 93.07(3) 
C5-Pt2-C4 87.7(7) 
C5-Pt2-C6 88.5(7) 
C4-Pt2-C6 87.1(8) 
C5-Pt2-N2 89.8(5) 
C4-Pt2-N2 92.6(6) 
C6-Pt2-N2 178.4(6) 
C5-Pt2-I1 91.2(4) 
C4-Pt2-I1 177.7(6) 
C6-Pt2-I1 90.8(5) 
N2-Pt2-I1 89.4(3) 
I2-Pt2-I1 86.66(3) 
C1-Pt1-I1 175.6(6) 
C2-Pt1-I1 93.0(6) 
C3-Pt1-I1 90.1(5) 
N1-Pt1-I1 92.0(3) 
Pt2-I2-Pt1 92.97(3) 
 
 
Table 2.3.5 Selected bond lengths [Å] and angles [°] for cis-[PtMe3(3-ClPy)I]2 
 
Pt1-C1  2.01(3) 
Pt1-C2  2.081(19) 
Pt1-C3  2.08(2) 
Pt1-N1  2.202(14) 
Pt1-I1 2.7766(15) 
Pt1-I2  2.7923(15) 
 
Pt2-C4  2.02(2) 
Pt2-C5  2.15(2) 
Pt2-C6  2.09(2) 
Pt2-N2 2.208(15) 
Pt2-I1 2.7827(15) 
Pt2-I2  2.8006(16) 
 
C1-Pt1-C3 87.4(10) 
C1-Pt1-C2 88.8(10) 
C3-Pt1-C2 86.8(9) 
C1-Pt1-N1 178.9(10) 
C3-Pt1-N1 91.6(8) 
C2-Pt1-N1 90.7(8) 
C1-Pt1-I1 89.5(8) 
C3-Pt1-I1 92.2(7) 
C2-Pt1-I1 178.0(6) 
N1-Pt1-I1 91.0(5) 
C1-Pt1-I2 90.6(8) 
C3-Pt1-I2 178.0(6) 
C2-Pt1-I2 93.6(6) 
N1-Pt1-I2 90.4(4) 
I1-Pt1-I2 87.44(4) 
C4-Pt2-C6 87.3(11) 
C4-Pt2-C5 86.6(9) 
C6-Pt2-C5 87.2(8) 
C4-Pt2-N2 179.6(9) 
C6-Pt2-N2 92.5(8) 
C5-Pt2-N2 93.6(7) 
C4-Pt2-I1 90.8(7) 
C6-Pt2-I1 92.5(6) 
C5-Pt2-I1 177.4(6) 
N2-Pt2-I1 88.9(4) 
C4-Pt2-I2 90.2(9) 
C6-Pt2-I2 177.5(6) 
C5-Pt2-I2 93.1(6) 
N2-Pt2-I2 90.0(5) 
I1-Pt2-I2 87.15(4) 
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3 Iodotrimethylplatinum(IV) Complexes of 2,2´-Bipyridines 
 
3.1 Introduction 
 
2,2´-Bipyridine and its derivatives have received much attention due to their exceptional 
coordination chemistry. Unlike many other common ligands, such as cyclopentadienyls and 
phosphines which are prone to oxidation, they are extremely stable in aqueous media and 
atmospheric oxygen.[68] The restricted rotation around the pyridyl-pyridyl bond during the 
complex formation results in an extremely stable species where nitrogen to metal σ-bond is 
further stabilised by the metal to ligand π-overlap. It was found that 2,2´-bipyridine 
complexes of transition metal such as ruthenium(II), osmium(II) or rhenium(I) possess 
interesting electrochemical and photochemical properties.[69-76] The transition metal 
complexes of 2,2´-bipyridine and its derivatives are also used as building blocks in supra-
molecular assemblies,[77] as electrochemical probes for DNA detection,[71,78] as electron 
transfer mediators for glucose oxidase[79] or as sensitizers in solar energy conversion.[80-82]  
 
The focus of the present research lies on the exchange of pyridine ligands with 2,2´-bipyridine 
ligands in the trimethylplatinum(IV) system. Thus the syntheses and characterization of 2,2´-
bipyridine complexes of trimethylplatinum(IV) become an essential step for this research. 
This chapter describes the syntheses and crystal structures of iodotrimethylplatinum(IV) 
complexes of six different 2,2´-bipyridines such as 2,2´-bipyridine (bipy), 4,4´-dimethyl-2,2´-
bipyridine (4Me-bipy), 5,5´-dimethyl-2,2´-bipyridine (5Me-bipy), 4,4´-dimethoxy-2,2´-
bipyridine (OMe-bipy), 4,4´-bis(dimethylamino)-2,2´-bipyridine (Me2N-bipy), and 4,4´-
dichloro-2,2´-bipyridine (Cl-bipy). The electronic effect of the substituent on both the 
solution and the solid state was examined and compared with the pyridine system. 
 
N
N
R
R
bipy: R = H
4Me-bipy: R = Me
OMe-bipy: R = OMe
Me2N-bipy: R = NMe2
Cl-bipy: R = Cl
N
N
R1
R1
5Me-bipy: R1 = Me
4,4´-Disubstituted-2,2´-bipyridine 5,5´-Disubstituted-2,2´-bipyridine
 
 
Scheme 3.1 2,2´-Bipyridine and its derivatives. 
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3.2 Syntheses and characterization of the complexes 
 
Mononuclear [PtMe3(L-L)I] (L-L = 2,2´-bipyridine and its derivatives) complexes were 
prepared by the treatment of iodotrimethylplatinum with 2,2´-bipyridines in equimolar ratio at 
room temperature in benzene (Scheme 3.2). 
 
[PtMe3I]4   +   4
N
N
R
R
C6H6
room temperature
Pt4
N
N
R
R
MeA
MeA
I
MeB
R : H, Me, OMe, NMe2, Cl
[PtMe3I]4   +   4 C6H6 Pt4
MeA
MeA
I
MeB
N
N
Me
Me
N
N
Me
Me
room temperature
 
 
Scheme 3.2 Reaction of iodotrimethylplatinum(IV) with 2,2´-bipyridine and its derivatives in benzene. 
 
Except [PtMe3(Cl-bipy)I], which is a deep yellow to brown coloured complex, all the 
mononuclear complexes are pale yellow in colour. None of the complexes are light or air 
sensitive. The complexes are soluble in nitrobenzene, chloroform; however, the complexes 
are not soluble to the same extent and it was found that the solubility of [PtMe3(Me2N-bipy)I] 
is lowest among all the mononuclear complexes. Moreover, the solubility of these 2,2´-
bipyridine complexes is much lower compared to that of the corresponding pyridine 
complexes in chloroform.  
 
The synthesized complexes were characterized by 1H NMR spectroscopy, IR spectroscopy, 
mass spectrometry and elemental analyses. Mass spectral analysis reflected the mononuclear 
nature of these complexes. For all the complexes, the highest m/z value corresponds to the 
loss of iodide, [M-I]+. In addition, in all cases, the observed isotope patterns were consistent 
with those calculated for the formulated species. The infrared data are consistent with the 
PtMe3 having facial octahedral coordination geometry.[39] The analytical data for all the 
complexes are reported in Chapter 5.3.4. 
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3.2.1 1H NMR studies of the complexes 
 
The 1H NMR data for the synthesized mononuclear complexes are noted in Table 3.1 and the 
1H NMR spectrum of [PtMe3(OMe-bipy)I] in CDCl3 is illustrated in Figure 3.1. The 
platinum-methyl regions of the spectra each consist of two principal methyl-platinum 
resonances in the integral ratio of 2:1, each with satellites due to coupling between the methyl 
protons and the 195Pt nuclei. The peak at the lower chemical shift (signal B) with relative 
integration 1 is due to the methyl group trans to iodide and the resonances at higher chemical 
shift (signal A) is due to the two methyl groups trans to the bipyridine ligand. The 2JPt-H scalar 
coupling constants observed for the methyl groups trans to I were higher than for the methyl 
groups trans to 2,2´-bipyridines, indicating that the bipyridines exert a stronger trans 
influence than iodide. 
 
0.81.01.21.41.6 ppm5678 ppm
B
AYC
D E F
X
Pt
I
MeA
MeB
MeA
N
N
OMe(C)
OMe(C)HD
HF
HE
,
 
 
Figure 3.1 The 400 MHz 1H NMR spectrum of [PtMe3(OMe-bipy)I] in CDCl3 at 300 K. For labelling, see inset. 
X is the solvent peak and Y is the peak for water present in CDCl3. 
 
Furthermore, an examination of the 2JPt-H scalar coupling constant for the methyl groups trans 
to bipyridine (signal A) in all the complexes, reveals a dependence on the chelate ligand, the 
trend in 2JPt-H scalar coupling constant is Cl-bipy > bipy ≈ 5Me-bipy ≈ 4Me-bipy ≈ OMe-bipy 
> Me2N-bipy. This leads to the conclusion that the trans influence of the bipyridines is 
strongly influenced by the electronic effect of the substituent attached to it. Electron donating 
substituent increases the trans influence of the bipyridines while trans influence of the 
bipyridines decreases considerably when an electron withdrawing substituent is attached to it. 
For 2,2´-bipyridine complex, the aromatic region comprised four signals while it is three for 
Chapter 3                                         Iodotrimethylplatinum(IV) Complexes of 2,2´-Bipyridines   
   
  53
the disubstituted 2,2´-bipyridine complexes. The highest frequency signal in each of the 
complexes displayed measurable 195Pt coupling by virtue of its proximity to the metal-
coordinated nitrogen. The chelate ligand sub-spectra were assigned on the basis of their scalar 
coupling networks and by comparison with the 1H NMR spectra of the free bipyridine ligand. 
 
 
Table 3.1 1H NMR dataa for the [PtMe3(L-L)I] (L-L = 2,2´-bipyridine and its derivatives) 
complexes in CDCl3 at 300 K 
 
 
Complex (chelate ligand) 
 
 
δ(Pt-Me)b 
 
Trans ligand 
 
δ(chelate H)c, e 
 
N N
HC
HF
HEHD
 
2,2´-Bipyridine (bipy) 
 
 
A 1.56 (70.5) 
B 0.64 (73.1) 
 
bipy 
I 
 
C 9.02 (6.1) (17.8)d 
D 8.23  
E 8.07 
F 7.64  
N N
Cl Cl
HE
HC
HD
 
4,4´-Dichloro-2,2´-bipyridine (Cl-bipy) 
 
A 1.56 (71.2) 
B 0.62 (72.3) 
Cl-bipy 
I 
C 8.91 (6.0) (19.2)d 
D 8.18 
E 7.66  
N N
HF
Me(C)
HD
HE
Me
 
5,5´-Dimethyl-2,2´-bipyridine (5Me-bipy) 
 
A 1.54 (70.4) 
B 0.62 (73.3) 
5Me-bipy 
I 
C 2.51 
D 8.77 (1.1) (12.7)d 
E 8.04  
F 7.81  
N N
Me Me(C)
HF
HD
HE
 
4,4´-Dimethyl-2,2´-bipyridine (4Me-bipy) 
 
A 1.51 (70.3) 
B 0.63 (73.5) 
4Me-bipy 
I 
C 2.57 
D 8.82 (5.8) (19.4)d 
E 8.01 
F 7.42   
N N
MeO OMe(C)
HF
HD
HE
 
4,4´-Dimethoxy-2,2´-bipyridine(OMe-bipy) 
 
A 1.48 (70.2) 
B 0.65 (73.7) 
OMe-bipy 
I 
C 4.02 
D 8.77 (6.4) (19.8)d 
E 7.58  
F 7.08  
N N
Me2N NMe2(C)
HF
HD
HE
 
4,4´-Bis(dimethylamino)-2,2´-bipyridine 
(Me2N-bipy) 
A 1.40 (69.6) 
B 0.68 (74.9) 
Me2N-bipy 
I 
C 3.16 
D 8.46 (6.6) (20.0)d 
E 7.14  
F 6.68  
 
a
 Chemical shifts quoted in ppm are relative to an internal solvent peak (CDCl3, δ = 7.26 ppm). b 2JPt-H/Hz in 
parentheses. c 3JH-H/Hz in parentheses. d  3JPt-H/Hz in parentheses. e Not all scalar coupling resolved.  
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3.3 X-ray crystallographic characterization of the complexes, [PtMe3(L-L)I] (L-L = 
bipy, 4Me-bipy, 5Me-bipy, OMe-bipy and Me2N-bipy) 
 
Single crystals of [PtMe3(OMe-bipy)I] were obtained by slow diffusion of n-hexane into its 
chloroform solution while the other four complexes were crystallized by mixing dilute 
benzene solution of iodotrimethylplatinum and corresponding 2,2´-bipyridine ligands in 
equimolar ratio. The crystal structure of all the complexes consists of a discrete monomeric 
unit in which the platinum atom is hexa-coordinated by the three methyl groups in a facial 
arrangement, a 2,2´-bipyridine ligand in a bidentate fashion and an iodine atom (Figures 3.2-
3.6). Experimental X-ray diffraction parameters and crystal data are reported in Tables 5.4.12-
5.4.16. The selected bond lengths and angles of [PtMe3(bipy)I] are given in Table 3.2, while 
selected bond lengths and angles of other complexes are listed in Table 3.3. 
 
 
 
 
Figure 3.2 Molecular structure of [PtMe3(bipy)I] showing the atom labelling scheme. Thermal ellipsoids are at 
the 50% probability level. Hydrogen atoms are omitted for clarity. 
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Figure 3.3 Molecular structure of [PtMe3(4Me-bipy)I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
 
 
Figure 3.4 Molecular structure of [PtMe3(5Me-bipy)I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
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Figure 3.5 Molecular structure of [PtMe3(OMe-bipy)I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
 
 
Figure 3.6 Molecular structure of [PtMe3(Me2N-bipy)I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 30% probability level. Hydrogen atoms are omitted for clarity. 
 
Chapter 3                                         Iodotrimethylplatinum(IV) Complexes of 2,2´-Bipyridines   
   
  57
The complex [PtMe3(Me2N-bipy)I] has eight molecules in its unit cell while each of the other 
complexes contains four molecules in their unit cell. Figure 3.7 shows the unit cell structure 
of [PtMe3(bipy)I]. However, a benzene molecule also crystallized with the complex 
[PtMe3(4Me-bipy)I] (see Figure 3.8). 
 
 
 
Figure 3.7 Unit cell structure of [PtMe3(bipy)I]. Thermal ellipsoids are at the 50% probability level. Hydrogen 
atoms are omitted for clarity. 
 
 
 
 
Figure 3.8 Unit cell structure of [PtMe3(4Me-bipy)I] showing solvent benzene. Thermal ellipsoids are at the 
50% probability level. Hydrogen atoms are omitted for clarity. 
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Each of the five complexes has distorted octahedral geometry around the platinum(IV) metal 
center. The N-Pt-N bite angle in all the complexes is almost the same (76.7° in 
[PtMe3(bipy)I], 76.3° in [PtMe3(4Me-bipy)I], 76.9° in [PtMe3(5Me-bipy)I],  76.2° in 
[PtMe3(OMe-bipy)I] and 76.1° in [PtMe3(Me2N-bipy)I]). This bite angle is close to the value 
found in reported [PtMe3(bipy)(pydz)][BF4] (75.3°),[50] [PtMe3(bipy)(C3H7NS2][BF4] 
(76.2°),[83] [PtMe3(bipy)(OCOMe)].H2O (76.7°),[84] and is somewhat larger than the bite angle 
found in [PtMe3(abpy)I] (73.5°),[85] [PtMe3(abpy)Br] (73.7°).[85]  Also, the N-Pt-N bite angle 
is much smaller than that found in the mononuclear pyridine complexes of iodotrimethyl-
platinum(IV) reported in Chapter 2, confirming the dependence of bite angle on the rigidity of 
coordinating ligand. 
 
The mean Pt-N bond distance (2.12 Å) in [PtMe3(bipy)I] is only slightly shorter than the 
mean Pt-N bond distance in the disubstituted bipyridine complexes (2.15 Å in [PtMe3(4Me-
bipy)I], 2.15 Å in [PtMe3(5Me-bipy)I], 2.16 Å in [PtMe3(OMe-bipy)I] and 2.15 Å in 
[PtMe3(Me2N-bipy)I]). This also shows that the Pt-N bond distances in the bipyridine 
complexes are not influenced significantly by the electronic effect of the bipyridine 
substituent as observed in the case of pyridine substituent (shown in Chapter 2). However, the 
Pt-N bond distances in the bipyridine complexes are marginally shorter than the Pt-N bond 
distances in the corresponding pyridine complexes (shown in Chapter 2.1 and 2.2), reflecting 
the better π acceptor character of the bipyridines compared to the pyridines.  
 
The Pt-I bond distance in all the bipyridine complexes is essentially identical (2.77-2.79 Å). 
Except [PtMe3(Me2N-bipy)I] where one of the two Pt-Ctrans N bonds is longer than the          
Pt-Ctrans I bond, in all the complexes the Pt-Ctrans I bond is longer than the Pt-Ctrans N bonds, but 
the difference is statistically insignificant.   
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Table 3.2 Selected bond lengths [Å] and angles [°] for [PtMe3(bipy)I] 
 
 
Pt1-C1  2.018(7) 
Pt1-C1i                                     2.018(7) 
Pt1-C2  2.047(9) 
 
Pt1-I3  2.7679(7) 
Pt1-N1  2.121(5) 
Pt1-N1i                                             2.121(5) 
 
C1-Pt1-C2 89.0(3) 
C1-Pt1-C1i 85.4(5) 
C1-Pt1-N1i 98.9(3) 
C2-Pt1-N1 88.5(2) 
C1-Pt1-N1 175.0(3) 
C1-Pt1-I3 91.1(2) 
C2-Pt1-I3  179.9(3) 
N1i -Pt1-I3 91.40(13) 
N1-Pt1-I3 91.40(13) 
N1i -Pt1-N1 76.7(3) 
 
Symmetry transformations used to generate equivalent atoms:  
(i) x,-y,z  
 
 
 
 
Table 3.3 Selected bond lengths [Å] and angles [°] for [PtMe3(L-L)I] (L-L = 4Me-bipy, 5Me-
bipy, OMe-bipy , Me2N-bipy) complexes 
 
  
[PtMe3(4Me-
bipy)I] 
 
[PtMe3(5Me-
bipy)I] 
 
 
[PtMe3(OMe-
bipy)I] 
 
[PtMe3(Me2N-
bipy)I] 
 
Pt1-C1  
 
2.030(5) 
 
2.041(6) 
 
2.036(7) 
 
2.057(15) 
Pt1-C2 2.038(6) 2.032(6) 2.056(8) 2.160(2) 
Pt1-C3 2.052(5) 2.051(7) 2.070(8) 2.060(2) 
Pt1-N1 2.152(4) 2.148(5) 2.155(6) 2.155(6) 
Pt1-N2 2.145(4) 2.155(5) 2.161(7) 2.135(12) 
Pt1-I3 2.7818(4) 2.7717(5) 2.7748(6) 2.7928(14) 
 
 
    
 
C1-Pt1-C2 84.8(3) 85.8(2) 85.6(3) 85.9(8) 
C2-Pt1-C3 87.7(3) 87.6(3) 88.1(4) 89.6(8) 
C1-Pt1-C3 87.9(2) 87.6(3) 87.9(3) 85.5(7) 
C1-Pt1-N1 174.8(2) 175.4(2) 173.2(3) 173.8(6) 
C2-Pt1-N1 99.0(2) 98.6(2) 99.7(3) 99.7(6) 
C3-Pt1-N1 88.7(2) 91.3(2) 88.0(3) 91.9(6) 
C1-Pt1-N2 99.8(2) 98.7(2) 98.3(3) 98.2(6) 
C2-Pt1-N2 174.5(2) 175.1(2) 175.6(3) 175.6(6) 
C3-Pt1-N2 89.4(2) 90.5(2) 89.9(3) 89.0(6) 
C1-Pt1-I3 91.55(17) 92.5(2) 89.7(2) 91.8(5) 
C2-Pt1-I3 93.3(2) 92.3(2) 91.3(3) 90.9(6) 
C3-Pt1-I3 178.8(2) 179.9(2) 177.6(2) 177.2(6) 
N1-Pt1-I3 91.83(11) 88.66(13) 94.40(14) 90.8(3) 
N2-Pt1-I3 89.71(11) 89.57(13) 90.94(17) 90.7(3) 
N1-Pt1-N2 76.27(15) 76.86(18) 76.2(2) 76.1(5) 
 
 
 
Chapter 3                                         Iodotrimethylplatinum(IV) Complexes of 2,2´-Bipyridines   
   
  60
3.4 X-ray crystallographic characterization of [PtMe3(Cl-bipy)I] 
  
Deep yellow crystals of [PtMe3(Cl-bipy)I] were obtained by mixing dilute benzene solution of 
iodotrimethylplatinum(IV) and 4,4´-dichloro-2,2´-bipyridine in equimolar ratio. The complex 
shows the expected fac-arrangement of the three methyl groups around the central platinum 
atom (Figure 3.9). The complex crystallizes in the P21/n space group with monoclinic crystal 
symmetry and contains four molecules in its unit cell. The experimental X-ray diffraction 
parameters and crystallographic data are given in Table 5.4.17, while selected bond lengths 
and angles are reported in Table 3.4.  
 
The Pt-I distance (2.78 Å) is essentially similar to the value found for the Pt-I bond in the 
complexes [PtMe3(L-L)I] (L-L = bipy, 4Me-bipy, 5Me-bipy, OMe-bipy and Me2N-bipy). The 
Pt-Ctrans I bond is marginally longer than the Pt-Ctrans N bonds. The Pt-N bond distances (2.13 
Å, 2.15 Å) are close to the values found for the other bipyridine complexes (shown in section 
3.3) and smaller than the Pt-N bond distances found for the pyridine complexes. Deviations 
from the idealized octahedral geometry are substantial, mainly due to the small bite angle of 
bipyridyl [N1-Pt1-N2 77.0°], which opens up the N1-Pt1-C2 and N2-Pt1-C1 cis angles to 
98.2° and 97.9° respectively, and narrows down the N1-Pt1-C1 and N2-Pt1-C2 trans angles 
to 174.6° and 174.8° respectively. 
 
 
 
Figure 3.9 Molecular structure of [PtMe3(Cl-bipy)I] showing the atom labelling scheme. Thermal ellipsoids are 
at the 50% probability level. Hydrogen atoms are omitted for clarity. 
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Table 3.4 Selected bond lengths [Å] and angles [°] for [PtMe3(Cl-bipy)I] 
 
 
Pt1-C1 2.018(12) 
Pt1-C2 2.051(11) 
Pt1-C3  2.088(15) 
 
 
Pt1-N1  2.128(10) 
Pt1-N2 2.150(9) 
Pt1-I3  2.7785(11) 
C1-Pt1-C2 86.8(5) 
C1-Pt1-C3 87.8(7) 
C2-Pt1-C3 86.7(6) 
C1-Pt1-N1 174.6(5) 
C2-Pt1-N1 98.2(4) 
C3-Pt1-N1 90.4(5) 
C1-Pt1-N2 97.9(5) 
C2-Pt1-N2 174.8(5) 
N1-Pt1-N2 77.0(4) 
C1-Pt1-I3 92.3(5) 
C2-Pt1-I3 92.2(4) 
C3-Pt1-I3 178.9(5) 
N1-Pt1-I3 89.6(3) 
N2-Pt1-I3 89.8(3) 
C3-Pt1-N2 91.2(5) 
 
 
 
 
The crystal packing of [PtMe3(Cl-bipy)I] also contains some additional features. Only one of 
the two chlorine atoms (labelled as Cl1) of [PtMe3(Cl-bipy)I] interacts with the hydrogen 
atom (labelled as H, which is bonded to C2) (interaction is shown by red colour dotted bond) 
of another molecule of [PtMe3(Cl-bipy)I] (see Figure 3.10) (the distance between them is 2.79 
Å which is less than the sum of the van der waals radii of H and Cl), thereby leading to the 
formation of an infinite chain of one dimensional zig-zag structure (Figure 3.11).      
 
 
 
 
Figure 3.10 A perspective view of [PtMe3(Cl-bipy)I] showing the intermolecular interaction (red colour dotted 
bond) between the hydrogen atom (H) and chlorine atom (Cl1). 
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Figure 3.11 A perspective view of an infinite chain of one dimensional zig-zag structure of [PtMe3(Cl-bipy)I]. 
 
 
π-π interaction[86,87] plays an important role in controlling the packing or assembly of 
compounds. Although each 4,4´-dichloro-2,2´-bipyridine is parallel to an adjacent one, the 
position of each is shifted so that one is not directly above the other. The perpendicular 
distance between the two parallel rings is approximately 3.90 Å. This weak π-π interaction 
holds the zig-zag chains together, supporting a two-dimensional layer structure (Figure 3.12). 
Similar π-π interactions between interlocking chains are also observed in the crystal packing 
of adamantane derivatives of bipyridines.[88,89]   
 
 
 
Figure 3.12 A perspective view of a two-dimensional framework structure of [PtMe3(Cl-bipy)I]. 
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3.5 Conclusion 
 
Reaction of iodotrimethylplatinum(IV) with 2,2´-bipyridines in equimolar ratio in benzene 
results in the formation of chelate complexes of bipyridines. The complexes were 
characterized by 1H NMR, EI-MS, IR spectroscopy and elemental analyses. The 2JPt-H 
coupling constant of these complexes confirms that the trans influence of the bipyridines is 
stronger than that of the iodide ligand and depends on the electronic nature of the substituent 
attached to the bipyridine ring. Electron donating substituents increase the trans influence of 
the bipyridines whereas electron withdrawing substituents reduce the extent of trans influence 
of the bipyridines. X-ray crystal structure analysis of the complexes reveals the fac-octahedral 
coordination of the PtMe3 moiety and bidentate coordination of the aromatic ligand. The Pt-N 
bond distances are not affected significantly by the electronic effect of the bipyridine 
substituent. However, the Pt-N bonds for the bipyridine complexes are slightly shorter than 
for the corresponding pyridine complexes, indicating that the bipyridine ring is a better π-
acceptor. The N-Pt-N bite angle for the bipyridine complexes is also much lower than that of 
the pyridines. The intermolecular non-covalent interaction between methyl hydrogen and 
chlorine atom in [PtMe3(Cl-bipy)I] leads to the formation of zig-zag chains. In turn, these 
interlocking chains are linked through weak π-π interactions and thereby generate two-
dimensional layer structure. 
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4 Ligand-Exchange Study on Iodotrimethylplatinum(IV) Complexes 
 
4.1 Introduction 
 
The presence of strongly electron donating methyl groups makes the ligand substitution 
reaction in methylplatinum(IV) complexes straightforward. The substitution reaction in these 
complexes can be electrophilic[90] as well as nucleophilic.[91,92] The reaction of a pyridine 
complex of iodotrimethylplatinum(IV) with 2,2´-bipyridine leads to the substitution of 
pyridine by 2,2´-bipyridine resulting in the formation of the chelate complex of 2,2´-
bipyridine. Thus, with a view to exploring the chelate effect in the trimethylplatinum(IV) 
system, this chapter deals with the exchange of pyridine ligands by the 2,2´-bipyridine ligands 
in the complexes of iodotrimethylplatinum(IV). Different types of pyridines (py, 4-MePy, 4-
OMePy and 4-DMAP) were substituted by the corresponding 2,2´-bipyridines (bipy, 4Me-
bipy, OMe-bipy and Me2N-bipy) (Scheme 4.1) in the iodotrimethylplatinum(IV) complexes 
to demonstrate the electronic effect of the substituent on the chelation reaction. The reactions 
were carried out in two solvents (CDCl3, an apolar solvent and nitrobenzene-d5, a polar 
solvent) to examine the solvent effect on the chelation reaction. 
 
N
R
NN
R R
Pyridines 2,2´-Bipyridines
py:            R = H
4-MePy:    R = Me
4-OMePy: R = OMe
4-DMAP:  R = NMe2
bipy:            R = H
4Me-bipy:    R = Me
OMe-bipy:   R = OMe
Me2N-bipy:  R = NMe2
 
 
Scheme 4.1 Different pyridines and corresponding 2,2´-bipyridines used for the chelation reaction in 
trimethylplatinum(IV) system. 
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4.2 Result and Discussion 
 
4.2.1 Syntheses and characterization of the complexes 
 
The complexes [PtMe3L2I] (L = py, 4-MePy, 4-OMePy, 4-DMAP) were synthesized by the 
treatment of tetranuclear iodotrimethylplatinum(IV) with pyridine ligands. Similarly, reaction 
of iodotrimethylplatinum(IV) with 2,2´-bipyridine and its derivatives results in the chelate 
complexes of 2,2´-bipyridines, [PtMe3(L-L)I] (L-L = bipy, 4Me-bipy, OMe-bipy and Me2N-
bipy). Full synthetic and analytical data of the complexes are reported in Section 5.3.3-5.3.4. 
 
 
4.2.2 Reaction of [PtMe3L2I] (L = py, 4-MePy and 4-OMePy) complexes with corres-
ponding 2,2´-bipyridines (bipy, 4Me-bipy and OMe-bipy) 
 
Reaction of iodotrimethylplatinum(IV) complexes of pyridine (py) and its 4-substituted 
derivatives (4-MePy, 4-OMePy) with the corresponding 2,2´-bipyridines (bipy, 4Me-bipy and 
OMe-bipy) results in the formation of two chelate complexes of bipyridines along with the 
release of free pyridines (see Scheme 4.2). The reactions were followed by 1H NMR 
spectroscopy. The 1H NMR spectra of an equimolar mixture of pyridine complex and the 
corresponding 2,2´-bipyridine ligand at equilibrium at 300 K for each of the three substitution 
reactions show signals for the three trimethylplatinum(IV) complexes (I, II and III, as shown 
in Scheme 4.2), free pyridine ligand, and unreacted 2,2´-bipyridine ligand. Each of the 
trimethylplatinum(IV) complexes consists of two platinum-methyl resonances, due to 195Pt-H 
scalar coupling, with an intensity ratio of 2:1. The 1H NMR data for all three reactions in 
CDCl3 and in nitrobenzene-d5 are reported in Table 4.1. The 1H NMR spectrum of an 
equimolar mixture of [PtMe3(py)2I] and bipy at equilibrium at 300 K in nitrobenzene-d5 is 
shown in Figure 4.1, while 1H NMR spectrum of an equimolar mixture of [PtMe3(4-
OMePy)2I] and OMe-bipy in CDCl3 at equilibrium at 300 K is illustrated in Figure 4.2. 
 
Pt
I
NMeA
MeB
NMeA
R
R
N
N
R
R
Pt
I
NMeC
MeD
NMeC
R
R
Pt
N
NMeE
MeF
NMeE
R
R
R
N
R
I +
I II
III
+ +
R = H, Me, OMe
 
 
Scheme 4.2 The substitution of pyridine ligands by the corresponding 2,2´-bipyridines in iodotrimethylplatinum 
complexes.  
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0.60.70.80.91.01.11.21.31.41.51.61.71.8 ppm
C
DE
F
A B
 
 
 
Figure 4.1 The platinum-methyl region in the 1H NMR spectrum of an equimolar mixture of [PtMe3(py)2I] and 
bipy in nitrobenzene-d5 at equilibrium at 300 K showing presence of three platinum(IV) complexes 
[PtMe3(py)2I] (I), [PtMe3(bipy)I] (II) and [PtMe3(bipy)(py)]I (III). For labelling, see Scheme 4.2. 
 
 
3.853.903.954.004.054.104.154.204.254.30 ppm
III
II
I
III
4-OMePy
OMe-bipy
 
 
Figure 4.2 The methoxy region in the 1H NMR spectrum of an equimolar mixture of [PtMe3(4-OMePy)2I] and 
OMe-bipy in CDCl3 at equilibrium at 300 K. I = [PtMe3(4-OMePy)2I]. II = [PtMe3(OMe-bipy)I]. III = 
[PtMe3(OMe-bipy)(4-OMePy)]I. The signal at the left correspond to the methoxy group of OMe-bipy in 
complex III, while the signal at the utmost right correspond to the methoxy group of the 4-OMePy in complex 
III.  
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4.2.3 Reaction of [PtMe3(4-DMAP)2I] with Me2N-bipy 
 
Reaction of [PtMe3(4-DMAP)2I] with Me2N-bipy leads to the formation of exclusively one 
chelate complex, [PtMe3(Me2N-bipy)(4-DMAP)]I. A small amount of [PtMe3(4-DMAP)3]I is 
also formed in solution due to the reaction of [PtMe3(4-DMAP)2I] with the free 4-DMAP 
ligand, generated in solution because of the substitution process (see Scheme 4.3). The 1H 
NMR data for the presence of different trimethylplatinum(IV) complexes for the reaction of 
an equimolar mixture of [PtMe3(4-DMAP)2I] and Me2N-bipy at equilibrium at 300 K in 
CDCl3 and in nitrobenzene-d5 is presented in Table 4.1. 
 
Pt
I
NMeA
MeB
NMeA
NMe2
NMe2
N
N
NMe2
NMe2
Pt
N
NMeE
MeE
NMeE
NMe2
NMe2
NMe2
N
NMe2
I +
+ Pt
N
NMeC
MeD
NMeC
NMe2
NMe2
NMe2
I +
[PtMe3(4-DMAP)2I]
[PtMe3(Me2N-bipy((4-DMAP)]I [PtMe3(4-DMAP)3]I
Me2N-bipy
4-DMAP
 
 
Scheme 4.3 The substitution of 4-DMAP by Me2N-bipy in iodotrimethylplatinum(IV) complex.  
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Table 4.1 1H NMR dataa for the reaction of an equimolar mixture of [PtMe3L2I] (L = 
pyridines) and corresponding 2,2´-bipyridines at equilibrium at 300 K in CDCl3 and in 
nitrobenzene-d5 
 
 
Reaction 
 
 
Pt(IV) species present 
in equilibrium 
 
 
δ(Pt-CH3)b, c  in 
CDCl3 
 
δ(Pt-CH3)b, c in 
nitrobenzene-d5 
 
Trans 
ligand 
 
Equimolar mixture  
of [PtMe3(py)2I] and 
bipy 
 
[PtMe3(py)2I] 
 
A 1.50 (70.3) 
B 1.20 (69.6) 
 
A 1.70 (70.4) 
B 1.29 (68.9) 
 
py 
I 
 
[PtMe3(bipy)I] C 1.56 (70.5) 
D 0.64 (73.1) 
C 1.81 (70.5) 
D 0.78 (72.6) 
bipy 
I 
 
[PtMe3(bipy)(py)]I E 1.23 (67.1) 
F 0.57 (70.3) 
E 1.31 (67.2) 
F 0.61 (70.5) 
bipy 
py 
 
 
 
Equimolar mixture  
of [PtMe3(4-MePy)2I]  
and 4Me-bipy 
[PtMe3(4-MePy)2I] A 1.45 (70.0) 
B 1.17 (70.0) 
A 1.69 (70.1) 
B 1.28 (69.2) 
4-MePy 
I 
 
[PtMe3(4Me-bipy)I] C 1.51 (70.3) 
D 0.63 (73.5) 
C 1.78 (70.3) 
D 0.81 (72.9) 
4Me-bipy 
I 
 
[PtMe3(4Me-bipy) 
(4-MePy)]I 
E 1.14 (66.9) 
F 0.52 (70.6) 
E 1.25 (67.2) 
F 0.61 (70.5) 
4Me-bipy 
4-MePy 
 
 
 
Equimolar mixture  
of [PtMe3(4-OMePy)2I]  
and OMe-bipy 
[PtMe3(4-OMePy)2I] A 1.42 (70.0) 
B 1.15 (70.2) 
A 1.69 (70.2) 
B 1.29 (69.4) 
4-OMePy 
I 
 
[PtMe3(OMe-bipy)I] C 1.48 (70.2) 
D 0.65 (73.7) 
C 1.77 (70.5) 
D 0.86 (73.0) 
OMe-bipy 
I 
 
[PtMe3(OMe-bipy) 
(4-OMePy)]I 
E 1.09 (67.2) 
F 0.50 (70.4) 
E 1.23 (67.4) 
F 0.64 (70.5) 
OMe-bipy 
4-OMePy 
 
 
 
Equimolar mixture  
of [PtMe3(4-DMAP)2I]  
and Me2N-bipy 
[PtMe3(4-DMAP)2I] A 1.35 (69.3) 
B 1.14 (71.5) 
Not present  4-DMAP 
I 
 
[PtMe3(Me2N-bipy) 
(4-DMAP)]I 
C 0.94 (67.0) 
D 0.43 (70.3) 
C 1.13 (67.1) 
D 0.65 (70.0) 
Me2N-bipy 
4-DMAP 
 
[PtMe3(4-DMAP)3]I E 0.92 (66.7) E 1.04 (66.7) 4-DMAP 
 
 
a
 Chemical shifts quoted in ppm are relative to internal solvent peaks (in the case of CDCl3, δ = 7.26 ppm; in the 
case of nitrobenzene-d5, δ = 8.11 ppm). b 2JPt-H/Hz in parentheses. c labelling refers to Schemes 4.2 and 4.3. 
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An analysis of Table 4.1 shows that changing the solvent from CDCl3 to nitrobenzene-d5 
causes the platinum-methyl resonances to shift to higher frequency in the 1H NMR spectrum. 
The difference in chemical shifts for the two platinum-methyl resonances is larger in the 
bipyridine complexes than in the pyridine complexes. Moreover, the difference in chemical 
shifts for the two platinum-methyl resonances is greater in the neutral chelate [PtMe3(L-L)I] 
(L-L = 2,2´-bipyridines) complexes than in the ionic chelate [PtMe3(L-L)L]I (L-L = 2,2´-
bipyridines, L = corresponding pyridines) complexes. The 2JPt-H scalar coupling constants 
indicate that the trans influence of the 2,2´-bipyridines is stronger than the corresponding 
pyridines (trans influence: bipy > py, 4Me-bipy > 4-Mepy, OMe-bipy > 4-OMePy, Me2N-
bipy > 4-DMAP). Also, the trans influence of the 2,2´-bipyridines is greater in the ionic 
chelate complexes than in the neutral chelate complexes. The results for the reaction of an 
equimolar mixture of [PtMe3L2I] (L = pyridines such as py, 4-MePy, 4-OMePy and 4-DMAP) 
and corresponding 2,2´-bipyridines at equilibrium in CDCl3 and in nitrobenzene-d5 are 
summarized in Table 4.2.  
 
Table 4.2 The reaction of an equimolar mixture of [PtMe3L2I] (L = pyridines) and 
corresponding 2,2´-bipyridines (L-L) at equilibrium at 300 K in CDCl3 and in nitrobenzene-d5 
a, b
 
 
Substitution of pyridine 
ligands by 2,2´-bipyridines 
 
In CDCl3 
 
In nitrobenzene-d5 
 
 
Chelate complex  
/Non-chelate 
complex  
 
 
Ionic chelate  
/Neutral chelate  
 
Chelate complex  
/Non-chelate 
complex  
 
Ionic chelate  
/Neutral chelate  
 
py by bipy 
 
15.67 
 
0.20 
 
13.29 
 
0.52 
 
4-MePy by 4Me-bipy 11.5 0.64 6.14 1.17 
 
4-OMePy by OMe-bipy 8.09 1.54 5.25 2.23 
 
4-DMAP by Me2N-bipy  19.0 Only ionic 
chelate present 
15.67 Only ionic 
chelate present 
 
a
 Chelate complex is the mixture of ionic chelate [PtMe3(L-L)L]I and neutral chelate [PtMe3(L-L)I]. Non chelate 
complex is [PtMe3L2I]. (L = pyridines such as py, 4-MePy and 4-OMePy; L-L = corresponding bipyridines such 
as bipy, 4Me-bipy and OMe-bipy). 
 
bIn the case of the substitution of 4-DMAP by Me2N-bipy, only the ionic chelate [PtMe3(Me2N-bipy)                 
(4-DMAP)]I is present in solution in both the solvents. In CDCl3, the non-chelate complex is the mixture of 
[PtMe3(4-DMAP)2I]  and [PtMe3(4-DMAP)3]I, while in nitrobenzene-d5, the non-chelate complex is [PtMe3(4-
DMAP)3]I. 
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Table 4.2 shows that the equilibrium for all the four substitution reactions in both the solvents 
(CDCl3 and nitrobenzene-d5) strongly favour the formation of chelate 2,2´-bipyridine 
complexes which are more stable than the corresponding non-chelate pyridine complexes. 
The formation of the chelate complexes at equilibrium for each of the four substitution 
reactions depends on the electronic effect of the substituent as well as on the nature of the 
solvent. As the electron donating property of the substituent increases from H to NMe2 in the 
order H < Me < OMe < NMe2, the population ratio of the ionic chelate [PtMe3(L-L)L]I to the 
neutral chelate [PtMe3(L-L)I] (L = pyridines, L-L = corresponding bipyridines) also increases 
in the same order in both the solvents. This can be rationalised in terms of the stability of the 
ionic chelates in solution. As the electron donating ability of the substituent increases, the 
electron density in both the pyridine and bipyridine ring N also increases. The resulting 
increase in the electron density on the aromatic ring N also causes an increase in the extent of 
Pt-N interaction which accounts for the increased stability of the ionic chelates in solution, 
and in the case of NMe2 substituent, the stability of the ionic chelate is so high (because of the 
extremely strong Pt-N interaction) that exclusively the ionic chelate [PtMe3(Me2N-bipy)(4-
DMAP)]I is formed in solution. The strength of the chelate effect for the different substituents 
in both the solvents is in the order: NMe2 > H > Me > OMe. To explain the above order of 
chelation among the substituents (H, Me, and OMe), the stability of the reactant complexes in 
solution is also taken into consideration. As the electron donating ability of the substituent 
increases from H to Me to OMe, the stability of the reactant non-chelate pyridine complexes 
also increases (from H to Me to OMe) due to the increasing Pt-N interaction in the reactant 
complexes, thereby leading to a decrease in the strength of the chelate effect. For H, Me and 
OMe substituents, the population ratio of the ionic chelate to the neutral chelate is more in 
nitrobenzene-d5 than in CDCl3. This is supported by the fact that the ionic complexes are 
more stable in polar solvent (nitrobenzene-d5) than in apolar solvent (CDCl3). The strength of 
chelation for a particular substituent is greater in CDCl3 than in nitrobenzene-d5. This is most 
likely due to the lower solvent stabilization of the reactant complexes in CDCl3 than in 
nitrobenzene-d5. 
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4.3 Conclusion 
 
The reaction of iodotrimethylplatinum(IV) complexes of pyridines, [PtMe3L2I] (L = py, 4-
MePy, 4-OMePy, 4-DMAP) with the corresponding 2,2´-bipyridines (bipy, 4Me-bipy, OMe-
bipy, Me2N-bipy) lead to the substitution of the pyridine ligands by the bipyridines, resulting 
in the formation of neutral [PtMe3(L-L)I] and ionic [PtMe3(L-L)L]I (L-L = 2,2´-bipyridines, L 
= corresponding pyridines) chelate complexes along with the release of pyridines. The 
equilibrium for all the substitution reactions strongly favours the formation of chelate 
complexes. The formation of chelate complexes in solution at equilibrium depends on the 
electronic effect of the substituents as well as on the nature of the solvent. Increasing electron 
donating ability of the substituent leads to an increase in the stability of the ionic chelate in 
solution. The tendency for the chelation is very high for strong electron donating substituents 
such as NMe2; however, for H and moderately electron donating substituents such as Me and 
OMe, increasing electron donating ability decreases the strength of the chelate effect. The 
stability of ionic chelate is more in nitrobenzene-d5 (polar solvent) than in CDCl3 (apolar 
solvent); however, the strength of chelation is greater in CDCl3 than in nitrobenzene-d5. 
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5 Experimental Section 
 
5.1 Characterization Methods 
 
5.1.1 1H NMR Spectroscopy 
 
1H NMR spectra were recorded on a Bruker Avance II 400 MHz spectrometer, operating at 
400 MHz. Chemical shifts are relative to an internal solvent peak (for CDCl3 stabilized with 
Ag-foil, δ = 7.26 ppm; for DMSO-d6, δ = 2.50 ppm; for D2O, δ = 4.79 ppm; for nitrobenzene-
d5, δ = 8.11 ppm).  
 
1H DOSY NMR spectra were recorded on a Bruker Avance III 600 MHz spectrometer, 
equipped with a 5 mm broadband BBO Z-gradient probe (maximum gradient strength 
53.5 G/cm), operating at 600 MHz. All diffusion experiments were performed with a 
convection suppressing Double STE pulse sequence in pseudo-two dimensional mode and 
processed with Bruker TOPSPIN software package (Version 2.0). The temperature was set 
and controlled at 298 K with airflow of 5351 h-1. For each experiment, 16 dummy scans and 
24 scans were used, with a relaxation delay of 2 s and a diffusion delay of 100 ms. The shape 
of the gradients was sinusoidal, with a length of 1 m, and the strength was varied in 32 
increments (2-95%) in a linear ramp. 
 
 
5.1.2 IR Spectroscopy 
 
Infrared spectra were recorded as pressed KBr discs on an IFS 48 spectrometer, equipped 
with a KBr beam splitter, operating in the region 4000-400 cm-1. 
 
5.1.3 Elemental Analysis 
 
Elemental analyses were performed on a Thermo Electron Flash EA 1112 series.  
 
 
5.1.4 EI-Mass Spectroscopy 
 
EI-mass spectra were acquired on a Finnigan MAT 95 (EI: 70 eV) mass spectrometer. 
 
 
Chapter 5  Experimental Section   
   
  73
5.2 Materials and Working Conditions 
 
The following compounds were commercially available: 
 
• Pyridine (py), 4-dimethylaminopyridine (4-DMAP), 4-cyanopyridine (4-CNPy), 2,2´-
bipyridine (bipy), nitrobenzene-d5 from Aldrich 
• Potassium hexachloroplatinate, 4-methylpyridine (4-MePy), 4-ethylpyridine (4-EtPy), 
4-methoxypyridine (4-OMePy), 4-tbutylpyridine (4-tBuPy), 3-bromopyridine (3-
BrPy), 3-methoxypyridine (3-OMePy), 4,4´-dimethoxy-2,2´-bipyridine (OMe-bipy) 
from Acros Organics 
• 3-Methylpyridine (3-MePy), 3-ethylpyridine (3-EtPy), 3-chloropyridine (3-ClPy), 
4,4´-dimethyl-2,2´-bipyridine (4Me-bipy), 5,5´-dimethyl-2,2´-bipyridine (5Me-bipy) 
from Alfa Aesar  
• 30% Hydrogen peroxide (H2O2) from Merck 
• CDCl3, DMSO-d6, D2O from Euriso-top 
• Magnesium turning, sodium metal, molecular sieve (3 Å), potassium bromide (KBr), 
sodium hydroxide (NaOH), calcium chloride (CaCl2), calcium hydride (CaH2), 
anhydrous calcium sulfate (CaSO4), anhydrous magnesium sulfate (MgSO4), glacial 
acetic acid (CH3COOH), oleum-sulfuric acid, fuming nitric acid from the chemical 
storage of the Institute of Inorganic and Analytical Chemistry, Justus-Liebig-
University of Giessen 
• Acetyl chloride (CH3COCl), methyl iodide (CH3I) and phosphorous trichloride (PCl3) 
from the chemical storage of the Institute of Organic Chemistry, Justus-Liebig- 
University of Giessen 
• The solvents acetone, benzene, chloroform, dichloromethane (DCM), diethyl ether, n-
hexane, n-pentane, methanol, ethanol from the chemical storage of the Institute of 
Inorganic and Analytical Chemistry, Justus-Liebig-University of Giessen 
• N,N-Dimethylformamide from the chemical storage of the Institute of Organic 
Chemistry, Justus-Liebig-University of Giessen 
 
All the chemicals were of reagent grade. Solvents for the air-sensitive reactions were 
redistilled under argon. The ligands 4,4´-bis(dimethylamino)-2,2´-bipyridine (Me2N-bipy), 
4,4´-dichloro-2,2´-bipyridine (Cl-bipy) and the complex [PtMe3I]4 were synthesized under 
inert conditions using  standard Schlenk techniques. The rest of the complexes were prepared 
under ambient conditions.  
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5.3 Syntheses 
 
5.3.1 Synthesis of Iodotrimethylplatinum(IV)
 
  
The complex iodotrimethylplatinum(IV) was prepared by the method of Baldwin et al.[28]  
 
The Grignard reagent, CH3MgI, was prepared by dropping 10.0 mL (22.8 g, 160 mmol) of 
methyl iodide in 40 mL of dry diethyl ether onto flame-dried magnesium turnings (2.20 g, 
90.4 mmol) under argon. The resulting black suspension was then stirred until the last pieces 
of magnesium were dissolved and subsequently filtered through a sintered-glass disk 
(medium porosity) directly into a dropping funnel mounted atop a flask which contained 
4.00 g (8.24 mmol) of finely powdered potassium hexachloroplatinate (K2PtCl6) in 20 mL of 
diethyl ether and 80 mL of benzene. The reaction mixture was allowed to warm gradually up 
to room temperature after the addition and left to stir under argon. Within 4 h, the mixture 
faded from yellow to white. After stirring the mixture overnight, the white salts were allowed 
to settle. The supernatant was then filtered through a medium sintered-glass disk under argon. 
The clear, nearly colourless filtrate was cooled to 0 °C and 10 mL of ice-cold acetone was 
slowly added dropwise to the stirring filtrate. As the acetone was added a vigorous reaction 
took place, which turned the mixture yellow and then orange. A two-phase mixture resulted 
with a yellow layer at the top and an orange layer below. After opening the flask to the air, 
50 mL of ice-cold water was added to the stirring mixture. The mixture was acidified with 
60 mL of 10% HCl which dissolves the solid and gives an orange-yellow organic layer over a 
pinkish orange aqueous layer with a small amount of orange solid at the interphase. The 
orange solid was filtered and the layers were separated. The aqueous layer was extracted with 
3 30-mL portions of benzene. The extracts were combined with the organic layer and dried by 
filtration through a cone of anhydrous CaSO4. The clear, yellow-orange solution then 
evaporated to dryness, and the resulting yellow solid dissolved in 40 mL of CHCl3. This 
solution was evaporated to about 15 mL, 15 mL of acetone was added, and the mixture was 
cooled in ice. The yellow crystals formed were collected and air-dried. Yield: 2.3 g (76%). 
 
1H NMR (CDCl3; ppm): δ = 1.72 (s, 9H, PtCH3, 2JPt-H: 77.3 Hz). 
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5.3.2 Syntheses of 4,4´-disubstituted-2,2´-bipyridine ligands 
 
5.3.2.1 Synthesis of 4,4´-bis(dimethylamino)-2,2´-bipyridine (Me2N-bipy) 
 
The ligand Me2N-bipy was synthesized by the following steps: 
 
Step 1 Synthesis of 2,2´-bipyridine N,N´-dioxide (bipy N-Oxide)[93] 
 
A 30 mL solution of 30% hydrogen peroxide was added to 2,2´-bipyridine (10.0 g, 64 mmol) 
in 50 mL of glacial acetic acid at a rate that maintained the temperature between 70 °C and 
80 °C. The mixture was stirred at 75 °C for an additional 8 h. The solution was then cooled to 
room temperature, and a large amount (750 mL) of acetone was added to precipitate the 
product as a white solid, which was collected by filtration and air-dried. Yield: 11.3 g 
(60 mmol, 94% yield). 
 
1H NMR (D2O; ppm): δ = 7.76 (m, 4H), 7.85 (m, 2H), 8.47 (m, 2H). 
 
Step 2 Synthesis of 4,4´-dinitro-2,2´-bipyridine N,N´-dioxide (O2N-bipy N-Oxide)[93] 
 
A solution of bipy N-Oxide (9.0 g, 47.8 mmol) in 26 mL of oleum-sulfuric acid was cooled to 
0 °C. Fuming nitric acid (20 mL) was carefully added, and the mixture was stirred at 100 °C   
for 8 h. The solution was then cooled to 0 °C and very cautiously poured onto ice water 
(200 g). The resultant yellow product was filtered off and washed with water until neutral. 
Yield: 9.6 g (34.5 mmol, 72%). 
 
1H NMR (DMSO-d6; ppm): δ = 8.38 (dd, 2H), 8.60 (d, 2H), 8.70 (d, 2H). 
 
Step 3 Synthesis of 4,4´-dichloro-2,2´-bipyridine N,N´-dioxide (Cl-bipy N-Oxide)[94] 
 
A suspension of 1 g of O2N-bipy N-Oxide (3.59 mmol) in 50 mL of acetyl chloride was 
refluxed under argon for 3 h. The solid product was filtered off, washed with 50 mL of diethyl 
ether, and dried under vacuum. Yield: 700 mg of pale yellow powder (2.72 mmol, 76%). 
 
1H NMR (CDCl3; ppm): δ = 7.35 (dd, 2H), 7.72 (d, 2H), 8.25 (d, 2H). 
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Step 4 Synthesis of 4,4´-bis(dimethylamino)-2,2´-bipyridine (Me2N-bipy)[93] 
 
A suspension of 1 g of Cl-bipy N-Oxide (3.89 mmol) in 150 mL DMF was refluxed under 
argon for 48 h. The solvent was evaporated nearly completely, and the crude product was 
dissolved in 100 mL of chloroform. Phosphorous trichloride (8.5 mL, 97.4 mmol) was added 
dropwise to the cooled solution at 0 °C. The reaction mixture was then refluxed for 3 h and 
then poured onto 250 mL of ice water. The chloroform layer was washed with 3 × 50 mL of 
water and the combined aqueous extracts were concentrated under vacuum to 75 mL and 
made alkaline with saturated aqueous sodium hydroxide. The resulting precipitate was 
recrystallized twice from water/methanol (1.5 v/v) to give 150 mg of the beige product Me2N-
bipy (0.62 mmol, 16%). 
 
1H NMR (DMSO-d6; ppm): δ = 3.02 [s, 12H, N(CH3)2], 6.63 (dd, 2H), 7.66 (d, 2H), 8.20 (d, 
2H). 
 
 
5.3.2.2 Synthesis of 4,4´-dichloro-2,2´-bipyridine (Cl-bipy)[94] 
 
A suspension of 1 g of O2N-bipy N-Oxide (3.59 mmol) in 50 mL of acetyl chloride was 
refluxed under argon for 3 h. The reaction mixture was cooled to 0 °C, and 8.8 mL of 
phosphorous trichloride (100 mmol) was added. The suspension was refluxed under argon 
for another 3 h. After cooling to room temperature, the reaction mixture was poured into 
150 mL of ice water and made alkaline with saturated sodium hydroxide solution. The 
resulting precipitate was filtered off and dissolved in 100 mL of dichloromethane. 
The solution was dried over MgSO4, and the solvent was removed in vacuum. The crude 
product was purified by column chromatography, using 1% methanol in dichloromethane as 
eluent. Recrystallization from ethanol/water (1.5 v/v) yielded 490 mg of white product 
(2.18 mmol, 61%). 
 
1H NMR (DMSO-d6; ppm): δ = 7.66 (dd, 2H), 8.36 (d, 2H), 8.68 (d, 2H). 
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5.3.3 Syntheses of mononuclear iodotrimethylplatinum(IV) complexes of pyridines 
 
5.3.3.1 Synthesis of [PtMe3(py)2I] 
 
The complex [PtMe3(py)2I] was synthesized by a slight modification of the route reported.[37] 
An excess of pyridine (0.2 mL, 2.48 mmol) was added to a stirred benzene solution (10 mL) 
of iodotrimethylplatinum (200 mg, 0.54 mmol). The reaction mixture was stirred at room 
temperature for 30 minutes. The benzene solution was then concentrated to about 2-3 mL and 
an excess of n-hexane (25 mL) added. The resultant white solid was isolated, washed with n-
hexane and dried in vacuo. Yield: 252 mg (0.48 mmol, 88%). 
 
1H NMR (CDCl3; ppm): δ = 1.20 [s, 3H, PtCH3 (trans to I), 2JPt-H: 69.6 Hz], 1.50 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.3 Hz], 7.35 (t, 2H, 3JH-H: 13.9 Hz), 7.85 (t, 4H, 3JH-H: 15.3 Hz), 
8.80 (d, 4H, 3JH-H: 4.9 Hz, 3JPt-H: 17.3 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ = 1.29 [s, 3H, PtCH3 (trans to I), 2JPt-H: 68.9 Hz], 1.70 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.4 Hz], 7.37 (t, 2H, 3JH-H: 13.5 Hz), 7.88 (t, 4H, 3JH-H: 
15.2 Hz), 8.93 (d, 4H, 3JH-H: 5.5 Hz, 3JPt-H: 18.0 Hz). 
 
Elemental analysis: C13H19IN2Pt (525.29 g.mol-1) 
Calculated (in %):      C: 29.72, H: 3.65, N: 5.33 
Experimental (in %):      C: 29.72, H: 3.57, N: 5.13 
 
IR (KBr, cm-1): 2959, 2898, 2818 (methyl C-H); 571, 558 (Pt-C)  
 
 
5.3.3.2 Synthesis of [PtMe3(4-MePy)2I] 
 
To a chloroform solution (10 mL) of iodotrimethylplatinum (150 mg, 0.41 mmol), an excess 
of 4-methylpyridine (0.15 mL, 1.54 mmol) was added and the reactants were stirred at room 
temperature for 30 minutes. After stirring, the solution was concentrated and 30 mL n-pentane 
added to precipitate the product as a pale yellow solid. The solid was filtered off, washed with 
n-pentane and air-dried. Yield: 185 mg (0.33 mmol, 82%). 
 
1H NMR (CDCl3; ppm): δ = 1.17 [s, 3H, PtCH3 (trans to I), 2JPt-H: 70.0 Hz], 1.45 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.0 Hz], 2.38 (s, 6H, CH3), 7.12 (d, 4H, 3JH-H: 6.0 Hz), 8.61 (d, 
4H, 3JH-H: 6.4 Hz, 3JPt-H: 19.0 Hz). 
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1H NMR (nitrobenzene-d5; ppm): δ = 1.28 [s, 3H, PtCH3 (trans to I), 2JPt-H: 69.2 Hz], 1.69 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.1 Hz], 2.28 (s, 6H, CH3), 7.12 (d, 4H, 3JH-H: 5.9 Hz), 8.73 
(d, 4H, 3JH-H: 6.4 Hz, 3JH-Pt: 19.1 Hz). 
 
Elemental analysis: C15H23IN2Pt (553.34 g.mol-1) 
Calculated (in %):      C: 32.56, H: 4.19, N: 5.06 
Experimental (in %):      C: 32.40, H: 4.10, N: 4.70 
 
IR (KBr, cm-1): 2951, 2893, 2813 (methyl C-H); 556, 543 (Pt-C)  
 
 
 
5.3.3.3 Synthesis of [PtMe3(3-MePy)2I] 
 
An amount of 150 mg of iodotrimethylplatinum(IV) (0.41 mmol) was dissolved in chloroform 
(10 mL) and 0.15 mL of 3-methylpyridine (1.54 mmol) was added to the solution. The 
reactants were stirred at room temperature for 30 minutes. After stirring, the solution was 
concentrated and an excess n-pentane (30 mL) added. The resultant pale yellow solid was 
isolated, washed with n-pentane and air-dried. Yield: 194 mg (0.35 mmol, 86%). 
 
1H NMR (CDCl3; ppm): δ = 1.18 [s, 3H, PtCH3 (trans to I), 2JPt-H: 69.8 Hz], 1.48 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.0 Hz], 2.35 (s, 6H, CH3), 7.20 (dd, 2H, 3JH-H: 13.2 Hz), 7.64 (d, 
2H), 8.51 (d, 2H, 3JH-H: 5.7 Hz, 3JPt-H: 17.8 Hz), 8.67 (s, br, 2H). 
 
Elemental analysis: C15H23IN2Pt (553.34 g.mol-1) 
Calculated (in %):      C: 32.56, H: 4.19, N: 5.06 
Experimental (in %):      C: 32.43, H: 4.10, N: 4.82 
 
IR (KBr, cm-1): 2960, 2899, 2818 (methyl C-H); 571, 556 (Pt-C) 
 
 
5.3.3.4 Synthesis of [PtMe3(4-EtPy)2I] 
 
To a chloroform solution (10 mL) of iodotrimethylplatinum(IV) (150 mg, 0.41 mmol), an 
excess of 4-ethylpyridine (0.15 mL, 1.32 mmol) was added and the solution stirred for 
30 minutes. After stirring, the solution was concentrated to about 2-3 mL and a large excess 
of n-pentane (20 mL) added to precipitate the complex [PtMe3(4-Etpy)2I] as a pale yellow 
product. The product was filtered, washed several times with n-pentane and air-dried. Yield: 
200 mg (0.34 mmol, 84%). 
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1H NMR (CDCl3; ppm): δ = 1.18 [s, 3H, PtCH3 (trans to I), 2JPt-H: 70.2 Hz], 1.45 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.1 Hz], 1.27 (t, 6H, CH3), 2.68 (q, 4H, CH2), 7.15 (d, 4H, 3JH-H: 
6.4 Hz), 8.64 (d, 4H, 3JH-H: 6.4 Hz, 3JPt-H: 18.9 Hz). 
 
Elemental analysis: C17H27IN2Pt (581.40 g.mol-1) 
Calculated (in %):      C: 35.12, H: 4.68, N: 4.82 
Experimental (in %):      C: 35.14, H: 4.41, N: 4.56 
 
IR (KBr, cm-1): 2964, 2897, 2815 (methyl C-H); 578, 554 (Pt-C)  
 
 
 
5.3.3.5 Synthesis of [PtMe3(3-EtPy)2I] 
 
0.15 mL of 3-ethylpyridine (1.32 mmol) was added to a stirred solution of iodotrimethyl-
platinum(IV) (150 mg, 0.41 mmol) in 10 mL of chloroform. The reaction mixture was stirred 
for an additional 45 minutes. After stirring, the solution was concentrated and 30 mL of n-
pentane added. The resultant pale yellow precipitate was filtered off, washed with n-pentane 
and air-dried. Yield: 162 mg (0.28 mmol, 68%). 
 
1H NMR (CDCl3; ppm): δ = 1.19 [s, 3H, PtCH3 (trans to I), 2JPt-H: 69.7 Hz], 1.48 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.0 Hz], 1.20 (t, 6H, CH3), 2.65 (q, 4H, CH2), 7.23 (dd, 2H), 7.66 
(d, 2H), 8.56 (d, 2H, 3JH-H: 5.7 Hz, 3JPt-H: 17.2 Hz), 8.64 (d, 2H). 
 
Elemental analysis: C17H27IN2Pt (581.40 g.mol-1) 
Calculated (in %):      C: 35.12, H: 4.68, N: 4.82 
Experimental (in %):      C: 35.03, H: 4.52, N: 4.62 
 
IR (KBr, cm-1): 2965, 2894, 2813 (methyl C-H); 578, 560 (Pt-C) 
 
 
 
5.3.3.6 Synthesis of [PtMe3(4-OMePy)2I]  
 
An amount of 150 mg of iodotrimethylplatinum(IV) (0.41 mmol) was dissolved in chloroform 
(10 mL) and 0.15 mL of 4-methoxypyridine (1.48 mmol) added to the stirred solution. The 
reactants were stirred at room temperature for 45 minutes. After stirring, the solution was 
concentrated to 2-3 mL and an excess of n-pentane (25 mL) added. The resultant pale yellow 
solid was isolated, washed with n-pentane and air-dried. Yield: 222 mg (0.38 mmol, 93%). 
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1H NMR (CDCl3; ppm): δ = 1.15 [s, 3H, PtCH3 (trans to I), 2JPt-H: 70.2 Hz], 1.42 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.0 Hz], 3.89 (s, 6H, OCH3), 6.80 (d, 4H, 3JH-H: 7.0 Hz), 8.58 (d, 
4H, 3JH-H: 7.0 Hz, 3JPt-H: 19.0 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ = 1.29 [s, 3H, PtCH3 (trans to I), 2JPt-H: 69.4 Hz], 1.69 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.2 Hz], 3.81 (s, 6H, OCH3), 6.79 (d, 4H, 3JH-H: 6.9 Hz), 8.70 
(d, 4H, 3JH-H: 6.8 Hz, 3JH-Pt: 19.1 Hz). 
 
Elemental analysis: C15H23IN2O2Pt (585.34 g.mol-1) 
Calculated (in %):      C: 30.78, H: 3.96, N: 4.79 
Experimental (in %):      C: 30.82, H: 3.97, N: 4.60 
 
IR (KBr, cm-1): 2961, 2894, 2815 (methyl C-H); 569, 540 (Pt-C)  
 
 
 
5.3.3.7 Synthesis of [PtMe3(3-OMePy)2I]  
 
To a chloroform solution (10 mL) of iodotrimethylplatinum(IV) (150 mg, 0.41 mmol), an 
excess of 3-methoxypyridine (0.15 mL, 1.48 mmol) was added and the solution stirred for 
45 minutes. The solution was then concentrated and 25 mL n-pentane added to precipitate the 
complex [PtMe3(3-OMepy)2I] as a pale yellow solid. The solid was filtered, washed with n-
pentane and air-dried. Yield: 203 mg (0.35 mmol, 85%). 
 
1H NMR (CDCl3; ppm): δ = 1.20 [s, 3H, PtCH3 (trans to I), 2JPt-H: 69.7 Hz], 1.49 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.4 Hz], 3.84 (s, 6H, OCH3), 7.24 (dd, 2H), 7.33 (d, 2H), 8.30 (d, 
2H, 3JH-H: 6.1 Hz, 3JPt-H: 16.9 Hz), 8.61 (d, 2H). 
 
Elemental analysis: C15H23IN2O2Pt (585.34 g.mol-1) 
Calculated (in %):      C: 30.78, H: 3.96, N: 4.79 
Experimental (in %):      C: 30.59, H: 3.86, N: 4.50 
 
IR (KBr, cm-1): 2960, 2899, 2817 (methyl C-H); 564 (Pt-C)  
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5.3.3.8 Synthesis of [PtMe3(4-DMAP)2I]  
 
The complex iodotrimethylplatinum(IV) (150 mg, 0.41 mmol) and 4-dimethylaminopyridine 
(100 mg, 0.82 mmol) were stirred in chloroform (10 mL) for 30 minutes. The resulting 
solution was then concentrated and 30 mL n-pentane added. The pale yellow solid which 
formed was isolated, washed with n-pentane and air-dried. Yield: 210 mg (0.34 mmol, 84%).  
 
1H NMR (CDCl3; ppm): δ = 1.14 [s, 3H, PtCH3 (trans to I), 2JPt-H: 71.5 Hz], 1.35 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 69.3 Hz], 3.02 [s, 12H, N(CH3)2], 6.40 (d, 4H, 3JH-H: 7.2 Hz), 8.29 
(d, 4H, 3JH-H: 7.2 Hz, 3JPt-H: 19.6 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ = 1.33 [s, 3H, PtCH3 (trans to I), 2JPt-H: 70.6 Hz], 1.70 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 69.3 Hz], 2.89 [s, 12H, N(CH3)2], 6.28 (d, 4H, 3JH-H: 7.0 Hz), 
8.38 (d, 4H, 3JH-H: 6.9 Hz, 3JH-Pt: 19.4 Hz). 
 
Elemental analysis: C17H29IN4Pt (611.43 g.mol-1) 
Calculated (in %):      C: 33.39, H: 4.78, N: 9.16 
Experimental (in %):      C: 33.55, H: 4.49, N: 8.96 
 
IR (KBr, cm-1): 2950, 2894, 2811 (methyl C-H); 572, 529 (Pt-C) 
 
 
5.3.3.9 Synthesis of [PtMe3(4-tBuPy)2I]  
 
0.16 mL of 4-tbutylpyridine (1.09 mmol) was added to a stirred chloroform solution (15 mL) 
of iodotrimethylplatinum(IV) (150 mg, 0.41 mmol). The reaction mixture was stirred for 
45 minutes. After stirring, the chloroform solution was concentrated and an excess of 
n-pentane (30 mL) added to precipitate the white solid. The solid was separated, washed with 
n-pentane and dried in vacuo. Yield: 205 mg (0.32 mmol, 79%). 
 
1H NMR (CDCl3; ppm): δ = 1.19 [s, 3H, PtCH3 (trans to I), 2JPt-H: 70.1 Hz], 1.45 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 69.9 Hz], 1.33 [s, 18H, C(CH3)3], 7.30 (d, 4H, 3JH-H: 6.7 Hz), 8.66 
(d, 4H, 3JH-H: 6.5 Hz, 3JPt-H: 19.0 Hz). 
 
Elemental analysis: C21H35IN2Pt (637.5 g.mol-1) 
Calculated (in %):      C: 39.56, H: 5.53, N: 4.39 
Experimental (in %):      C: 39.31, H: 5.37, N: 4.28 
 
IR (KBr, cm-1): 2963, 2897, 2816 (methyl C-H); 571, 544 (Pt-C)  
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5.3.3.10 Synthesis of [PtMe3(4-CNPy)2I]  
 
250 mg of 4-cyanopyridine (2.40 mmol) and iodotrimethylplatinum(IV) (150 mg, 0.41 mmol) 
were dissolved in chloroform (10 mL) and stirred for 35 minutes. The solution was then 
concentrated and excess n-pentane (30 mL) added. The yellow solid which formed was 
isolated, washed with n-pentane and air-dried. Yield: 204 mg (0.35 mmol, 87%). 
 
1H NMR (CDCl3; ppm): δ = 1.18 [s, 3H, PtCH3 (trans to I), 2JPt-H: 67.3 Hz], 1.53 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 71.2 Hz], 7.64 (d, 4H, 3JPt-H: 6.5 Hz), 9.04 [d, 4H, 3JH-H: 6.4 Hz, 
3JPt- H: 17.9 Hz). 
 
Elemental analysis: C15H17IN4Pt (575.30 g.mol-1) 
Calculated (in %):      C: 31.32, H: 2.98, N: 9.74 
Experimental (in %):      C: 31.25, H: 2.88, N: 9.55 
 
IR (KBr, cm-1): 2962, 2899, 2816 (methyl C-H); 563 (Pt-C) 
 
 
5.3.3.11 Synthesis of [PtMe3(3-BrPy)2I]  
 
An excess of 3-bromopyridine (0.2 mL, 2.08 mmol) was added to a solution of iodotrimethyl-
platinum(IV) (150 mg, 0.41 mmol) in chloroform (10 mL). The reactants were stirred for 
45 minutes, after which the volume of the solution was reduced to 3-4 mL. Addition of n-
pentane (30 mL) produced a pale yellow product, which was filtered, washed with n-pentane 
and air-dried. Yield: 250 mg (0.37 mmol, 90%). 
 
1H NMR (CDCl3; ppm): δ = 1.17 [s, 3H, PtCH3 (trans to I), 2JPt-H: 68.3 Hz], 1.51 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 71.1 Hz], 7.28 (dd, 2H), 8.01 (d, 2H), 8.79 (d, 2H), 8.83 (d, 2H). 
 
Elemental analysis: C13H17Br2IN2Pt (683.08 g.mol-1) 
Calculated (in %):      C: 22.86, H: 2.51, N: 4.10 
Experimental (in %):      C: 22.59, H: 2.45, N: 3.90 
 
IR (KBr, cm-1): 2959, 2893, 2815 (methyl C-H); 575, 554 (Pt-C)  
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5.3.3.12 Synthesis of [PtMe3(3-ClPy)2I]  
 
To a chloroform solution (10 mL) of iodotrimethylplatinum(IV)
 
(150 mg, 0.41 mmol), an 
excess of 3-chloropyridine (0.2 mL, 2.10 mmol) was added and the resulting solution was 
stirred for 45 minutes. After stirring, the solution was concentrated to 3-4 mL and large 
excess of n-pentane (35 mL) was added to precipitate the complex as a pale yellow product. 
The product was filtered, washed several times with n-pentane and air-dried. Yield: 223 mg 
(0.375 mmol, 92%). 
 
1H NMR (CDCl3; ppm): δ = 1.18 [s, 3H, PtCH3 (trans to I), 2JPt-H: 68.3 Hz], 1.52 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 71.1 Hz], 7.34 (dd, 2H), 7.87 (d, 2H), 8.75 (d, 2H), 8.77 (d, 2H). 
 
Elemental analysis: C13H17Cl2IN2Pt (594.18 g.mol-1) 
Calculated (in %):      C: 26.28, H: 2.88, N: 4.71 
Experimental (in %):      C: 25.96, H: 2.72, N: 4.52 
 
IR (KBr, cm-1): 2962, 2899, 2815 (methyl C-H); 572, 554 (Pt-C). 
 
 
 
5.3.4 Syntheses of iodotrimethylplatinum(IV) complexes of 2,2´-bipyridines 
 
5.3.4.1 Synthesis of [PtMe3(bipy)I]  
 
The complex [PtMe3(bipy)I] was synthesized according to the method of Clegg et al.[39] A 
benzene solution (6 mL) of iodotrimethylplatinum(IV)
 
(200 mg, 0.54 mmol) was mixed with 
a benzene solution (6 mL) of 2,2´-bipyridine (85 mg, 0.54 mmol). The solution was filtered 
immediately, and the filtrate allowed to stand. The pale yellow crystals that formed were 
filtered, washed with n-hexane and air-dried. Yield: 255 mg (0.49 mmol, 89%). 
 
1H NMR (CDCl3; ppm): δ = 0.64 [s, 3H, PtCH3 (trans to I), 2JPt-H: 73.1 Hz], 1.56 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.5 Hz], 7.64 (m, 2H), 8.07 (m, 2H), 8.23 (d, 2H), 9.02 (d, 2H, 
3JH-H: 6.1 Hz, 3JPt-H: 17.8 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ = 0.78 [s, 3H, PtCH3 (trans to I), 2JPt-H: 72.6 Hz], 1.81 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.5 Hz], 7.67 (m, 2H), 8.08 (m, 2H), 8.33 (d, 2H), 9.08 (d, 2H, 
3JH-H: 6.4 Hz, 3JPt-H: 18.5 Hz). 
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Elemental analysis: C13H17IN2Pt (523.28 g.mol-1) 
Calculated (in %):      C: 29.84, H: 3.27, N: 5.35 
Experimental (in %):      C: 30.05, H: 3.46, N: 5.42 
 
IR (KBr, cm-1): 2957, 2892, 2811 (methyl C-H); 573, 557 (Pt-C)  
 
EI-MS: m/z 395 [M-I]+ 
 
 
5.3.4.2 Synthesis of [PtMe3(4Me-bipy)I]  
 
Iodotrimethylplatinum(IV)
 
(200 mg, 0.54 mmol) was dissolved in benzene (15 mL) and 4,4´-
dimethyl-2,2´-bipyridine (100 mg, 0.54 mmol) added to the stirred solution. The reactants 
were stirred for another 1.5 h. The resulting pale yellow solid was filtered off, washed with 
n-hexane and dried under vacuum. Yield: 258 mg (0.47 mmol, 86%). 
 
1H NMR (CDCl3; ppm): δ = 0.63 [s, 3H, PtCH3 (trans to I), 2JPt-H: 73.5 Hz], 1.51 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.3 Hz], 2.57 (s, 6H, CH3), 7.42 (d, 2H), 8.01 (s, br, 2H), 8.82 (d, 
2H, 3JH-H: 5.8 Hz, 3JPt-H: 19.4 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ = 0.81 [s, 3H, PtCH3 (trans to I), 2JPt-H: 72.9 Hz], 1.78 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.3 Hz], 2.52 (s, 6H, CH3), 7.42 (d, 2H), 8.05 (s, br, 2H), 8.87 
(d, 2H, 3JH-H: 5.6 Hz, 3JPt-H: 19.6 Hz). 
 
Elemental analysis: C15H21IN2Pt (551.33 g.mol-1) 
Calculated (in %):      C: 32.68, H: 3.84, N: 5.08 
Experimental (in %):      C: 32.46, H: 3.97, N: 4.98 
 
IR (KBr, cm-1): 2952, 2890, 2809 (methyl C-H); 556, 521 (Pt-C)  
 
EI-MS: m/z 423 [M-I]+ 
 
 
5.3.4.3 Synthesis of [PtMe3(5Me-bipy)I]  
 
An amount of 100 mg of 5,5´-dimethyl-2,2´-bipyridine (0.54 mmol) was added to a stirred 
solution of iodotrimethylplatinum(IV)
 
(200 mg, 0.54 mmol) in benzene (14 mL) for 1.5 h. 
The resulting pale yellow solid was filtered off, washed with n-hexane and dried in vacuum. 
Yield: 270 mg (0.49 mmol, 90%). 
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1H NMR (CDCl3; ppm): δ = 0.62 [s, 3H, PtCH3 (trans to I), 2JPt-H: 73.3 Hz], 1.54 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.4 Hz], 2.51 (s, 6H, CH3), 7.81 (d, 2H), 8.04 (s, 2H), 8.77 (d, 2H, 
3JH-H: 1.1 Hz, 3JPt-H: 12.7 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ 0.82 [s, 3H, PtCH3 (trans to I), 2JPt-H: 72.7 Hz], 1.83 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.3 Hz], 2.35 (s, 6H, CH3), 7.80 (d, 2H), 8.13 (2H), 8.93 (s, 
br, 2H). 
 
Elemental analysis: C15H21IN2Pt (551.33 g.mol-1) 
Calculated (in %):      C: 32.68, H: 3.84, N: 5.08 
Experimental (in %):      C: 32.49, H: 3.92, N: 4.89 
 
IR (KBr, cm-1): 2963, 2897, 2812 (methyl C-H); 558, 537 (Pt-C)  
 
EI-MS: m/z 423 [M-I]+ 
 
 
 
5.3.4.4 Synthesis of [PtMe3(OMe-bipy)I]  
 
To a benzene solution (10 mL) of iodotrimethylplatinum(IV)
 
(200 mg, 0.54 mmol), the ligand 
4,4´-dimethoxy-2,2´-bipyridine (120 mg, 0.56 mmol) was added and the solution was stirred 
at room temperature for 2 h. The pale yellow solid formed was then filtered off, washed with 
benzene and dried under vacuum. Yield: 267 mg (0.46 mmol, 84%). 
 
1H NMR (CDCl3; ppm): δ = 0.65 [s, 3H, PtCH3 (trans to I), 2JPt-H: 73.7 Hz], 1.48 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 70.2 Hz], 4.02 (s, 6H, OCH3), 7.08 (dd, 2H), 7.58 (d, 2H), 8.77 (d, 
2H, 3JH-H: 6.4 Hz, 3JPt-H: 19.8 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ 0.86 [s, 3H, PtCH3 (trans to I), 2JPt-H: 73.0 Hz], 1.77 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 70.5 Hz], 3.96 (s, 6H, OCH3), 7.09 (d, 2H), 7.61 (d, 2H), 8.83 
(d, 2H, 3JH-H: 6.4 Hz, 3JPt-H: 19.9 Hz). 
 
Elemental analysis: C15H21IN2O2Pt (583.33 g.mol-1) 
Calculated (in %):      C: 30.89, H: 3.63, N: 4.80 
Experimental (in %):      C: 30.78, H: 3.76, N: 4.72 
 
IR (KBr, cm-1): 2945, 2892, 2811 (methyl C-H); 575, 522 (Pt-C)  
 
EI-MS: m/z 455 [M-I]+ 
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5.3.4.5 Synthesis of [PtMe3(Me2N-bipy)I]  
  
132 mg of 4,4´-bis(dimethylamino)-2,2´-bipyridine (0.55 mmol) was added to a stirred 
solution of iodotrimethylplatinum (200 mg, 0.54 mmol) in benzene (15 mL) and the reactants 
were stirred at room temperature for 1 h, after which the resultant pale yellow solid was 
isolated, washed in benzene and dried in vacuum. Yield: 286 mg (0.47 mmol, 87%). 
 
1H NMR (CDCl3; ppm): δ = 0.68 [s, 3H, PtCH3 (trans to I), 2JPt-H: 74.9 Hz], 1.40 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 69.6 Hz], 3.16 [s, 12H, N(CH3)2], 6.68 (dd, 2H), 7.14 (d, 2H), 8.46 
(d, 2H, 3JH-H: 6.6 Hz, 3JPt-H: 20.0 Hz). 
 
1H NMR (nitrobenzene-d5; ppm): δ = 0.97 [s, 3H, PtCH3 (trans to I), 2JPt-H: 74.2 Hz], 1.76 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 69.5 Hz], 3.04 [s, 12H, N(CH3)2], 6.58 (dd, 2H), 7.16 (d, 2H), 
8.50 (d, 2H, 3JH-H: 6.6 Hz, 3JPt-H: 20.0 Hz). 
 
Elemental analysis: C17H27IN4Pt (609.42 g.mol-1) 
Calculated (in %):      C: 33.51, H: 4.47, N: 9.19 
Experimental (in %):      C: 33.66, H: 4.29, N: 8.96 
 
IR (KBr, cm-1): 2941, 2890, 2811 (methyl C-H); 562 (Pt-C) 
 
EI-MS: m/z 481 [M-I]+ 
 
 
 
5.3.4.6 Synthesis of [PMe3(Cl-bipy)I]  
 
To a benzene solution (10 mL) of iodotrimethylplatinum
 
(200 mg, 0.54 mmol), 4,4´-dichloro- 
2,2´-bipyridine (125 mg, 0.56 mmol) in benzene (6 mL) was added and stirred for 2 h. The 
yellow solid which formed was isolated, washed with n-hexane and dried in vacuum. Yield: 
297 mg (0.50 mmol, 92%). 
 
1H NMR (CDCl3; ppm): δ = 0.62 [s, 3H, PtCH3 (trans to I), 2JPt-H: 72.3 Hz], 1.56 [s, 6H, 
PtCH3 (trans to N), 2JPt-H: 71.2 Hz], 7.66 (dd, 2H), 8.18 (d, 2H), 8.91 (d, 2H, 3JH-H: 6.0 Hz, 
3JPt-H: 19.2 Hz). 
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1H NMR (nitrobenzene-d5; ppm): δ 0.83 [s, 3H, PtCH3 (trans to I), 2JPt-H: 72.1 Hz], 1.80 [s, 
6H, PtCH3 (trans to N), 2JPt-H: 71.3 Hz], 7.66 (2H), 8.25 (d, 2H), 9.00 (d, 2H, 3JH-H: 6.0 Hz, 
3JPt-H: 13.5 Hz). 
 
Elemental analysis: C13H15Cl2IN2Pt (592.16 g.mol-1) 
Calculated (in %):      C: 26.37, H: 2.55, N: 4.73 
Experimental (in %):      C: 26.55, H: 2.46, N: 4.42 
 
IR (KBr, cm-1): 2952, 2891, 2808 (methyl C-H); 562, 533 (Pt-C) 
 
EI-MS: m/z 462 [M-I]+ 
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5.4 Crystallography 
 
The single crystal X-ray diffraction studies for the platinum(IV) complexes were performed 
with the following equipment: 
 
• A STOE IPDS diffractometer equipped with a low temperature system (Karlsruher 
Glastechnisches Werk), a graphite monochromator and IP detector system. MoKα 
radiation (λ = 0.71069 Å) was used. The frames were integrated with the STOE 
software package.[95] Multi-scan absorption corrections were applied.[96] 
 
• A smart CCD Bruker-AXS diffractometer equipped with a graphite monochromator 
and a CCD detector. MoKα radiation (λ = 0.71073 Å) was used. Cell refinement and 
data reduction were carried out with the SAINT software.[97] The collected reflections 
were corrected for absorption effects using multi-scan SADABS programme.[98]  
 
The structures were solved using the programme SHELXS-97[99] and refined by full-matrix 
least squares on F2 with SHELXL-97 programme.[99] All the non-hydrogen atoms were refined 
with anisotropic thermal parameters. Hydrogen atoms were introduced in proper positions 
with isotropic thermal parameters using the ‘riding model’. Mercury[100] and DIAMOND[101] 
programmes were used for structure drawing. 
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Table 5.4.1 Crystal data and structure refinement for [PtMe3(4-DMAP)2I] 
 
 
Empirical formula  C17H29IN4Pt 
Formula weight  611.43 
Temperature  133(2) K 
Wavelength  0.71073 Å 
Diffractometer type SMART CCD Bruker AXS 
Crystal size 0.35 x 0.13 x 0.11 mm3 
Crystal colour and shape yellow, needle 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 7.7058(13) Å α= 90° 
 b = 15.118(3) Å β= 97.363(3)° 
 c = 17.171(3) Å γ = 90° 
Volume 1983.8(6) Å3 
Z 4 
Density (calculated) 2.047 Mg/m3 
Absorption coefficient 8.634 mm-1 
F(000) 1160 
Theta range for data collection 1.80 to 30.55° 
Index ranges -11 ≤ h ≤ 10, -21 ≤ k ≤ 20, -16 ≤ l ≤ 24 
Reflections collected 32045 
Independent reflections 6040 [R(int) = 0.0212] 
Completeness to theta = 30.55° 0.993  
Absorption correction multi-scan 
Max. and min. transmission 0.746 and 0.403 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6040 / 0 / 215 
Goodness-of-fit on F2 1.052 
Final R indices [I>2σ(I)] R1 = 0.0170, wR2 = 0.0395 
R indices (all data) R1 = 0.0207, wR2 = 0.0408 
Largest diff. peak and hole 1.985 and -0.470 e.Å-3 
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Table 5.4.2 Crystal data and structure refinement for [PtMe3(3-BrPy)2I] 
 
 
Empirical formula  C13H17Br2IN2Pt 
Formula weight  683.08 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.21 x 0.10 x 0.08 mm3 
Crystal colour and shape yellow, needle 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 10.3932(14) Å α= 90° 
 b = 14.1705(14) Å β= 104.290(16)° 
 c = 12.1056(17) Å γ = 90° 
Volume 1727.7(4) Å3 
Z 4 
Density (calculated) 2.626 Mg/m3 
Absorption coefficient 14.523 mm-1 
F(000) 1240 
Theta range for data collection 2.48 to 28.14° 
Index ranges -13 ≤ h ≤ 13, -18 ≤ k ≤ 17, -15 ≤ l ≤ 16 
Reflections collected 15116 
Independent reflections 4158 [R(int) = 0.0826] 
Completeness to theta = 28.14° 0.983  
Absorption correction multi-scan  
Max. and min. transmission 0.3329 and 0.1295 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4158 / 0 / 176 
Goodness-of-fit on F2 0.914 
Final R indices [I>2σ(I)] R1 = 0.0485, wR2 = 0.1153 
R indices (all data) R1 = 0.0724, wR2 = 0.1255 
Largest diff. peak and hole 3.274 and -2.592 e.Å-3 
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Table 5.4.3 Crystal data and structure refinement for [PtMe3(4-MePy)2I] 
 
 
Empirical formula  C15H23IN2Pt 
Formula weight  553.34 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS  
Crystal size 0.16 x 0.16 x 0.16 mm3 
Crystal colour and shape yellow, cube 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 11.2077(15) Å α= 90° 
 b = 12.9162(13) Å β= 98.822(16)° 
 c = 12.2592(16) Å γ = 90° 
Volume 1753.7(4) Å3 
Z 4 
Density (calculated) 2.096 Mg/m3 
Absorption coefficient 9.752 mm-1 
F(000) 1032 
Theta range for data collection 3.11 to 28.08° 
Index ranges -14 ≤ h ≤ 14, -17 ≤ k ≤ 17, -16 ≤ l ≤ 16 
Reflections collected 15855 
Independent reflections 3952 [R(int) = 0.0612] 
Completeness to theta = 28.08° 0.924  
Absorption correction multi-scan 
Max. and min. transmission 0.2310 and 0.1861 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3952 / 0 / 178 
Goodness-of-fit on F2 0.939 
Final R indices [I>2σ(I)] R1 = 0.0360, wR2 = 0.0814 
R indices (all data) R1 = 0.0582, wR2 = 0.0881 
Largest diff. peak and hole 1.981 and -2.500 e.Å-3 
 
 
 
 
 
 
 
 
Chapter 5  Experimental Section   
   
  92
 
Table 5.4.4 Crystal data and structure refinement for [PtMe3(4-EtPy)2I] 
 
 
Empirical formula  C17H27IN2Pt 
Formula weight  581.40 
Temperature  133(2) K 
Wavelength  0.71073 Å 
Diffractometer type SMART CCD Bruker AXS 
Crystal size 0.41 x 0.21 x 0.18 mm3 
Crystal colour and shape yellow, prism 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 12.0156(17) Å α= 90° 
 b = 12.0304(17) Å β= 102.370(3)° 
 c = 13.4566(19) Å γ = 90° 
Volume 1900.0(5) Å3 
Z 4 
Density (calculated) 2.032 Mg/m3 
Absorption coefficient 9.007 mm-1 
F(000) 1096 
Theta range for data collection 1.74 to 30.58° 
Index ranges -17 ≤ h ≤ 15, -17 ≤ k ≤ 16, -19 ≤ l ≤ 19 
Reflections collected 30876 
Independent reflections 5837 [R(int) = 0.0201] 
Completeness to theta = 30.58° 0.999  
Absorption correction multi-scan  
Max. and min. transmission 0.433 and 0.238 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5837 / 0 / 195 
Goodness-of-fit on F2 1.102 
Final R indices [I>2σ(I)] R1 = 0.0150, wR2 = 0.0358 
R indices (all data) R1 = 0.0187, wR2 = 0.0373 
Largest diff. peak and hole 0.552 and -1.457 e.Å-3 
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Table 5.4.5 Crystal data and structure refinement for [PtMe3(4-OMePy)2I] 
 
 
Empirical formula  C15H23IN2O2Pt 
Formula weight  585.34 
Temperature  133(2) K 
Wavelength  0.71073 Å 
Diffractometer type SMART CCD Bruker AXS 
Crystal size 0.28 x 0.12 x 0.04 mm3 
Crystal colour and shape yellow, needle 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 17.304(3) Å α= 90° 
 b = 8.2179(14) Å β= 90° 
 c = 25.158(4) Å γ = 90° 
Volume 3577.4(11) Å3 
Z 8 
Density (calculated) 2.174 Mg/m3 
Absorption coefficient 9.576 mm-1 
F(000) 2192 
Theta range for data collection 2.00 to 30.57° 
Index ranges -24 ≤ h ≤ 24, -11 ≤ k ≤ 9, -35 ≤ l ≤ 35 
Reflections collected 52384 
Independent reflections 5485 [R(int) = 0.0439] 
Completeness to theta = 30.57° 0.999  
Absorption correction multi-scan  
Max. and min. transmission 0.746 and 0.416 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5485 / 0 / 195 
Goodness-of-fit on F2 1.130 
Final R indices [I>2σ(I)] R1 = 0.0352, wR2 = 0.0825 
R indices (all data) R1 = 0.0439, wR2 = 0.0862 
Largest diff. peak and hole 2.927 and -1.818 e.Å-3 
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Table 5.4.6 Crystal data and structure refinement for [PtMe3(3-OMePy)2I] 
 
 
Empirical formula  C15H23IN2O2Pt 
Formula weight  585.34 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.53 x 0.11 x 0.08 mm3 
Crystal colour and shape yellow, needle 
Crystal system  Monoclinic 
Space group  P21/a 
Unit cell dimensions a = 14.7578(15) Å α= 90° 
 b = 7.6872(9) Å β= 113.803(11)° 
 c = 17.2104(18) Å γ = 90° 
Volume 1786.4(3) Å3 
Z 4 
Density (calculated) 2.176 Mg/m3 
Absorption coefficient 9.588 mm-1 
F(000) 1096 
Theta range for data collection 2.76 to 28.10° 
Index ranges -19 ≤ h ≤ 19, -10 ≤ k ≤ 10, -22 ≤ l ≤ 22 
Reflections collected 15226 
Independent reflections 4317 [R(int) = 0.0586] 
Completeness to theta = 28.10° 0.992  
Absorption correction multi-scan 
Max. and min. transmission 0.5049 and 0.1635 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4317 / 0 / 196 
Goodness-of-fit on F2 0.986 
Final R indices [I>2σ(I)] R1 = 0.0320, wR2 = 0.0920 
R indices (all data) R1 = 0.0389, wR2 = 0.0952 
Largest diff. peak and hole 2.755 and -1.636 e.Å-3 
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Table 5.4.7 Crystal data and structure refinement for trans-[PtMe3(py)I]2 
 
 
Empirical formula  C16H28I2N2Pt2 
Formula weight  892.38 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.48 x 0.40 x 0.16 mm3 
Crystal colour and shape yellow, prism 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 17.433(2) Å α= 90° 
 b = 10.0346(9) Å β= 118.295(15)° 
 c = 13.7500(19) Å γ = 90° 
Volume 2118.0(5) Å3 
Z 4 
Density (calculated) 2.799 Mg/m3 
Absorption coefficient 16.110 mm-1 
F(000) 1600 
Theta range for data collection 3.60 to 28.12° 
Index ranges -21 ≤ h ≤ 23, -13 ≤ k ≤ 12, -18 ≤ l ≤ 18 
Reflections collected 9143 
Independent reflections 2536 [R(int) = 0.0686] 
Completeness to theta = 28.12° 0.975  
Absorption correction multi-scan  
Max. and min. transmission 0.1160 and 0.0285 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2536 / 0 / 104 
Goodness-of-fit on F2 1.044 
Final R indices [I>2σ(I)] R1 = 0.0437, wR2 = 0.1068 
R indices (all data) R1 = 0.0479, wR2 = 0.1092 
Largest diff. peak and hole 3.055 and -3.466 e.Å-3 
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Table 5.4.8 Crystal data and structure refinement for cis-[PtMe3(4-EtPy)I]2 
 
 
Empirical formula  C20H36I2N2Pt2 
Formula weight  948.49 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.34 x 0.32 x 0.16 mm3 
Crystal colour and shape yellow, plate 
Crystal system  Orthorhombic 
Space group  Pnam 
Unit cell dimensions a = 10.7003(10) Å α= 90° 
 b = 12.7871(9) Å β= 90° 
 c = 18.4091(17) Å γ = 90° 
Volume 2518.8(4) Å3 
Z 4 
Density (calculated) 2.501 Mg/m3 
Absorption coefficient 13.554 mm-1 
F(000) 1728 
Theta range for data collection 3.33 to 27.03° 
Index ranges -13 ≤ h ≤ 13, -15 ≤ k ≤ 15, -23 ≤ l ≤ 23 
Reflections collected 19833 
Independent reflections 2719 [R(int) = 0.0679] 
Completeness to theta = 27.03° 0.953  
Absorption correction multi-scan  
Max. and min. transmission 0.1480 and 0.0562 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2719 / 0 / 126 
Goodness-of-fit on F2 1.102 
Final R indices [I>2σ(I)] R1 = 0.0485, wR2 = 0.1262 
R indices (all data) R1 = 0.0535, wR2 = 0.1328 
Largest diff. peak and hole 2.890 and -4.746 e.Å-3 
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Table 5.4.9 Crystal data and structure refinement for cis-[PtMe3(4-OMePy)I]2 
 
 
Empirical formula  C18H32I2N2O2Pt2 
Formula weight  952.44 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.24 x 0.23 x 0.18 mm3 
Crystal colour and shape yellow, plate 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 10.4070(9) Å α= 90° 
 b = 11.7649(6) Å β= 98.377(10)° 
 c = 20.7823(17) Å γ = 90° 
Volume 2517.4(3) Å3 
Z 4 
Density (calculated) 2.513 Mg/m3 
Absorption coefficient 13.568 mm-1 
F(000) 1728 
Theta range for data collection 2.34 to 25.97° 
Index ranges -12 ≤ h ≤ 12, -14 ≤ k ≤ 13, -25 ≤ l ≤ 25 
Reflections collected 18359 
Independent reflections 4928 [R(int) = 0.0548] 
Completeness to theta = 25.97° 0.995 
Absorption correction multi-scan  
Max. and min. transmission 0.1115 and 0.0529 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4928 / 0 / 245 
Goodness-of-fit on F2 0.925 
Final R indices [I>2σ(I)] R1 = 0.0287, wR2 = 0.0728 
R indices (all data) R1 = 0.0402, wR2 = 0.0761 
Largest diff. peak and hole 1.091 and -1.363 e.Å-3 
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Table 5.4.10 Crystal data and structure refinement for cis-[PtMe3(4-CNPy)I]2 
 
 
Empirical formula  C18H26I2N4Pt2 
Formula weight  942.41 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.76 x 0.16 x 0.16 mm3 
Crystal colour and shape yellow, needle 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 22.7305(14) Å α= 90° 
 b = 12.1314(9) Å β= 98.978(7)° 
 c = 8.8971(5) Å γ = 90° 
Volume 2423.3(3) Å3 
Z 4 
Density (calculated) 2.583 Mg/m3 
Absorption coefficient 14.090 mm-1 
F(000) 1696 
Theta range for data collection 2.35 to 26.01° 
Index ranges -27 ≤ h ≤ 27, -14 ≤ k ≤ 14, -10 ≤ l ≤ 10 
Reflections collected 17266 
Independent reflections 4585 [R(int) = 0.0813] 
Completeness to theta = 26.01° 0.964  
Absorption correction multi-scan 
Max. and min. transmission 0.1348 and 0.0423 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4585 / 0 / 242 
Goodness-of-fit on F2 1.000 
Final R indices [I>2σ(I)] R1 = 0.0720, wR2 = 0.1799 
R indices (all data) R1 = 0.0800, wR2 = 0.1857 
Largest diff. peak and hole 6.440 and -5.116 e.Å-3 
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Table 5.4.11 Crystal data and structure refinement for cis-[PtMe3(3-ClPy)I]2.[PtMe3I]4 
 
 
Empirical formula  C28H62Cl2I6N2Pt6 
Formula weight  2429.64 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.08 x 0.06 x 0.02 mm3 
Crystal colour and shape yellow, needle 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 9.8450(5) Å α= 90° 
 b = 15.0987(9) Å β= 90° 
 c = 33.7665(18) Å γ = 90° 
Volume 5019.3(5) Å3 
Z 4 
Density (calculated) 3.215 Mg/m3 
Absorption coefficient 20.476 mm-1 
F(000) 4256 
Theta range for data collection 1.81 to 23.29° 
Index ranges -10 ≤ h ≤ 10, -16 ≤ k ≤ 16, -37 ≤ l ≤ 37 
Reflections collected 27403 
Independent reflections 7201 [R(int) = 0.0770] 
Completeness to theta = 23.29° 0.998  
Absorption correction multi-scan 
Max. and min. transmission 0.3108 and 0.1554 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7201 / 0 / 416 
Goodness-of-fit on F2 0.955 
Final R indices [I>2σ(I)] R1 = 0.0362, wR2 = 0.0894 
R indices (all data) R1 = 0.0431, wR2 = 0.0913 
Largest diff. peak and hole 2.092 and -1.282 e.Å-3 
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Table 5.4.12 Crystal data and structure refinement for [PtMe3(bipy)I] 
 
 
Empirical formula  C13H17IN2Pt 
Formula weight  523.28 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.16 x 0.16 x 0.14 mm3 
Crystal colour and shape yellow, cube 
Crystal system  Monoclinic 
Space group  I2/m 
Unit cell dimensions a = 7.7977(9) Å α= 90° 
 b = 13.2724(14) Å β= 90.639(14)° 
 c = 14.4543(17) Å γ = 90° 
Volume 1495.8(3) Å3 
Z 4 
Density (calculated) 2.324 Mg/m3 
Absorption coefficient 11.426 mm-1 
F(000) 960 
Theta range for data collection 2.98 to 28.16° 
Index ranges -10 ≤ h ≤ 10, -17 ≤ k ≤ 17, -19 ≤ l ≤ 19 
Reflections collected 6662 
Independent reflections 1877 [R(int) = 0.0596] 
Completeness to theta = 28.16° 0.98  
Absorption correction multi-scan  
Max. and min. transmission 0.2198 and 0.1248 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1877 / 0 / 85 
Goodness-of-fit on F2 1.038 
Final R indices [I>2σ(I)] R1 = 0.0306, wR2 = 0.0838 
R indices (all data) R1 = 0.0347, wR2 = 0.0856 
Largest diff. peak and hole 1.591 and -1.609 e.Å-3 
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Table 5.4.13 Crystal data and structure refinement for [PtMe3(4Me-bipy)I]. 0.5 C6H6 
 
 
Empirical formula  C18H24IN2Pt 
Formula weight  590.38 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.33 x 0.30 x 0.29 mm3 
Crystal colour and shape yellow, cube 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 11.8248(12) Å α= 90° 
 b = 8.3843(7) Å β= 96.794(12)° 
 c = 19.403(2) Å γ = 90° 
Volume 1910.2(3) Å3 
Z 4 
Density (calculated) 2.053 Mg/m3 
Absorption coefficient 8.961 mm-1 
F(000) 1108 
Theta range for data collection 3.22 to 27.05° 
Index ranges -14 ≤ h ≤ 14, -10 ≤ k ≤ 10, -24 ≤ l ≤ 24 
Reflections collected 15096 
Independent reflections 4076 [R(int) = 0.0492] 
Completeness to theta = 27.05° 0.969 
Absorption correction multi-scan 
Max. and min. transmission 0.1084 and 0.0451 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4076 / 0 / 205 
Goodness-of-fit on F2 1.052 
Final R indices [I>2σ(I)] R1 = 0.0313, wR2 = 0.0769 
R indices (all data) R1 = 0.0359, wR2 = 0.0803 
Largest diff. peak and hole 1.218 and -2.185 e.Å-3 
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Table 5.4.14 Crystal data and structure refinement for [PtMe3(5Me-bipy)I]  
 
 
Empirical formula  C15H21IN2Pt 
Formula weight  551.33 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.27 x 0.24 x 0.07 mm3 
Crystal colour and shape yellow, prism 
Crystal system  Monoclinic 
Space group  P21/a 
Unit cell dimensions a = 9.0193(10) Å α= 90° 
 b = 12.3325(14) Å β= 105.756(11)° 
 c = 15.1944(14) Å γ = 90° 
Volume 1626.6(3) Å3 
Z 4 
Density (calculated) 2.251 Mg/m3 
Absorption coefficient 10.514 mm-1 
F(000) 1024 
Theta range for data collection 3.24 to 28.10° 
Index ranges -11 ≤ h ≤ 11, -16 ≤ k ≤ 16, -19 ≤ l ≤ 19 
Reflections collected 14169 
Independent reflections 3914 [R(int) = 0.0588] 
Completeness to theta = 28.10° 0.989 
Absorption correction multi-scan 
Max. and min. transmission 0.4910 and 0.2303 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3914 / 0 / 178 
Goodness-of-fit on F2 0.966 
Final R indices [I>2σ(I)] R1 = 0.0295, wR2 = 0.0716 
R indices (all data) R1 = 0.0405, wR2 = 0.0742 
Largest diff. peak and hole 2.220 and -0.877 e.Å-3 
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Table 5.4.15 Crystal data and structure refinement for [PtMe3(OMe-bipy)I] 
 
 
Empirical formula  C15H21IN2O2Pt 
Formula weight  583.33 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.27 x 0.25 x 0.22 mm3 
Crystal colour and shape yellow, plate 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 11.1515(11) Å α= 90° 
 b = 11.6097(15) Å β= 103.077(12)° 
 c = 13.6162(14) Å γ = 90° 
Volume 1717.1(3) Å3 
Z 4 
Density (calculated) 2.256 Mg/m3 
Absorption coefficient 9.975 mm-1 
F(000) 1088 
Theta range for data collection 2.68 to 28.15° 
Index ranges -14 ≤ h ≤ 13, -15 ≤ k ≤ 15, -18 ≤ l ≤ 17 
Reflections collected 15369 
Independent reflections 4053 [R(int) = 0.0679] 
Completeness to theta = 28.15° 0.964 
Absorption correction multi-scan  
Max. and min. transmission 0.1409 and 0.0792 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4053 / 0 / 196 
Goodness-of-fit on F2 0.858 
Final R indices [I>2σ(I)] R1 = 0.0416, wR2 = 0.1108 
R indices (all data) R1 = 0.0502, wR2 = 0.1169 
Largest diff. peak and hole 2.285 and -3.396 e.Å-3 
 
 
 
 
 
 
 
 
Chapter 5  Experimental Section   
   
  104
 
Table 5.4.16 Crystal data and structure refinement for [PtMe3(Me2N-bipy)I] 
 
 
Empirical formula  C17H27IN4Pt 
Formula weight  609.42 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal colour and shape yellow, plate 
Crystal size 0.58 x 0.24 x 0.16 mm3 
Crystal system  Orthorhombic 
Space group  Pcan 
Unit cell dimensions a = 13.7054(11) Å α= 90° 
 b = 17.6237(14) Å β= 90° 
 c = 18.1731(16) Å γ = 90° 
Volume 4389.5(6) Å3 
Z 8 
Density (calculated) 1.844 Mg/m3 
Absorption coefficient 7.804 mm-1 
F(000) 2303 
Theta range for data collection 2.19 to 25.96° 
Index ranges -16 ≤ h ≤ 16, -14 ≤ k ≤ 21, -22 ≤ l ≤ 22 
Reflections collected 21595 
Independent reflections 4236 [R(int) = 0.0967] 
Completeness to theta = 25.96° 0.984  
Absorption correction multi-scan 
Max. and min. transmission 0.3003 and 0.2449 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4236 / 0 / 216 
Goodness-of-fit on F2 0.927 
Final R indices [I>2σ(I)] R1 = 0.0606, wR2 = 0.1461 
R indices (all data) R1 = 0.1299, wR2 = 0.1694 
Largest diff. peak and hole 1.962 and -0.981 e.Å-3 
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Table 5.4.17 Crystal data and structure refinement for [PtMe3(Cl-bipy)I] 
 
 
Empirical formula  C13H15Cl2IN2Pt 
Formula weight  592.16 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Diffractometer type STOE IPDS 
Crystal size 0.84 x 0.48 x 0.24 mm3 
Crystal colour and shape yellow, prism 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 7.8468(7) Å α= 90° 
 b = 18.2385(17) Å β= 98.854(12)° 
 c = 11.4267(12) Å γ = 90° 
Volume 1615.8(3) Å3 
Z 4 
Density (calculated) 2.434 Mg/m3 
Absorption coefficient 10.913 mm-1 
F(000) 1088 
Theta range for data collection 2.85 to 26.93° 
Index ranges -9 ≤ h ≤ 8, -23 ≤ k ≤ 23, -14 ≤ l ≤ 14 
Reflections collected 12733 
Independent reflections 3268 [R(int) = 0.0621] 
Completeness to theta = 26.93° 0.931  
Absorption correction multi-scan 
Max. and min. transmission 0.1048 and 0.0145 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3268 / 0 / 176 
Goodness-of-fit on F2 1.968 
Final R indices [I>2σ(I)] R1 = 0.0881, wR2 = 0.2229 
R indices (all data) R1 = 0.0911, wR2 = 0.2286 
Largest diff. peak and hole 5.215 and -13.392 e.Å-3 
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6 Summary 
 
In this doctoral thesis, iodotrimethylplatinum(IV) complexes of different pyridine and 
2,2´-bipyridine ligands are investigated. Scheme 6.1 shows the pyridine and 2,2´-bipyridine 
ligands used in this thesis. 
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Scheme 6.1 The pyridine and 2,2´-bipyridine ligands used in this doctoral work. 
 
 
Iodotrimethylplatinum(IV) complexes of pyridine and its mono-substituted derivatives are 
demonstrated in Chapter 2. The crystal structures of both the mononuclear [PtMe3L2I] (L = 
4-DMAP, 4-MePy, 4-EtPy, 4-OMePy, 3-OMePy and 3-BrPy) and dinuclear trans-
[PtMe3(py)I]2 and cis-[PtMe3LI]2 (L = 4-EtPy, 4-OMePy, 4-CNPy and 3-ClPy) complexes 
reveal an octahedral coordination around the platinum(IV) and a facial arrangement of the 
methyl groups. The crystal structure of the dinuclear complexes confirms that the iodide 
ligand acts as a bridging ligand that holds the two platinum metal ions together. Figures 6.1 
and 6.2 illustrates the crystal structures of mononuclear [PtMe3(4-DMAP)2I] and dinuclear 
trans-[PtMe3(py)I]2, respectively.  
Chapter 6  Summary   
   
  107
 
 
Figure 6.1 Molecular structure of [PtMe3(4-DMAP)2I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
 
Figure 6.2 Molecular structure of trans-[PtMe3(py)I]2 showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms omitted for clarity. 
 
 
The reaction of the mononuclear [PtMe3L2I] (L = pyridines) complexes with [PtMe3I]4 in 
chloroform results in the formation of the corresponding dinuclear complexes (both cis and 
trans isomers) of pyridines (Scheme 6.2). Although the pyridine substituents have no 
significant influence on the crystal structures of either the mononuclear or the dinuclear 
complexes, the equilibrium population of these complexes in solution depends largely on the 
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electronic effect of the pyridine substituent as well as on the steric bulk of the pyridine 
substituent. An electron donating substituent such as NMe2 favours the mononuclear form 
over the dinuclear form. On the other hand, the dinuclear forms are more stable than the 
mononuclear forms for pyridines containing electron withdrawing substituents. The trans 
form is more stable than the cis form in all the dinuclear complexes of pyridines as the latter 
exhibit steric interaction among the pyridine ligands which is absent in the former case. With 
increasing steric bulk of the pyridine substituent the stability of the cis isomer also decreases 
in solution; however, steric interaction among the pyridine ligands in the cis dimeric form is 
less in the case of 3-substituted pyridines than in the case of 4-substituted pyridines.  
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Scheme 6.2 The reaction of an equimolar mixture of iodotrimethylplatinum and mononuclear [PtMe3L2I] (L= 
pyridines) leading to the formation of cis and trans dinuclear complexes. 
 
 
The weak Pt-N interaction in the mononuclear iodotrimethylplatinum(IV) complexes of 
electron withdrawing pyridines such as 4-CNPy, 3-BrPy also causes dissociation in solution 
resulting in the formation of dinuclear complexes and free pyridine ligands, thereby an 
equilibrium between these species is formed in solution. The extent of dissociation also 
depends on the concentration of the mononuclear complexes of electron withdrawing 
pyridines. 
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Scheme 6.3 The dissociation of mononuclear pyridine complexes of iodotrimethylplatinum(IV), showing the 
formation of dinuclear complexes. L = 4-CNPy, 3-BrPy. 
 
 
Iodotrimethylplatinum(IV) on treatment with 2,2´-bipyridine and its derivatives gives mono-
nuclear 2,2´-bipyridine complexes (Chapter 3). The EI-Mass spectra analyses of the 
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complexes gave the highest m/z value for the species [M-I]+, reflecting the mononuclear 
nature of the complexes. The 1H NMR spectrum of the complexes shows that the trans 
influence of 2,2´-bipyridine ligand depends on the electronic effect of the substituent. The 
crystal structure of the complexes, [PtMe3LI] (L = bipy, 4Me-bipy, 5Me-bipy, OMe-bipy, 
Me2N-bipy and Cl-bipy) confirms the fac-octahedral coordination of the PtMe3 moiety and 
the bidentate coordination of the 2,2´-bipyridines. Figure 6.3 shows the crystal structure of 
[PtMe3(OMe-bipy)I].  
 
 
 
Figure 6.3 Molecular structure of [PtMe3(OMe-bipy)I] showing the atom labelling scheme. Thermal ellipsoids 
are at the 50% probability level. Hydrogen atoms are omitted for clarity. 
 
 
Bond length comparison shows that Pt-N bond distances in bipyridine complexes are slightly 
shorter than in the corresponding pyridine complexes, reflecting the better π-acceptor 
character of the 2,2´-bipyridines. In addition, the N-Pt-N bite angle in the bipyridine 
complexes is much lower than in the pyridine complexes. However, the Pt-C, Pt-N and Pt-I 
bond distances in the complexes do not change significantly. In the crystal packing of 
[PtMe3(Cl-bipy)I], intermolecular non-covalent interaction between methyl hydrogen and 
chlorine atom leads to the formation of zig-zag chain structures, which are  linked through 
weak π-π interactions to form two-dimensional layer structure (Figure 6.4).  
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Figure 6.4 A perspective view of a two-dimensional framework structure of [PtMe3(Cl-bipy)I].     
 
 
The reaction of iodotrimethylplatinum(IV) complexes of pyridines (py, 4-MePy, 4-OMePy, 
4-DMAP) with the corresponding 2,2´-bipyridines (bipy, 4Me-bipy, OMe-bipy, Me2N-bipy) 
lead to the substitution of ligands resulting in the formation of chelate bipyridine complexes 
(described in Chapter 4).  
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Scheme 6.4 The substitution of pyridine ligands by the corresponding 2,2´-bipyridines in 
iodotrimethylplatinum(IV) complex.  
 
Pt
I
NMeA
MeB
NMeA
NMe2
NMe2
N
N
NMe2
NMe2
Pt
N
NMeE
MeE
NMeE
NMe2
NMe2
NMe2
N
NMe2
I +
+ Pt
N
NMeC
MeD
NMeC
NMe2
NMe2
NMe2
I +
[PtMe3(4-DMAP)2I]
[PtMe3(Me2N-bipy((4-DMAP)]I [PtMe3(4-DMAP)3]I
Me2N-bipy
4-DMAP
 
Scheme 6.5 The substitution of 4-DMAP by Me2N-bipy in iodotrimethylplatinum(IV) complex.  
 
The equilibrium for these substitution reactions strongly favours the formation of chelate 
products. The formation of chelate complexes in solution at equilibrium depends largely on 
the electronic effect of the substituent as well as on the nature of the solvent. 
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7 Zusammenfassung 
 
In dieser Arbeit wurden Iodidotrimethylplatin(IV)-Komplexe mit verschiedenen Pyridin- und 
2,2´-Bipyridin-Liganden untersucht. Schema 7.1 zeigt eine Übersicht der einzelnen Pyridin 
und 2,2´-Bipyridin-Liganden. 
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Schema 7.1 Übersicht der in dieser Arbeit verwendeten Pyridine und 2,2´-Bipyridine. 
 
 
Iodidotrimethylplatin(IV)-Komplexe von Pyridin und seinen monosubstituierten Derivaten 
werden in Kapitel 2 behandelt. Die Kristallstrukturen von sowohl mononuklearen [PtMe3L2I] 
(L = 4-DMPA, 4-MePy, 4-EtPy, 4-OMePy, 3-OMePy und 3-BrPy) als auch dinuklearen 
trans-[PtMe3(py)I]2 und cis-[PtMe3LI]2 (L = 4-EtPy, 4-OMePy, 4-CNPy und 3-ClPy) 
Komplexen zeigen eine oktaedrische Koordination des Platin(IV) und eine faciale Anordnung 
der Methylgruppen. Die Kristallstrukturen von dinuklearen Komplexen bestätigen, dass der 
Iodid-Ligand als verbrückender Ligand, der zwei Platin-Ionen zusammenhält, dient. Die 
Abbildungen 7.1 und 7.2 zeigen beispielhaft die Kristallstrukturen von mononuklearem 
[PtMe3(4-DMPA)2I] und dinuklearem trans-[PtMe3(py)I]2.  
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Abb. 7.1 Molekulare Struktur von [PtMe3(4-DMPA)2I]. Thermische Ellipsoide sind am 50% 
Wahrscheinlichkeitslevel. Wasserstoffatome wurden zur besseren Übersichtlichkeit weggelassen. 
 
 
 
Abb. 7.2 Molekulare Struktur von trans-[PtMe3(py)I]2. Thermische Ellipsoide sind am 50% 
Wahrscheinlichkeitslevel. Wasserstoffatome wurden zur besseren Übersichtlichkeit weggelassen. 
 
Die Reaktion von mononuklearen [PtMe3L2I]-Komplexen (L = Pyridin) mit [PtMe3I]4 in 
Chloroform resultiert in der Bildung des entsprechenden dinuklearen Pyridinkomplexes 
(sowohl cis- als auch trans-Isomer). Obwohl die Pyridinsubstituenten keinen signifikanten 
Einfluss auf die Kristallstruktur sowohl von mononuklearen als auch von dinuklearen 
Komplexen haben, hängt das Gleichgewichtsverhältnis beider Spezies in Lösung zu einem 
großen Teil von den elektronischen Einflüssen der Substituenten, sowie deren sterischem 
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Anspruch ab. Ein elektronenschiebender Substituent wie NMe2 zieht die mononukleare Form 
der dinuklearen vor. Auf der anderen Seite ist die dinukleare Form für Pyridine mit 
elektronenziehenden Substituenten stabiler als die mononukleare. Die trans-Form ist für alle 
dinuklearen Pyridinkomplexe stabiler als die cis-Form, da letztere sterische 
Wechselwirkungen zwischen den Pyridinliganden verursacht, die in der trans-Form nicht 
vorkommen. Mit steigendem sterischen Anspruch der Pyridinsubstituenten sinkt auch die 
Stabilität des cis-Isomers in Lösung. Die sterische Wechselwirkung zwischen den 
Pyridinliganden ist in der dimeren cis-Form bei 3-substituierten Pyridinen geringer als bei den 
4-substituierten. 
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Me
I
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L
L
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L
Me
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I
I
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L
Me
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I
I
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L
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trans-[PtMe3LI]2 cis-[PtMe3LI]2
4 n (1-n)+
 
 
Schema 7.2 Die Reaktion einer äquimolaren Mischung aus Iodidotrimethylplatin(IV) und mononuklearem 
[PtMe3L2I] (L = Pyridin), die zur Bildung von dinuklearen cis- und trans- Komplexen führt. 
 
 
Die schwache Pt-N-Wechselwirkung in mononuklearen Iodidotrimethylplatin(IV)-
Komplexen mit elektronenziehenden Pyridinen wie 4-CNPy oder 3-BrPy verursacht eine 
Dissoziation der Komplexe in Lösung, die in der Bildung von dinuklearen Komplexen und 
freien Pyridinliganden resultiert, wobei ein Gleichgewicht zwischen beiden Spezies in Lösung 
vorliegt. Der Grad der Dissoziation hängt auch von der Konzentration der mononuklearen 
Komplexe mit elektronenziehenden Pyridinen ab.   
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Schema 7.3 Die Dissoziation von mononuklearen Pyridin-Komplexen von Iodidotrimethylplatin zu dinuklearen 
Komplexen (L = 4-CNPy, 3-BrPy). 
 
Die Reaktion von Iodidotrimethylplatin(IV) mit 2,2´-Bipyridin und dessen Derivaten erzeugt 
mononukleare 2,2´-Bipyridin-Komplexe (s. Kap. 3). Die EI-Massenspektren dieser Komplexe 
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zeigten das höchste m/z Verhältnis für die entsprechenden [M-I]+ Spezies, was die 
mononukleare Natur dieser Komplexe reflektiert. Die 1H-NMR Spektren zeigen, dass der 
trans-Einfluss der 2,2´-Bipyridinliganden von den elektronischen Effekten des Substituenten 
abhängt. Die Kristallstrukturen der Komplexe [PtMe3LI] (L = bipy, 4Me-bipy, 5Me-bipy, 
OMe-bipy, Me2N-bipy and Cl-bipy) bestätigen die fac-oktaedrische Koordination des PtMe3-
Rests und die bidentale Koordination der 2,2´-Bipyridine. Die Abbildung 7.3 zeigt die 
Kristallstruktur von [PtMe3(OMe-bipy)I]. 
 
 
 
Abb. 7.3 Molekulare Struktur von [PtMe3(OMe-Bipy)I]. Thermische Ellipsoide sind am 50% 
Wahrscheinlichkeitslevel. Wasserstoffatome wurden zur besseren Übersichtlichkeit weggelassen. 
 
 
Ein Vergleich der Bindungslängen zeigt, dass der Pt-N Bindungsabstand in Bipyridin-
Komplexen leicht kürzer ist als in den entsprechenden Pyridin-Komplexen, was die besseren 
π-Akzeptor Eigenschaften von 2,2´-Bipyridinen zeigt. Des Weiteren ist der N-Pt-N Winkel in 
Bipyridin-Komplexen wesentlich kleiner als in Pyridin-Komplexen. Die Pt-C, Pt-N und Pt-I 
Bindungslängen der Komplexe ändern sich hingegen nicht signifikant. In der Kristallpackung 
von [PtMe3(Cl-bipy)I] führen intermolekulare, nicht kovalente Wechselwirkungen zwischen 
den Methyl-Wasserstoffatomen und den Chloratomen zu der Ausbildung von kettenartigen 
Zick-Zack-Strukturen, die über schwache π-π-Wechselwirkungen zur Ausbildung einer 
zweidimensionale Schichtstruktur führen (Abb. 7.4). 
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Abb. 7.4 Die zweidimensionale Gerüststruktur von [PtMe3(Cl-bipy)I]. 
 
Die Reaktion von Iodidotrimethylplatin(IV)-Pyridinkomplexen (py, 4-MePy, 4-OMePy, 
4-DMAP) mit den entsprechenden 2,2´-Bipyridinen (bipy, 4Me-bipy, OMe-bipy, Me2N-bipy) 
führt zu einer Substitution der Liganden, die in der Bildung von Chelat-Bipyridin-Komplexen 
resultiert (beschrieben in Kapitel 4). 
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Schema 7.4 Die Substitution von Pyridinliganden durch die korrespondierenden 2,2´-Bipyridine an 
Iodidotrimethylplatin(IV)-Komplexen (R = H, Me, OMe). 
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Schema 7.5 Die Substitution von 4-DMAP durch Me2N-bipy an Iodidotrimethylplatin(IV)-Komplexen. 
 
Im Gleichgewicht ist die Bildung des Chelatprodukts bei dieser Substitutionsreaktion stark 
bevorzugt. Die Bildung von Chelat-Komplexen in Lösung hängt im Gleichgewicht zu einem 
großen Teil von den elektronischen Effekten der Substituenten sowie von der Natur des 
Lösungsmittels ab. 
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8.2 Abbreviations 
 
Å    Angstrom 
α    alpha 
β    beta 
°    degree 
°C    degree celsius 
δ    chemical shift (NMR) 
γ    gyromagnetic ratio 
ħ    reduced Planck constant 
λ    X-ray wavelength 
1H      proton 
Abb.    Abbildung 
abpy    2,2´-azobispyridine 
Bo    external magnetic field 
BAB    1,2-bis(N-7-azaindolyl)benzene 
bipy    2,2´-bipyridine 
bipy N-Oxide   2,2´-bipyridine N,N´-dioxide 
br    broad signal (NMR) 
BrPy    bromopyridine 
bpym    2,2´-bipyrimidine 
CHIP    cis-dichloro-trans-dihydroxy-bis-isopropylamineplatinum(IV) 
Cl-bipy   4,4´-dichloro-2,2´-bipyridine 
Cl-bipy N-Oxide  4,4´-dichloro-2,2´-bipyridine N,N´-dioxide 
ClPy    chloropyridine 
cm    centimetre 
CNPy    cyanopyridine 
COSY    correlation spectroscopy 
D    diffusion coefficient 
d    doublet(NMR)  
dd    doublet of doublets (NMR) 
DCM    dichloromethane 
DMAP   dimethylaminopyridine 
dmas    (dimethylarsino)sulphide 
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DMF    N,N-dimethylformamide 
DMG    dimethylglyoxime 
DMSO   dimethyl sulfoxide 
DNA    deoxyribonucleic acid 
DOSY    diffusion ordered spectroscopy 
EI    electron ionisation 
en    ethylenediamine 
EtPy    ethylpyridine 
eV    electron volt 
EXSY    exchange spectroscopy 
fac    facial 
h    hour(s) 
Hz    hertz 
I    Nuclear Spin 
IR    infrared 
J    spin-spin coupling constant 
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